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Abstract
Interest in copper-based compounds in medicine is due to the fact that copper, unlike platinum and
gold, often employed in cancer chemotherapy, is a ubiquitous bioelement involved in several processes
of metabolic enzymes in living organisms. In addition, altered levels of intracellular copper are often
known to be related to both some genetic disorders and other serious pathologies such as prostate and
lung cancer. On the basis of this evidence, several therapies based on administration of copper salts in
the presence of chelating agents capable of transporting the bioelement have recently been developed.
Intracellular copper intake in living organisms is strictly regulated by a complex membrane protein system
with an active transport function. In humans, these proteins, hCTR1, are characterized by several
methionine- and histidine-rich aminoacidic sequences, putative binding sites for Cu(I). Several studies,
based on in vitro and competition experiments in solution between these substrates and monovalent Cu(I)
and Ag(I) and divalent Cu(II) and Zn(II), have demonstrated that these transport proteins have a specific
a nity for the unstable Cu(I) rather than for the more stable Cu(II) ion. Despite this, most research in
the past on the development of copper compounds with potential anti-tumor activity mainly focused on
Cu(II) derivatives. However, in the last few years scientific attention has also been devoted to Cu(I)
compounds. In particular, a new class of Cu(I) compounds with hydrophilic phosphines, characterized
by both high thermodynamic stability and good solubility in aqueous solution (see figure below), has
recently been proposed. Among these compounds, the monodentate species exhibit good to moderate
cytotoxic activity in vitro, whereas the activity of the chelate complex and that of the free phosphines
are negligible. The cytotoxic activity of Cu(I) complexes seems to be linked to the complex abilities
of binding biological substrates after dissociation of one or more phosphine ligands. Matching this
suggestion, some preliminary ESI-MS experiments show that, at the high dilutions required by in vitro
and MS experiments (10 5   10 6 mol/L) the chelate complex (1) retains its tetracoordination, whereas
complexes including monodentate phosphines (2), (3) are partially dissociated. This result reveals the
importance of obtaining more information about the Structure/Stability-Activity Relationship (SSAR)
of these compounds in biological environments. With this aim, our work focused on two main topics:
1) study of the formation equilibria of Cu(I) complexes with PTA in aqueous solution; 2) extension of
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study to the formation of analogous complexes of Ag(I). This cation is isoelectronic with Cu(I) and may
form phosphine complexes with similar cytotoxic activity. In order to carry out this study, a series of
microcalorimetric, spectrophotometric and potentiometric experiments was designed to find the stability
constants and thermodynamic functions (DG, DH, DS) concerning the formation of both Cu(I)- and
Ag(I) - PTA complexes in solution. In addition, for more information on the interactions of Cu(I) and
Ag(I) with residues present in the binding sites of copper-transport membrane proteins hCTR1, solution
studies were extended to the interactions between Cu(I) and Ag(I) and the amino acids methionine and
histidine. To date, there are very few studies on this topic, although they are essential to acquire the
necessary information to clarify the still not fully understood mechanisms of intracellular copper intake.
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CHAPTER 1
Introduction
1.1. The use of metal-based compounds in medicine
Since the early 1970s, following the discovery of the anti-tumor properties of cisplatin,
several metal-based compounds have been developed as potential anticancer agents.
The anti-tumor neoplastic activity of a metal compound depends on the nature of the
metal itself, its oxidation state, and coordination chemistry: the coordinative mechanisms
which occur in vivo between the metal cation and the biological substrates are the key
processes of the biological activity of these compounds, the chemistry of which cannot
be mimicked by organic compounds. Among several metal-based compounds, those of
platinum(II) have been the most frequently used in the clinical treatment of several types of
cancers, including those of the genito-urinary and colorectal tracts and non-small cell lung
cancers [1, 2]. As an ancestor of platinum-based drugs, cis-diamino dichloro platinum(II),
commonly known as cisplatin (figure 1.1) has been used for decades in clinical practice, in
view of its remarkably efficacy in the treatment of several neoplastic diseases, particular
those of the genito-urinary tract [3].
Pt
H3N Cl
ClH3N
Figure 1.1.: Structure of cisplatin.
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However, the efficacy of cisplatin is severely limited by several serious drawbacks [4]:
several cancers have intrinsic resistance to treatment with this drug, whereas acquired
resistance is observed after early treatment cycles in other clinical cases [5, 6]. In addition,
collateral toxicity is the factor that most limits the use of cisplatin: nephrotoxicity and
neurotoxicity are particularly important [7]. Lastly, the poor solubility of cisplatin is
another problem which makes its administration difficult.
In view of these considerations, thousands of alternative platinum-based compounds as
potential anticancer agents have been studied and developed in the last few decades [5, 8, 9].
Several complexes of group 11 metal cations have also been studied, including gold(I),
gold(III) and copper(II) compounds. In particular, Auranofin, a thioglucose derivative of
triethylphosphine gold(I) used as an anti-arthritic drug [10], showed in vivo anti-tumor
activity against P388 leukemia when tested on a panel of murine models [11]. With the aim
of finding new compounds with cytotoxic activity toward a wider range of cancer diseases,
P. Sadler et al. tested the toxicity of a series of monocationic bis-diphosphine gold(I)
compounds, such as [Au(dppe)2]Cl, toward a panel of human tumor cell lines including
M5076 reticulum cell carcinoma, B16 melanoma and P388 leukemia [12, 13]. The results of
the trials indicated that these gold(I) derivatives have good cytotoxicity toward the cell
lines tested and, remarkably, higher drug tolerance profiles compared with those of cisplatin.
These encouraging results paved the way for research on new gold-based compounds as
potential anticancer drugs and, as a rational extension, also on copper(II) and copper(I)
derivatives. Researches on copper compounds for clinical use, are also aimed by the fact that
copper, unlike platinum and gold, is an endogenous metal cation. As it will be discussed in
the next section, copper is a fundamental cofactor of several metalloproteins and is involved
in several metabolic processes. Therefore, due to the ubiquity of copper in our organism,
the copper-based drugs potentially have a wide spectrum of biological substrates to target,
unlike those of platinum and gold, which exert their cytotoxic activity toward a relatively
small number of biomolecules.
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CuICuI CuICu(I)
linear trigonal tetrahedral
CuII CuII CuII CuIICu(II)
square planar square pyramidal trigonal
bipyramidal
octahedral
Figure 1.2.: Most common coordinative geometries in Cu(I) and Cu(II) complexes. Most favored
Cu(I) geometries are linear (CN = 2), trigonal (CN = 3) and tetrahedral (CN = 4). Cu(II) forms
tetracoordinate complexes (CN = 4), usually with square-planar arrangement. Other common
geometries are square-pyramidal and trigonal bipyramidal (CN = 5) and octahedral (CN=6).
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1.2.1. Inorganic chemistry of copper compounds
Copper is the 29th element of the periodic table and the first of the three transition
metals of the group 11, further including silver and gold. Cu(I) and Cu(II) are the two
most important and common oxidation states in compounds of this metal, although some
examples of Cu(III) and Cu(IV) compounds are known too [14].
The chemistry of Cu(I)
Cu(I) and Cu(II) have both the typical behavior of soft cations (for more details see
appendix section B on page 105). Cu(I) has a d10 electronic configuration, and strongly
prefers to form covalent compounds with neutral or low-charged anionic ligands containing
sulfur-donor groups, such as thiolates and thioethers, aromatic sp2 amines and phosphines.
Due to the d10 configuration (which corresponds to a ground state term 1S), Cu(I) com-
pounds typically show diamagnetic properties and are generally colorless, except if the
ligand itself is colored or if color derives from charge-transfer bands. The relative stabilities
of Cu(II) and Cu(I) are indicated by the following potential data:
3
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Cu+ + e  = Cu, E0 = 0.52V (1.1)
Cu2+ + e  = Cu+, E0 = 0.153V (1.2)
whence:
Cu + Cu2+ = 2Cu+, E0 =  0.37V, K = [Cu
2+]
[Cu+]2
= 106 (1.3)
As implied by the last expression, in aqueous solutions only low equilibrium concentrations
of Cu(I) (< 10 2 M) can exist. The chemical equilibrium between the two species strongly
depends on the nature of the solvent, and on the nature of the ligands and coordinating
anions present in solution. For example, Cu(I) in aqueous environments is known to be
stabilized by chloride anions (> 0.1 M), with which it forms a series of stable chloro
complexes [15], as reported in equation (1.4):
Cu+ + nCl  = [CuCln]1 n; n = 1  3 (1.4)
In these complexes, the Cu(I) center has the typical linear or trigonal coordinative geome-
tries. Another example is the stabilization of the Cu(I) oxidation state in an acetonitrile
solution: in this solvent Cu(I) is highly stabilized by formation of a tetracoordinate adduct
with the –CN group of acetonitrile. This complex has a characteristic tetrahedral geometry
and can be isolated as a solid compound with formula [Cu(MeCN)4][X], where X is a
non-coordinating anion such as ClO 4 , [BF4] , [PF6]  [16].
The chemistry of Cu(II)
Most Cu(I) compounds are easily oxidized to Cu(II) compounds, which are more stable.
The aqueous solution chemistry of Cu(II) is well-known, and a large number of salts, many
of which are water-soluble, exist in addition to a wealth of complexes. In water solutions
Cu(II) forms stable complexes with both amines and carboxylate organic anions. Several
4
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examples of Cu(II) chloro complexes, weaker than those of Cu(I), are also known.
Stereochemistry and properties of Cu(II) compounds. The d9 configuration makes
Cu(II) subject to Jahn-Teller distortion: according to the Crystal Field Theory, a Cu(II)
ion placed in a field with cubic symmetry (i.e., regular octahedral or tetrahedral) undergoes
deep modifications in its stereochemistry. In a strong octahedral field, d-valence orbitals are
split into a doubly degenerate (ground state) set and a triple-degenerate set. When Cu(II)
is six-coordinated, the octahedron is severely distorted. The most frequently observed
effect is elongation along one fourfold axis, leading to coordinative geometry characterized
by a planar array of four short and two long Cu(II)–ligand bonds. In the limit case, the
elongation leads to the removal of the apical ligands, with the formation of a tetracoordinate
square-planar complex.
Due to the Jahn-Teller distortion, a characteristic absorbance band corresponding to the
transition eg ! t2g is generally observable in the region between 600 and 900 nm. This
absorption gives to Cu(II) complexes their typical blue or greenish colors.
Another important characteristic of Cu(II) compounds is their paramagnetic behavior in
a magnetic field. This is due to the presence of an unpaired electron in the d9 configuration.
The magnetic moments of simple Cu(II) complexes (those lacking Cu–Cu interactions) are
generally in the range of 1.75 to 2.20 BM, regardless of stereochemistry and independent of
temperature, except at very low temperatures (< 5 K) [16].
Aqueous chemistry and complexes of Cu(II). Most Cu(II) salts dissolve easily in water,
giving the aqua ion [Cu(H2O)6]2+. Addition of ligands to such aqueous solutions leads to
the formation of complexes by successive displacement of water molecules. For example,
it is known that Cu(II) in aqueous solution forms up to four complexes with ammonia:
[Cu(H2O)6]2+ + nNH3   [Cu(NH3)n(H2O)6 n]2+, n = 1–4. Due to the Jahn-Teller effect
Cu(II) does not bind fifth and sixth ammonia molecules in octahedral complexes. Stepwise
stability constants for to the formation of 5– or 6– coordinate Cu(II) complexes with
different ligands are consequently characterized by very low values. reflecting the weak
nature of complexes of these species.
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1.2.2. Biochemistry of copper uptake and its distribution
Copper is an essential trace element common in all living organisms. It is present as a
cofactor in several metalloproteins with enzymatic functions: its unique redox chemistry,
based on the easily reversible couple Cu(II)/Cu(I), is crucial for several biochemical processes,
including iron trafficking, DNA synthesis and mitochondrial respiration [17]. Copper is
also found in several enzymes, such as cytochrome oxidase and ascorbate oxidase, and is
also present in superoxide dismutase (SOD), the biochemical role of which, as the name
implies, is to catalyze the dismutation of superoxide ions. This task in particular is very
delicate, because it involves the production of free radicals and reactive oxygen species
(ROS) which, if not properly handled by the enzymatic systems, can cause serious damage
to several biological substrates, including lipid peroxidation in membranes, direct oxidation
of proteins, and cleavage of DNA and RNA chains. Copper levels in human organism
therefore need to be strictly regulated by several homeostatic mechanisms, in order to
ensure a proper intracellular supply of the metal without reaching toxic concentrations.
At the protein level, two families of membrane proteins control copper homeostasis [18]:
copper excretion is governed by the ATP-dependent pumps ATP7A and ATP7B [19, 20],
and copper uptake is mediated by the copper transport proteins (Ctr). This family of
transporters is widely present in all eukaryotic organisms. In humans, protein hCtr1 consists
in a chain of 190 amino acid residues arranged in a main intermembrane domain of three
alpha helices (3TMDs) [21, 22] with amino and carboxyl groups located on the opposite
sides of the hydrophobic membrane environment.
The homotrimeric structure of the three TMD domains of hCtr1 has recently been
resolved [18]. TMD2, which is crucial for copper binding, has a conserved “Mets” motif, a
methionine-rich sequence of the form MXXXM, where M is a methionine residue and “X”
indicates one of several other amino acids. Various studies concur that this aminoacidic
cluster is a critical site for copper uptake [23, 24].
The extracellular domain of hCtr1 is composed of a N-terminal tail of 66 amino acids
containing two Mets methionine-rich motifs, whose thioether groups are binding sites for
the biometal, and also histidine residues, which may also be putative binding sites for
copper. The cytosolic portion presents a His-Cys-His sequence which XAS study indicates
6
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Cu+$
Cu+$
Cu+$ Cu+$Copper 
chaperone 
“Mets” motifs 
His/Cys motifs Cuproenzymes 
Figure 1.3.: Sketch of mammalian copper transport protein (Ctr1). Mets sequences in extracellular
tail bind Cu(I) through histidine and methionine groups, thus stabilizing cation in monovalent state.
Cu(I) is transported inside cell, where it is bound by cysteine/histidine motifs which pass metal to
a copper chaperone which finally delivers copper to cytosolic metalloproteins.
is a coordination site for copper via cysteine residues, or histidine if cysteine is not present
[25].
According to the current hypotheses [26, 27], Ctr1 specifically binds the monovalent Cu(I)
rather than Cu(II), with the methionine residues of the Mets motifs in the extracellular
domain. The cuprous cation passes through the 3TMD domains and is coordinated by the
cysteine/histidine residues of the intracellular tail. The membrane protein then releases the
metal to the cytosolic copper chaperones, which deliver the biometal to the cuproenzymes
[28, 29] (sketch in figure 1.3).
Methionine residue is known to be a prominent binding site for a metal cation with soft
properties such as Cu(I), which prefers coordination through the sulfur-donor group rather
than oxygen- and nitrogen-containing ligands [30]. Since Cu(II) the thermodynamically
stable copper species in aqueous environments, it is still not completely clear why biological
systems choose to acquire copper in its monovalent state. In a biological perspective,
one explanation is the need to achieve high specificity toward copper rather than other
metals present in aqueous environments, to ensure close regulation of the bioelement.
Biological binding sites such as the thiolate and thioether groups do show high specificity
7
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toward monovalent soft cations such as Cu(I), which are relatively uncommon in aqueous
environments, whereas divalent cations such as Cu(II) and Zn(II), the coordination chemistry
of which is similar, are more common, so that specificity toward a particular divalent cation
is lower. Matching this observation, experiments on yeast have shown that Cu(II) is reduced
to Cu(I) prior to its intracellular acquisition [31]. A recent study in solution also proved
that methionine-rich Mets sequences bind monovalent cations Ag(I) and Cu(I) selectively,
rather than the divalent Zn(II), and no competition is observable between divalent and
monovalent cations [21].
Once the cell membrane has been passed, copper ions are bound by cytosolic chaperone
proteins which play a crucial role: on one hand, they must bind the metal cation tightly
enough to avoid its premature release into the cytosolic environment; on the other, they
must do so quite weakly, to allow the chaperone to exchange the biometal for the target
metalloproteins where copper is required. Many studies confirm the critical role of the
several specific chaperones in copper delivery [32]. It should be noted that, although this
task requires fine tuning of the coordinative properties of the copper binding site, the
number of possible amino acid residues capable of binding copper is rather limited: the list
includes the methionine thioether group, cysteine thiolate, histidine imidazole nitrogens,
and the carboxylate group of aspartate and glutamate. Interestingly, copper can form
an arene-complex with an aromatic ring such as that of a tryptophan residue [33]. Less
common are examples of complexes with the serine hydroxyl group and tyrosine phenolic
oxygen [34]. In addition to the various chemical properties of the ligand groups themselves,
copper trafficking proteins possess complex secondary structures which can finely tune
coordination sites, for selectivity and a suitable affinity for the metal [34]. In fact, as in the
more general context of inorganic chemistry, copper ions also have different coordinative
geometries in biological environments. For instance, the most common arrangements of
Cu(I) in some cupro-enzymes include dicoordinate linear complexes with two cysteinate
residues in Atx1 (see figure 1.4 a) [35], trigonal distorted geometry presumed for the
Cu(I) core in the mitochondrial assembly protein, SCO1 (fig. 1.4 b) [36], and a distorted
tetrahedral arrangement in the periplasmic copper binding protein Cusf in prokaryotic cells
(fig. 1.4 c).
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Figure 1.4.: Examples of coordinative geometries of copper found in biological adducts: (a) linear
geometry in cysteinate-copper adducts in Atx1; (b) trigonal complex of copper with two cysteinate
residues and a histidine (presumed structure in SCO1 protein); (c) distorted tetrahedral geometry
in Cusf prokaryotic binding proteins)
1.2.3. Copper and human health disorders
Copper, like iron and zinc, is one of the various trace elements required by our organism
for several biological processes. However, as previously noted, due to the critical role played
by copper in oxidation processes involving the production of ROS, its intracellular levels
must be closely regulated. For instance, in Esherichia coli models, homeostatic levels of
Fe(III) and Zn(II) cations are known to be allowed to reach concentrations within 100
mmol/dm3, whereas copper must be strictly maintained below 100 mmol/dm3. Disrupted
copper homeostasis, which is often due to genetic dysfunctions of some of the various
mechanisms of intake, transport, delivery and excretion, can lead to serious disorders, such
as Menkes’ and Wilson’s diseases, caused respectively by decreased and enhanced systemic
copper acquisition. Other pathologies, such as the neurodegenerative Alzheimer’s disease
and some cancer malignancies are related to altered copper levels in the human organism
[37].
The Wilson’s Disease (WD)
Wilson’s disease is an autosomal recessive genetic disorder, caused in the ATP7B gene,
which encodes for a copper transport protein, located in the trans-Golgi network, and
involved in copper excretion into bile [38, 39]. The main pathophysiology linked to copper
toxicity in the development of WD includes copper-mediated oxidative damage, activation
of cell death pathways, and release of copper in the plasma pool into extra-hepatic tissues.
As a consequence, general increment of copper levels in liver is observed, while the levels of
ceruloplasmin (Cp) protein, which is the main copper transport protein in blood, decrease
9
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Figure 1.5.: Copper chelators used in clinical WD treatment.
as an effect of the diminished function of the ATP7B protein [40].
Therapies for patients with WD include oral administration of chelating agents to capture
the copper excess. In particular, three compounds, d-penicillamine, trientine and ammonium
tratrathiomolybdate (figure 1.5) are used to treat WD [41] of patients with symptoms of
hepatic insufficiency or chronic active hepatitis. D-penicillamine was the first drug to be
used, but it has several limitations due to its toxic side-effects [41, 42]. Although trientine
and ammonium tetrathiomolybdate have fewer potential side-effects, they must still be
carefully monitored. A second generation of tetrathiomolybdate with chinoline (fig. 1.5)
has been reported to stabilize the disease, primarily by SOD inhibition [43, 44].
The Menkes’ Disease (MD)
Menkes’ disease (MD) is a genetic disorder caused by dysfunction in the ATP7A gene
encoding for ATPase, a copper transport protein [45]. ATPase is a pump protein which
plays the role of transporting copper into the trans-Golgi network. Copper is then delivered
to the proper copper enzymes, including dopamine-b-hydroxylase; ATPase is also involved
in copper excretion from the cell. As a result of the mutation in the ATP7A gene, copper
excretion and trafficking mechanisms are greatly altered, leading to copper accumulation in
peripheral tissues in the form of copper metallothionein.
Patients with MD undergo progressive neurological impairments due to copper deficiency
in the brain. Although in MD patients unaltered mechanisms of copper uptake and excretion
in liver are observed, as well as normal levels of hepatic cuproenzymes, copper absorption in
gastrointestinal tract is greatly decreased. In particular, diminished uptake of the metal in
the intestinal tract results in a shortage of exchangeable copper and therefore a deficiency
of copper proteins, which play critical roles at developmental level [46].
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The most frequent clinical treatment for MD patients consists of intravenous or subcuta-
neous administration of copper salts, to compensate for copper deficiency due to decreased
uptake [47]. A further identification of the copper-histidine system in normal human
serum and acquired knowledge about its biochemistry and physiological significance led to
treatment of MD with copper-histidine formulations [43, 48]. Although most of the copper
in human serum is bound to Cp even when not in an exchangeable form, the formation of
the albumin-copper-histidine ternary complex provides the actual carrier necessary for the
regulation and control of copper transport across the cell membrane [43, 48].
The Alzheimer Disease (AD)
Alzheimer’s disease is a well-known neurodegenerative disease, characterized by pro-
gressive patterns of cognitive and functional impairments. Altered levels of copper in the
human organism have been related to the physiopathology of AD: one study reports that
elevated free copper plasma concentrations were found in AD patients [37], and increased
concentrations of copper have also been found in cerebrospinal fluid together with normal
plasma copper levels [49].
Although copper is known to be involved in the development of degeneration, its role it
is not completely clear. A prominent suggestion about copper involvement in AD may be
via its interaction with amyloid precursor protein and b-amyloid peptide in self-aggregating
plaques and neurofibrillary tangles, which may contribute to the pathogenesis of the disorder
via cellular oxidative stress [50, 51]. Copper can induce aggregation of amyloidogenic peptide
and the production of ROS, which oxidize b-amyloid peptide [52]. Patients with AD reveal
extracellular deposition of Ab peptides in senile plaques and intracellular accumulation of
hyperphosphorylated t-protein in neuronal cells as neurofibrillary tangles [43].
Treatment for AD consists of the administration of copper chelators to sequester copper.
In particular, some derivatives of 8-hydroxy quinoline (see figure 1.6), i.e., P-OHQ, have
recently been proposed [53]. It has been proven that these compounds act as strong
tetradentate ligands toward divalent cations such as Cu(II) and Zn(II) and they have been
assessed as potential metal-chelating agents in AD treatment.
A recent study suggested that P-OHQ chelates can dissolve Ab deposits by removing
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Figure 1.6.: Chemical structure of P-OHQ.
copper from amyloid aggregates [53]. P-OHQ can also inhibit the production of hydrogen
peroxide induced by the formation of copper adducts with Ab proteins, and involved in the
toxicity of the peptide [54].
1.3. The role of biologic copper in cancer and copper-based
anticancer drugs
Cancer diseases are generally accompanied by significant changes in metabolic rates in
cells. Such altered states have been related, among other factors, to deregulated copper
handling by proteins involved in the uptake and trafficking of copper ions [55]. Since
down-regulated cell respiration has been found in many types of cancer, the involvement
of copper in angiogenesis is under investigation [43], and many Cu(II) chelate compounds
showing cytotoxic activity have been extensively developed in the last few decades [50].
In general, copper-based drugs show a wide range of various biological pharmacodynamics
and thus possible diverse mechanisms lying behind their cytotoxicity: for example, chelate
compounds of curcuminoids significantly reduce solid tumors in mice. Complexes of pyridine-
2-carbohydrazide have quite prominent cytotoxic activity against colon cancer cell lines,
according to a mechanism which inhibits the expression of c-Src, a non-receptor tyrosine
kinase involved in the growth-mediated signaling pathway [56]. The varying biological
activity of these copper-based drugs, compared with those of the well-praised platinum ones,
not only implies diverse pharmacodynamics but also a considerable spectrum of biological
targets. As previously mentioned, this is not surprising, in view of the ubiquity of copper
in our organism and its many biological roles. In general, platinum-based compounds
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interact with DNA, inducing crosslinks, whereas copper compounds more probably interact
with enzymes and inhibit vital cell functions. The next sections provide some examples of
copper-based drugs with potential anticancer activity and the biological targets with which
they interact.
Copper compounds as proteasome inhibitors.
Proteasome is a large protein complex present in both the nucleus and cytosol of cells.
It represents the main part of a biological enzymatic system which is used by eukaryotic
organisms to regulate intracellular levels of proteins. The role of proteasome is to catalyze
the hydrolytic degradation of unneeded or damaged proteins. Prior to being degraded,
proteins are “flagged” by a ubiquitin tail, a chain of 76 amino acid residues. The flag
is used by proteasome to identify the protein and to start hydrolysis. Proteasome is
essential for many cellular roles, including response to oxidative stress, regulation of gene
expression and induction of apoptosis [57, 58]. Deregulated function of the ubiquitin-
proteasome system may lead to accumulation of unwanted proteins and to the incapability
of eliminating damaged proteins with aberrant functions. Therefore, inhibition of the
proteasome-ubiquitin pathway may be a key factor for the anti-tumor activity of a drug.
Several studies in the field of medicinal bioinorganic chemistry have established a rela-
tionship between proteasome inhibition, cancer and copper, so that a new class of so-called
organic copper compounds has been developed in the last ten years [59]. In these drugs,
copper is coordinated either to neutral heteroatomic molecules such as phenanthroline, or
to anionic organic ligands such as 8-hydroxyquinolinate, pyrrolidine dithiocarbamate or
(pyridine-2-yl methylamino) methyl phenolate (fig. 1.7). These compounds are efficient
inhibitors of the chymotrypsin-like activity of proteasome, whereas the free ligands in
themselves are not particularly good inhibitors. This result shows that copper plays a
crucial role in the proteasomal function inhibition induced by these compounds. It has also
been found that organic complex formation is essential for copper uptake and transportation
in cells [60].
More recently, some new ternary copper complexes with 1,10-phenanthroline and indole-
3-acetate (fig. 1.8) have been reported as potential anticancer agents acting via proteasome
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Figure 1.7.: Ligands used to design Cu(II) organic compounds with proteasomal inhibitor functions.
H
N
O
O
Cu
H
N
O
O
N N
Figure 1.8.: chemical structure of bis-indole acetate phenanthroline Cu(II), a novel potent inhibitor
of proteasome activity and apoptosis-inducer.
inhibition [61]. It has been found that this complex is a potent inhibitor of the proteasomal
activity and induces apoptosis in MDA-MB-231 human breast cancer cells.
Copper and angiogenesis
Angiogenesis is the biological process of creation of new blood vessels from the existing
vascular bed. In normal health conditions this is a tightly regulated process and its up-
regulation is usually interpreted as a signal of a pathological condition. Angiogenesis is
an essential process for cancer development and metastasis [62], since the creation of new
vessels is essential for the diffusion of tumors during the metastatic process. On this basis
have been developed in the last decades several therapies based on anti-angiogenetic drugs.
Among different strategies several drugs that could act as potential copper scavengers have
been developed. It is known that copper deficiency can inhibit angiogenesis, preventing the
growth of tumor cells or an inflammation to spread [50], but, since the role of copper in the
angiogenetic process is not yet fully understood, further research is needed for this purpose.
Anyway copper was found to be a cofactor required by several angiogenetic mediators,
including Vascular Endothelial Growth Factor (VEGF), basic Fibroblast Growth Factor
(bFGF), and Interleukine 1 and 8 (IL-1, IL-8) [63–65].
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Copper compounds in cancer chemotherapy
The first treatments of several types of cancer have been made with copper chelators
such as 8-OHQ and tetrathiomolybdate derivatives, known to be copper-scavengers and
yet successfully employed in Wilson disease treatment. These compounds were reported
to be of therapeutic value in the treatment of several types of cancer diseases, for their
anti-angiogenetic and anticancer effects.
Binary Cu(II) complexes. Several binary complexes of Cu(II) with N, O or S donor
ligands have been synthesized and their biological activity tested.
The binary complex 2,6-bis(benzimidazo-2-yl)pyridine Cu(II) chloride exhibit a cyto-
toxicity through metalloprotease activity [66]: experiment showed that the complex binds
bovine serum albumin causing site-specific cleavages, in the protein when the system is
incubated in atmospheric conditions. The cleavage and thus the biological activity seem to
be related to the activation of dioxygen by the metal bound to the protein.
A series of copper(II) complexes with thiosemicarbazone derivatives have been reported to
inhibit enzymatic activity of DNA ribonucleotide diphosphate reductase and to induce cell
apoptosis, thus suggesting these derivatives are potential anticancer drugs [67]. Similarly
Cu(II) nitrophenone thiosemicarbazone complexes have been found to show cytotoxic
activity against tripanosoma in vitro.
Ternary Cu(II) complexes. Several Cu(II) ternary complexes bearing one or two N, N-
and N, O- bidentate ligands have been synthesized and their biological activity tested. In
these complexes, copper binds a N, N-donor chelate ligand such as 1,10-phenanthroline or
2,2’-bipyridine and a N, N- or a O, O- chelate ligand such acetyl acetonate or glycinate.
Such class of compounds exhibits antineoplastic activity against a variety of tumor cell
lines both in vitro and in vivo. It has been found that they interact with mitochondria
of both healthy and tumor cells inhibiting the oxidative phosphorylation process and the
mitochondrial respiration [68]; moreover they exhibit high affinity towards plasmid, genomic
and internucleosomal DNA.
Finally a number of complexes of Cu(II) with Schiff bases derivatives and 2-amino-2-
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Figure 1.9.: Examples of Cu(I) – diphenyl phosphine chelate compounds prepared in the last
decades and tested ad anticancer agents in vitro.
thiazoline have been reported to show significant anti-inflammatory and anticancer activity
against various cell lines [69].
1.3.1. Cu(I) phosphino complexes as anticancer agents
Most of the research done until now on the design of new copper compounds with potential
anti-tumor activity has been mainly focused on Cu(II) derivatives, more likely than on Cu(I)
ones, even if the experimental evidences, yet discussed in the previous sections, confirm that
copper is acquired by cells, and trafficked, in its monovalent oxidation state. According to
that, Cu(I) derivatives might be indeed of interest as prominent anticancer drugs. However,
Cu(I) derivatives are generally unstable in aqueous environments, especially in the presence
of potentially oxidant species that can promote Cu(I) oxidation. Cu(I) complexes designed
in order to obtain anticancer drugs, should bear ligands able both to strongly bind Cu(I), in
order to stabilize it in its monovalent state, and meanwhile to ensure a good hydrosolubility
to the whole metal compound.
With this aim, several phosphino Cu(I) compounds of the type [Cu(P–P)2][Cl] P–P
= dppe: 1,2-bis(diphenylphosphino)ethane, dppp = 1,2-bis(diphenylphosphino)propane,
dppey = 1,2-bis(diphenylphosphino)ethylene, were designed in these last decades (figure
1.9). These compounds showed cytotoxic activity against several tumor cell lines, including
B16 melanoma, P388 leukemia, and M5076 reticulum cell carcinoma [13, 70].
Despite the encouraging results obtained by the preliminary in vitro assays, the presence
of a number of phenyl groups appended to the phosphorous atom determined a strong
lipophilic character to the resulting metal complexes, thus causing undesired toxicity in
animal models and precluding clinical trials in humans [71].
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Figure 1.10.: Structures of the Cu(I) phosphino complexes recently prepared as anti-tumor agents.
1.4. Recent Cu(I) phosphino complexes with potential
anti-tumor activity, and introduction to the present work
In order to obtain Cu(I) compounds with potential anticancer activity, characterized
by higher hydrophilicity and lower systemic toxicity in vivo than the diphenylphosphine
chelate derivatives previously studied, Tisato et al. [72] prepared a new class of tetra-
coordinated Cu(I) complexes with monodentate or chelate phosphine ligands (fig. 1.10).
These compounds proved to be easier to handle during in vitro tests and, more importantly,
retained their cytotoxic activity against a panel of human tumor cell lines.
These complexes are bis-substituted or tetra-substituted derivatives [Cu(bhpe)2][PF6] and
[Cu(thp)4][PF6], [Cu(PTA)4][PF6] (bhpe = bis[bis(hydroxymethyl)phosphino] ethane), thp
= tris(hydroxymethyl)phosphine, PTA = 1,3,5-triaza-7-phosphaadamantane) (see Figure
1.10). They are examples of fully phosphinated Cu(I) compounds, perfectly soluble in
aqueous solutions. Phosphinic hydrophilic ligands are also characterized by high stability
in aqueous environments and low cytotoxicity. The metal ion coordination sphere of these
complexes, as assessed both in the solid state by X-ray crystallographic analyses and
in solution by multinuclear NMR spectroscopy, is identical, presenting four equivalent
phosphorus donors in a tetrahedral arrangement. However, the in vitro cytotoxic activity
of the above complexes is very different: (1) in the figure exhibits negligible cytotoxicity
[73], whereas (3) and (2) respectively show moderate and good cytotoxic activity in vitro.
In particular compound (2) is an effective anti-tumor agent toward various tumor cell lines,
including cisplatin-resistant ones [73].
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Preliminary physicochemical characterization of these tetracoordinate Cu(I) compounds
was made by electron spray ionization mass spectrometry (ESI-MS). The results obtained
with this technique were not consistent with some NMR experiments. As a matter of
fact, NMR studies showed that Cu(I) is always tetracoordinated (to four monodentate
ligands in (2), (3) (Figure 1.10) or to two bidentate chelate ligands in (1)) in aqueous
solutions and at the relatively high concentration required by this technique (10 2   10 3
M). The fragmentation patterns of the complexes in ESI experiments indicated that, at ESI
concentrations (10 5   10 6 M), chelate complex (1) retains its tetracoordinate “CuP4”
arrangement, whereas monodentate complexes (2) and (3) are partially dissociated to
lower stoichiometry species [72].
A further UV-Vis spectrophotometry study carried out in acetonitrile (AN) [72] gave
a convincing interpretation of the difference between the results obtained by the two
techniques, and deeper insight into the differing in vitro cytotoxicity of these compounds.
Speciation plots, calculated by the formation constants of the complexes [Cu(PTA)n]+
(n = 1–4) in AN showed that, although very strong, [Cu(PTA)4]+ complex is partially
dissociated at high dilution. In particular, the much more stable chelate complex (1) (fig.
1.10) is not dissociated and, having all its coordination sites occupied, is characterized by
modest cytotoxic activity in vitro. Conversely, complexes (2) and (3), monodentate and
less stable, can dissociate at high dilutions one or more of the phosphinic ligands thereby
allowing copper to interact with biologically important substrates. This is a convincing
demonstration that studies of this type, giving an accurate description of the relative
stabilities of the complexes in the prevailing conditions of use, should always integrate the
design of new metal-based compounds with potential therapeutic effects.
Given the attractive cytotoxic properties shown by [Cu(thp)4]+ and [Cu(PTA)4]+, the
synthetic and biological studies of Cu(I) phosphine compounds have been recently widen
to isostructural Ag(I) and Au(I) analogs [74]. Three series of water soluble complexes,
namely [M(thp)4]+, [M(PTA)4]+, [M(thpp)4]+ (thpp = tris(hydroxyphosphyl)phosphine),
have been prepared (Fig. 1.11), in order to obtain metal derivatives with steric-electronic
as well as hydrophilic-lipophilic properties which could be tuned by modification of the
ligand. These new derivatives were tested as cytotoxic agents against a panel of several
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Figure 1.11.: Structures of the coinage metal-phosphine complexes recently synthesized (M =
Cu+, Ag+, Au+).
human tumor cell lines also including a defined cisplatin resistant cell line. The best results
in term of in vitro anti-tumor activity were achieved with the metal-thp derivatives and,
among the coinage metal complexes, copper derivatives proved to be the most efficient [74].
Aim of the work
The first aim of this research focused on two main objectives: 1) to extend the study on
formation equilibria of [Cu(PTA)n]+ complexes (Figure 1.12) in water, and 2) to amplify
studies to novel compounds of Ag(I). Ag(I) is isoelectronic with Cu(I), therefore the two
cations should have similar coordination chemistry and their compounds characterized
by comparable cytotoxic activity. This notwithstanding, studies on the speciation and
biological activity of Ag(I)–phosphine complexes, similar to those of Cu(I) already tested,
are not reported in literature to the best of our knowledge.
Figure 1.12.: structure of the hydrophilic phosphine PTA and of the complexes Cu(I), Ag(I)–PTA.
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Although it is known that bioabsorption of copper occurs by complexation of the
monovalent metal cation by the thioether group of methionine residues in the copper
transport proteins of the cell membrane [21, 22], the scientific literature does not yet contain
rigorous studies on quantification of the affinity of Cu(I) toward mehionine. In addition,
only few and not conclusive, investigations about the competition between Cu(I) and Ag(I)
toward methionine are found in the literature [21]. Therefore, the second aim of this thesis
work was the determination of the thermodynamic parameters (DG, DH, DS) for the
complex formation of Cu(I) and Ag(I) with this amino acid in aqueous solution.
Studies were carried out by means of potentiometry, microcalorimetry and UV-Vis
spectrophotometry at 25 °C. In all cases, to keep the activity coefficients of the species in
solution constant, all the solutions were prepared in a proper ionic medium with a constant
concentration 0.1 or 1.0 M.
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Experimental
A first series of experiments on the Cu(I)–PTA system, carried out by means of spec-
trophotometric titrations, allowed the determination of the stability constants of the
complexes formed by the metal cation and the phosphine in the experimental conditions
used. The results obtained were then used to correlate the composition of species in solution
at different concentrations of total metal (speciation), with the biological activity of the
compounds in vitro. The speciation model obtained for the Cu(I)–PTA system by means
of the spectrophotometric approach was then confirmed, and integrated, with a series of
microcalorimetric experiments. Microcalorimetry allowed a further and independent deter-
mination of the formation constants for the Cu(I)–PTA complexes in the same conditions of
the UV-Vis experiments as well as the direct determination of the enthalpies of formation
of the complexes in solution, successively used to build a complete set of complex formation
thermodynamic functions (DG, DH, TDS) necessary for a complete description of the
systems in solution.
A series of potentiometric and microcalorimetric experiments were also performed in
order to study the formation of the analogous Ag(I)–PTA complexes, [Ag(PTA)n]+ (n =
1–4), in aqueous solution.
The results of the thermodynamic and ESI-MS studies [72] concerning the stability of
tetracoordinated [M(PTA)4]+ (M = Cu(I), Ag(I)) complexes in aqueous solution [75] are
compared and discussed in Chapter 3.
In view of the good results obtained by microcalorimetry in studying the M–PTA systems,
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the same technique was also employed to investigate the formation of adduct of Cu(I) and
Ag(I) whith methionine, the prominent binding site for these soft cations in the copper
trasport proteins of the cell membrane.
The speciation model suggested by these studies are well consistent with some recent
data concerning the interaction between Cu(I) and the h-Ctr proteins in solution [21, 22].
2.1. Techniques
2.1.1. Potentiometry
Potentiometry is one of the most frequently used method to determine the stability
constants of complex species in solution, because of its great accuracy and precision [76].
Potentiometry consists of measuring the potential between two electrodes in contact with
the solution. The potential is affected by the presence of the analytes in solution, and its
value is related to their concentration. Experiments are usually carried out at a constant
temperature, since the value of the electrodic potential also depends on temperature. To
perform a potentiometric measurement, an indicator electrode, which must be sensitive to
any variation in the concentration of the analyte, and a reference electrode, the potential of
which remains constant during measurement, are required. Potentiometry uses electrodes
which are selectively sensitive to one ion of interest: in this study, glass membrane and
silver electrodes were used, since they are sensitive to the concentration of hydrogen and
silver ions respectively. The main limitation of potentiometry is the essential requirement
of a suitable reversible electrode sensitive to the ion to be analyzed. However, studying a
system at equilibrium can often be achieved, although a suitable reversible electrode is not
available for direct measurement of the analyte concentration. For example, although the
formation of a complex between a metal ion and a ligand cannot be directly evaluated with
an electrode sensitive to changes in the concentration of the metal ion, it is possible to assess
the competition between that metal and the hydrogen ion toward ligand complexation,
if the ligand is both a basic species and a Lewis donor. In this case, the system can be
studied by means of a series of properly designed potentiometric titrations, with a glass
electrode to measure the pH of the solution.
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Electrodic potentials depend on the activity of the species in solution and originate
from two main factors: the redox equilibrium of the analyte and its concentration in
solution. Given a general analytical species Mn+, which can undergo the following reversible
equilibrium of reduction:
Mz+ + ne  ! M(z n)+ (2.1)
The observed electrodic potential, E, of a solution in which the above equilibrium takes
place is given by the Nernst equation:
E = E0 +
RT
nF
ln
{Mz+}
{M(z n)+} (2.2)
Where E0 is the standard potential of the redox couple at 298.15 K, F is one Faraday
charge, 96,485 C, n is the number of electrons involved in the reduction process and {X} is
the activity of species X. Equation (2.2) provides the relationship between the measured
potential and the activity of the species in solution. During experiments, however, we do
not deal with the activities of the species but with their concentrations. Activities and
concentrations are related to each other by the expression:
{X} =  X · [X] (2.3)
Where term g is the activity coefficient of species X, which depends on the temperature
of the solution and its ionic strength.
For reliable thermodynamic data for describing a chemical equilibrium, it is therefore
necessary to keep activity coefficients g of the species in solution constant during the
experiments. The experiments must therefore be carried out at a constant temperature,
using a thermostatic control apparatus. In addition, to keep the ionic strength of the
solution constant, a sufficiently high concentration of an inert background electrolyte must
be used. In experiments carried out in aqueous solution, 0.1 or 1.0 M sodium perchlorate
or nitrate are usually employed.
In the case of constant activity coefficients, equation (2.2) may be rewritten in terms of
concentrations, replacing standard potential E0 with formal potential, E00 :
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E = E0
0
+
RT
nF
ln
[Mz+]
[M(z n)+]
, where : E0
0
= E0 +
RT
nF
ln
 Mz+
 M(z n)+
(2.4)
Methods. Experiments performed to study the protonation of PTA and its complexation
by Ag(I) were carried out by means of a series of potentiometric titrations (see section 2.3).
A glass membrane electrode (Metrohm Unitrode) was used to study phosphine protonation,
and the formation of silver(I) complexes of PTA was followed by a massive silver electrode
(Metrohm Combined Ag-ring). Titrant volumes were added with an automatic burette
(Metrohm Dosimat 665 ). Experimental data (E, mV vs Vadded, mL) were collected with
home-made software (WinTit) and processed with the Hyperquad 2006 minimization
program [77, 78], in order to find the speciation model for the best description of the
experimental data (for details, see appendix section D.3 on page 126).
2.1.2. UV-Vis spectrophotometry
Ultraviolet and visible spectrophotometry (UV-Vis) is a technique generally less accurate
and precise than potentiometry [79]. Therefore, if potentiometry can be used to investigate
the system, spectrophotometry should be regarded as a complementary technique.
Spectrophotometric investigation of chemical equilibria is based on changes in the UV-Vis
absorption spectrum of an analyte when it forms complexes in solution. The Lambert-Beer
Law governs the light absorption of a specific absorber in spectrophotometry. This law
states that a linear relationship exists between the absorbance of an analyte in solution
and the product between its concentration and the path length of the measurement cell,
according to the well-known expression:
A  = "  · C · l (2.5)
where: A  is the absorbance of the analyte at wavelength  , C is its molar concentration,
l is cell path length (usually expressed in centimeters) and "  is the molar absorbance of
the analyte at the wavelength of  . Now, in a solution where the absorbing analyte, a0,
forms n complexes (a1, a2, . . . , an), each of them with a characteristic absorption spectrum,
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the absorbance of the solution at a given wavelength l is:
A  = l · (" ,0 · C0 + " ,1 · C1 + · · ·+ " ,n · Cn) (2.6)
where " ,0, " ,1, . . . are the molar absorbances of species a0, a1, . . . and Cn are their
concentrations in solution.
Methods. In this study, spectrophotometry was used to study the complex formation
between Cu(I) and PTA in aqueous solution. Experiments were carried out in a series of
batch titrations (see section 2.2.3 on page 43). The absorbance spectra of the solutions were
collected on a Varian Cary 4000 spectrophotometer equipped with a thermostatic Peltier
system, which ensures temperature control during experiments. Experimental data were
collected with the instrument software and processed with the Hyperquad 2006 minimization
program to obtain the speciation model which best reproduces the experimental data.
2.1.3. Cyclic voltammetry
Cyclic voltammetry (CV) is another electrochemical technique used to study equilibrium
systems and chemical kinetics in solution. A cyclic voltammetry experiment is usually
carried out at constant temperature in a thermostated cell not stirred during experiments.
Measurements require three electrodes: a working electrode, a counter-electrode and a
reference electrode. In a typical CV experiment, the potential of the working electrode
is ramped linearly with time to a chosen potential and then lowered to the initial value
in the same way. The electric current through the working electrode versus the applied
voltage is recorded, and the diagram of the electric current vs applied potential is called
voltammogram. Voltammograms are typically characterized by anodic and cathodic peaks
with potential values related to the processes of oxidation and reduction of the species in
solution. A voltammetric study can generally provide information about the complexes
formed in solution and their redox stability.
Methods. CV was used here for a preliminary investigation on the equilibria of formation
of Cu(I)–PTA complexes in aqueous solution and to evaluate their redox stability in the
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operating conditions.
2.1.4. Microcalorimetry
Calorimetry is an experimental technique used to measure the reaction heat of a chemical
process. Isothermal calorimetry means that the reaction heats involved are studied in
isothermal conditions, recording the heat exchange between the reaction vessel and a
thermostated bath. Isothermal microcalorimetry is an advanced calorimetric method used
to measure reaction heats within the microjoule range. It is thus a very useful technique,
suitable to study reactions involving even very small quantities of reagents. A typical
microcalorimetric experiment consists of measuring the reaction heat generated when known
volumes of titrant (of the order of tenths of mL) are added to a reaction cell containing 1–3
mL of titrand. The application field of isothermal microcalorimetry in chemical equilibrium
studies is very attractive, because it offers the possibility of using a single technique to
determine the thermodynamic properties (DG, DH and DS) of a wide range of different
types of interactions, including the formation of inorganic complexes in water or in non-
aqueous solvents, and the binding between small organic molecules such as medicinal
compounds with larger biological substrates as proteins.
Given the great sensitivity of this technique, microcalorimetry is suitable to determine the
stability constants of very weak complexes [80, 81], since these processes usually involve the
development of small amounts of reaction heats. In the present work, it is also shown that
microcalorimetry is an excellent technique for studying the formation of strong complexes,
since such studies usually require low concentrations of the complexing species in solution
and imply low or very low reaction heats.
When solutions of a metal ion M and a ligand L are mixed in a microcalorimeter reaction
cell to form a series of successive complexes according toM+ nL  MLn, reaction heat Q,
released or absorbed, is given by:
Q = V ([ML] HML + [ML2] HML2 + · · ·+ [MLn] HMLn) + Hdil,
and : [MLn] =  n[M][L]n
(2.7)
where V is the total volume of the cell solution,  HMLi is the molar formation enthalpy of
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the MLi complex, and  Hdil is dilution heat. Since the formation of every complex implies
a definite reaction heat, microcalorimetry is usually employed to measure the enthalpies of
formation of the complexes once their stability constants are known. However, in some cases
as previously noted, the microcalorimetric approach also allows the direct and simultaneous
determination of reaction enthalpies DHn and stability constants  n of the complex species
formed in solution. The values of formation enthalpies obtained by direct calorimetric
measurements are much more accurate than those obtained by measuring the temperature
dependence of the stability constants with the Vant’ Hoff relationship.
Methods. A Thermometric TAM III isothermal microcalorimeter (Figures 2.1 and 2.2)
was used to study the formation of Cu(I), Ag(I) complexes with PTA (sections 2.2, 2.3)
and with the amino acid methionine (see section 2.4). The instrument is composed of two
cylindrical metal housings containing the measure and reference cells. The two calorimeter
units (Fig. 2.2) are housed in an aluminum holder block in contact with a thermostatic bath
(Fig. 2.1). The bath temperature is maintained constant within variations of ±2 · 10 4 K
by a series of fine thermostatic regulation systems, and the aluminum holder block ensures
that temperature fluctuations are even smaller than 1 mK in the calorimeter units, within
the working range of 278–353 K. Sensitive thermocouple circuits lying on the bottom of
the unit are used to detect temperature differences within 10 6 K between reference and
measure cells.
The reference cell is usually filled with water, or preferably with a solution of the same
ionic medium employed during the experiments, so that the reference solution has the same
vapor pressure as the solution in the measure cell. The reference and measure cells are
made of an inert Hastelloy alloy. The measure cell is usually filled with an initial volume of
2.50 – 2.75 mL of the titrand solution. It is then sealed and fixed to a vertical metal tree
equipped with a Hastelloy stirrer to mix the reactants. A Hamilton gastight glass syringe
(V = 0.250 – 0.500 mL) connected to a gold capillary cannula is used as a burette to add
the titrant to the cell solution. A stepping motor controls the volume dispensed by the
burette. In a typical experiment, successive volumes of 5 – 20 mL of titrant are added to
the measure cell.
27
2.1. Techniques
digital voltmeter
(DVM)
connections to exte
water circul
///
rnal
ator
hinged cover
measuring cyl inder
water thermostat
water pump
temperature regulator unit
Fig.2 Thermal Activity Monitor
Figure 2.1.: TAM III (Thermal Activity Moni-
tor) isothermal microcalorimeter.
In all cylindgr types (Fig.a), measurement
takes place in a measuring cup sandwiched
between a pair of Peltier thermopile heat
sensors. These sensors are in contact with a
metal heat sink. The system is designed so that
the main path for the flow of heat to or from
the measuring cup is through the Peltier
elements. A precision wire-wound resistor is
located within each measuring cup to represent
a reaction during electrical calibration. This
entire assemblv is located in a stainless steel
canister in the lower part of the measuring
cylinder.
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Fig.5 Twin Measuring Principle
In the 25 ml cylinder, there is a single Peltier
element mourited on the base of the single
measuring cup, and thermal reference is made
to the stabilitv of the water thermostat.
Samples ar. i"nt oduced to the monitor, either
in sealed ampoules, or by pumping through
small bore flow tubes. Several types of cylinder
and accessories are available to accomodate a
wide range of sample types for measurement.
The sample is pre-equilibrated within the
cylinder before introduction to the measuring
cup. Samples, held in glass or stainless steel
sealed ampoules are lowered on the ampoule
lifters into the neck of the measurins cvlinder
(Fig.a). The ampoule is retained in t-"he neck by
a magnetic disk in the top cap of the ampoule
lifter. The outside of the neck is in direct
contact with the water in the thermostat bath,
therefore there is a rapid exchange of heat
between the ampoule and the water via the
/ v"" 
ple flow
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With the exception of the 25ml cylinder, all
cvlinders are constructed in twin.form, with
two measuring cup assemblies in each cylinder.
In each measuring cup, the two Peltier
detectors are connected in series (Fig.5). The
sum of the voltage signal from this pair of
detectors is referred to the sum of the voltage
signal from the pair on the other measuring cup
in the same cylinder. The two pairs are
connected in series, but in opposition, so that
the resultant signal represents the difference in
heat flow from the two measuring cups. This
design allows one measurement cup assembly,
or si-de, to be used for the sample, and the other
to be used as a blank, or reference.
Peltier
elements
Figure 2.2.: detail of TAM III measuring unit
cylinder
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System calibrations. Before each experiment, the system must be calibrated, for correct
information about thermal variations in the measure cell during a thermal event, i.e., when
a chemical reaction in solution takes place, after the addition of a certain amount of titrant.
A precision calibration heater resistor is built into the measuring unit. The calibration
resistor is integral with the measuring cup, to simulate a thermal event as closely as possible.
This ensures that the output from the detector is also as near as possible identical when
the same power is dissipated from both resistor and the reaction cell. During calibration, a
known current is passed through the appropriate heater resistor and, because the resistor
value is known, the thermal power dissipated is also known. The recorder deflection due
to the thermal power dissipated gives the calibration level, which may then be used to
determine quantitative experimental results.
The instrument has several power amplifiers with different full-scale offsets. During our
experiments, power ranges of 30, 100 and 300 mW were used.
Figure 2.3 shows an example of the output of dynamic calibration in the range scale of
100 mW. During dynamic calibration, the dedicated resistors are first supplied with 40% of
the selected full-scale power value for a fixed time (Figure 2.3, A). This is then increased
to 95% (Figure 2.3, B), and the response rate of the system is stored in memory. This
operation proceeds automatically, until sufficient information has been taken into memory.
As the figure shows, the output response of the corrected signal (red curve) of a titration
peak after calibration is quite fast, and takes into account all the reaction heat due to the
addition of a volume of titrant in the course of a few minutes.
A good standard practice which we adopt is to perform several automatic calibrations
of the system during an experiment, especially in the case of long-running measurements
lasting several hours, during which both external conditions and calorimeter cell thermal
capacity may vary. An example of an output of a microcalorimetric titration is shown in
Figure 2.4. The enthalpy graph refers to acid-base titration of phosphine PTA. In this
experiment, a dynamic calibration was performed every ten additions of titrand. The
reaction heat decreases near the equivalent point, and the last small titration peaks simply
provide the dilution heat of the titrant in the cell solution.
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Figure 2.3.: example of dynamic calibration during microcalorimetric titration.
Figure 2.4.: example of microcalorimetric corrected output (acid-base titration of amino functions
of phosphine PTA).
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Data processing. Experimental data from microcalorimetric titrations (Qex, mJ) were
collected with the instrument software Win DigiTam and corrected for dilution heat
(Qreaction = Qex   Qdil). The stepwise reaction heats (Qreaction,i) and volume of titrant
added during titration (Vadd, mL) were then processed with minimization software based on
the Letagrop approach [82–86] (see appendix section D.4 for further details) in order to
obtain the reaction enthalpies and stability constants which best reproduce the experimental
data, according to a given speciation hypothesis.
2.2. Formation of Cu(I)–PTA complexes
The formation of complexes between Cu(I) and PTA was studied by both spectrophoto-
metric and microcalorimetric approaches.
This study presented considerable difficulties, because Cu(I) is a thermodynamically
unstable species in aqueous solution and spontaneously tends to undergo fast disproportion-
ation to Cu(II) and metallic copper. An affordable method used to stabilize the monovalent
oxidation state of the cation, among those reported in the literature, is to use the chloride ion
as a complexing (and thus stabilizing) agent. In chloride solutions, copper(I) forms a series
of successive complexes, stable to disproportionation, with general formula [CuCln]1 n.
Several studies show that, in aqueous solutions with low concentrations of chloride ions
(< 0.1 M), Cu(I) mainly forms 1:1 and 1:2 complexes [CuCl](aq) and [CuCl2]  [15, 87–
97], whereas the formation of a third 1:3 complex is ascertained with higher chloride
concentrations (  1.0 M). Recently, Brugger et al. [15] determined the structure of
complexes [CuCl2]  and [CuCl3]2  in an XAS study in solution. The results show that
Cu(I) has a slightly distorted linear geometry in [CuCl2]  and a trigonal planar arrangement
in [CuCl3]2 . The same authors also verified that, in solutions with higher chloride
concentration (> 3 M), no complexes after [CuCl3]2  form at all.
A recent theoretical molecular dynamics study, comprising ab-initio calculations, by
Sherman [98], also confirmed these data. The most comprehensive study of the speciation
of chlorocomplexes in solution was that of Sharma and Millero [92], who evaluated the
stability constants of three successive chlorocomplexes with general formula [CuCln]1 n
( n, with n = 1 – 3), forming in solution at relatively high concentrations of chloride (0.100
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Table 2.1.: calculated formation constants of complexes [CuCln]1 n (n = 1 – 3) at in infinite
dilution and NaCl 0.1 and 1.0 M.
species log  0 [92] log  n (NaCl 0.1 M) log  n (NaCl 1.0 M)
[CuCl](aq) 3.10 2.87 2.68
[CuCl2]
  5.42 5.20 5.07
[CuCl3]
2  4.75 4.72 4.78
– 5.00 M). For these species, the same authors also calculated stability constants at infinite
dilution (thermodynamic stability constants,  0n ), providing for each of the species in
solution the related Pitzer’s parameters [99, 100] which describe variations in the activity
coefficients of species  n with the ionic medium (for a detailed discussion of the relationship
between  n and ionic strength of solution, see appendix C on page 113).
The thermodynamic formation constant of the generic complex [CuCln]1 n is given by:
Cu+ + nCl    [CuCln]1 n,  0n =
 
[CuCln]1 n
 
{Cu+} {Cl }n (2.8)
where {X} is the activity of species X. The value of the constant refers to ideal conditions
of infinite dilution. Working with an ionic medium of defined concentration, in our case NaCl
1.0 M, the formation constants of complexes  0n can therefore be calculated by substituting
in equation (2.8) the values of the activity coefficients of the individual species, according
to:
 0n =
 (1M)CuCln
⇥
[CuCln]1 n
⇤
 (1M)Cu [Cu
+] · ( (1M)Cl )n [Cl ]n
, whence: (1M)n =  0n ·
 (1M)CuCln
 (1M)Cu · ( (1M)Cl )n
(2.9)
Using Pitzer’s parameters [92], we therefore calculated the formation constants of the
three [CuCln]1 n (n = 1 – 3) complexes in 1.0 M NaCl, the ionic medium used to carry out
later experiments with PTA. The calculated values of the formation constants are listed in
Table 2.1 (for details of the calculation, see appendix section C.3.1 on page 116).
Figure 2.5 shows the variations in the relative abundances of species [CuCln]1 n as a
function of total chloride concentration, in a solution containing a total concentration of
metal ion 1.00 mM. The speciation plot shows that, in 1.0 M NaCl, Cu(I) is quantitatively
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Figure 2.5.: relative abundances of copper(I)
chloride complexes at various chloride concen-
trations for [Cu+]tot = 1.0 mM and m = 1.0 M
at 25.0 °C.
Figure 2.6.: relative abundance of copper(I)
chloride complexes at [Cl ]tot = 1.0 M, T =
25.0 °C.
complexed by chloride forming [CuCl2]  (67%) and [CuCl3]2  (33%). It should be empha-
sized that in this case (1 M NaCl) the relative abundance of the complexes in solution
remains constant with the concentration of the metal, although the total concentration of
Cu(I) is significantly lowered (see figure 2.6).
It is of interest to note that, as the aim of the study was to evaluate the stability of
copper(I) complexes in conditions close to those of biological systems, the most suitable
ionic medium for these experiments would have been NaCl 0.1 M, closer to that of biological
environments. However, it was necessary to work in 1.0 M NaCl, not only to avoid Cu(I)
disproportionation, but also to achieve the best experimental conditions to minimize Cu(I)
oxidation by atmospheric oxygen. Sharma and Millero [101] did point out that Cu(I),
although stabilized in its monovalent state by chloride, is subject to oxidation by atmospheric
oxygen even at high chloride concentrations (0.1 – 6 M), according to the reactions:
Cu+ +O2 ! Cu2+ +O· 2
2O· 2 + 2H+ ! H2O2 +O2
Cu+ +H2O2 ! Cu2+ +OH· +OH 
(2.10)
To overcome the considerable difficulties due to the instability of the metal ion in aqueous
systems, we devised various experimental approaches (see later), in order to carry out
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thermodynamic studies in experimental conditions avoiding both the disproportionation
of Cu(I) and its possible oxidation by oxygen. Because of the special affinity of Cu(I)
for chloride ion, the formation of copper(I)–PTA complexes in NaCl 1M should occur by
displacement of one or more chlorides from the coordination sphere of the metal ion. As a
result, the stability constants obtained in this work do not refer to equation (2.11), but
rather to the processes of substitution of chloride ions in the coordination sphere of Cu(I)
by PTA, shown in eq. (2.12):
Cu+ + nPTA  [Cu(PTA)n]+ (2.11)
[CuClm]
1 m + nPTA  [CuClm x(PTA)n]x m+1 + xCl  (2.12)
With: n = 1– 4, m = 2 – 3, x = 0 – 3. For this reason, our stability constants must be
regarded as conditional stability constants, referring to a system in which total chloride
concentration was 1.0 M.
Because of the easy oxidation of Cu(I) in these equilibrium systems, in order to verify
whether the presence of Cu(II) in solution could interfere with complexation, it was first
necessary to study the Cu(II)/PTA system.
2.2.1. Chemicals
PTA
1,3,5-triaza-7-phosphadamantane (PTA) was prepared according to published procedures
[102, 103], with slight modifications done in order to obtain the compound with a high
purity and to minimize its oxidation during the purification process. 50 g (210 mmol) of
tetra hydroxyethyl phosphonium chloride (THPC, Aldrich, 80% water solution) and 25 g
of ice were weighed in a 200 mL beaker. THPC salt was neutralized to tris hydroxyethyl
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phosphine by dropwise addition of 17 g of a 50% NaOH aqueous solution under vigorous
stirring. In this and in the following preparation steps it was important to not exceed pH
8–9 to avoid unwanted phosphine oxidation. 90 g (900 mmol) of formaldehyde (30% water
solution, Fluka) and 30 g (214 mmol) of hexamethylene tetramine (HMTA, assay > 99%,
Fluka) were then added to the basic solution. The reactions leading to the formation of
the product are exothermic therefore, in order to avoid unwanted PTA oxidations, it was
important to prevent warming of the reaction mixture above room temperature. To do this,
the reactants were added dropwise and the reaction vessel was cooled into a ice/water bath.
The reaction mixture was kept under stirring for 12 h at room temperature. The product
was concentrated by evaporation of the solvent at room temperature. Crystals of PTA were
then separated by the mother liquors and rapidly washed with cold ethanol. The product,
once dried under vacuum, was dissolved in chloroform and filtered to separate any trace of
NaCl. Chloroform was then evaporated under vacuum and phosphine dissolved in methanol
to eliminate any trace of its oxidation product, insoluble in this alcohol. The product
obtained after the solvent evaporation was again purified by a second slow recrystallization
from water at room temperature. The final product so obtained had a very good purity
(>99.5%), suitable for thermodynamic studies, even if the reaction yield was low (3-5%).
Elemental analysis: PTA, C6H12N3P, FW = 157.15 g/mol. % calculated (% found): C
45.86 (45.77), H 7.70 (7.46), N 26.74 (26.52).
CuCl
The solid salt used to prepare stock solutions of Cu(I) was obtained by an easy procedure
that involves a comproportionation reaction between Cu(II) and metallic copper.
Preparation. 10 g of CuCl2 (⇡ 74 mmol) (Aldrich, pur > 99.0 %) were dissolved in 100
mL of a 10% HCl aqueous solution containing 10 g of metallic copper (beads, Aldrich).
The comproportionation reaction was completed in 1 h by heating the solution near to
the boiling point, under stirring. The reaction mixture was concentrated to small volume
and the white solid obtained was filtered, washed (first with several portions of a cold 0.1
M HCl solution and then twice with ethanol and diethyl ether) and dried under vacuum.
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The final product was a crystalline white powder that was stored under nitrogen to avoid
copper(I) oxidation by the atmospheric oxygen.
2.2.2. Interaction between Cu(II) and PTA in aqueous solution
To check in advance if Cu(II) could react with PTA, we made some preliminary tests,
during which known quantities of PTA were added to solutions of Cu(II) (0.5–5 mM in
NaCl 1.0 M) to PTA:Cu(II) molar ratios up to 10:1. In all cases, a rapid color fading of the
solution was observed, from light blue (typical of that of the cupric aquoion) to colorless.
In addition, the formation of a white precipitate was always observed in the solutions
with a higher metal ion concentration (1–5 mM). These experiments suggested that a
reaction occurred, possibly involving the Cu(II)-promoted phosphine oxidation, leading to
the formation of stable [Cu(PTA)n]+ complexes according to the reactions:
2Cu2+ + PTA+H2O  2Cu+ + PTAox + 2H+
Cu+ +mCl    [CuClm]1 m
[CuClm]1 m + nPTA  [CuClm x(PTA)n]1 m+x + xCl 
(2.13)
The heat involved in these processes was also measured by means of some microcalorimetric
titrations. Figure 2.7 shows, as an example, that the amount of heat evolved per volume of
PTA added to the metal solution is almost constant and independent from the PTA to Cu
molar ratio. The slope of the line Qtot. vs Vadded (see plot (b) in Figure 2.7) indicate an
average reaction heat of 44.7 kJ per mole of PTA.
In order to provide a rational description of the reactions occurring when PTA is mixed
with solutions of Cu(II), we carried out some cyclic voltammetry (CV) experiments. In
these experiments we obtained information about: a) the stability of Cu(I) in NaCl 1.0
M; b) the stability of PTA under the same conditions; c) the reaction between Cu(II) and
PTA.
All the CV experiments were performed in a thermostated cell at 25 °C. The solutions
in the measuring cell were prepared by dissolving weighed quantities of CuCl or CuCl2 in
a known volume of NaCl 1.0 M. Increasing amounts of a PTA solution (50.0 mM) were
then added to the cell solution. Before each experiment all the solutions were thoroughly
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(a) (b)
Figure 2.7.: microcalorimetric titration, 2.74 mL of a Cu(II) solution 0.985 mM titrated with
successive additions of 10 mL of a 20.0 mM PTA solution in NaCl 1.0 M.
degassed by an argon flux in order to protect them from the atmospheric oxygen.
Two platinum electrodes (working electrode and counter electrode) and a reference
electrode (saturated calomel, SCE) were used to carry out the voltammetric measurements.
The CV curves (current intensity, A, vs. potential, V ), which show characteristic peaks in
the correspondence of the oxidation and reduction potentials of the species investigated,
were collected and processed with the GPES software provided by the manufacturer.
Two preliminary experiments were carried out in order to study the redox system
Cu(II)/Cu(I) in NaCl 1.0 M. During these experiments, the cyclic voltammograms of
solutions of CuCl or CuCl2 in the range of potentials of 0.0–0.5 V were collected with a
fixed scan rate of 0.1 V/s. The voltammograms are shown in Figure 2.8.
The black curve in the figure is the voltammogram of a copper(I) solution, the red one is
that of a copper(II) solution. The two curves show that the redox system is reversible and
independent of the particular oxidation state of the species in the starting solution. This
result was expected, and is a proof of the particular stability of Cu(I) in NaCl 1.0 M. In
both experiments, marked and distinct oxidation/reduction waves are shown, characterized
by well-defined anodic and cathodic potential peaks.
A second series of experiments was dedicated to the study of the electrochemical behavior
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Figure 2.8.: voltammograms of Cu(I) (1.0 mM) and Cu(II) (1.0 mM) in NaCl 1.0 M.
Figure 2.9.: voltammograms of PTA solutions in NaCl 1.0 M at di erent scan rates (from 0.02 to
0.10 V/s).
of the phosphine. In this case, a series of voltammograms were collected for a 1.0 mM
solution of PTA degassed with anoxic argon. The voltammograms were recorded at different
scan rates (see Figure 2.9). The results of these experiments show that the phosphine can
be oxidized in aqueous solution and that this oxidation occurs in an irreversible manner,
since the reduction peaks are not observable in the voltammetric curves.
A third set of CV experiments was carried out in order to study the formation of Cu(I)–
PTA complexes in NaCl 1.0 M. For this purpose, a solution of CuCl 1.0 mM in NaCl 1.0 M
was prepared in the cell, then successive volumes of a solution of PTA 20.0 M were added
until the molar ratio Cu(I):PTA in the measuring cell was 1:4. The CV curves are shown
in Figure 2.10. Two distinct oxidation peaks of Cu(I) are observable in the voltammograms
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(a) (b)
Figure 2.10.: voltammograms of a 1.0 mM Cu(I) solution containing increasing amounts of PTA
(NaCl 1.0 M).
in Fig. 2.10(a). The first peak occurs at a potential corresponding to the oxidation of
[CuClm]1 m complexes (0.189 V ), as previously observed, whereas the second is shifted
toward more positive potentials (0.425 V ). In addition, as the concentration of PTA is
increased, the second anodic peak gradually shifts towards higher potentials (0.460 V ).
More important, the peak current for the oxidation of [CuClm]1 m decreases while that of
the Cu(I)–PTA complexes increases as the concentration of PTA is increased. This confirms
the formation of successive Cu(I)–PTA complexes which stabilize the monovalent oxidation
state of the metal ion, shifting the redox potential to more positive values. Oxidation of
Cu(I)–PTA complexes is an irreversible process; there is no reduction peak coupled with
the oxidation one observed for Cu(I)–PTA to be assigned to the reduction of Cu(II)–PTA.
This is a clear indication that no complexation reactions between Cu(II) and PTA take
place.
As observed in the preliminary experiments, also in this case, when the molar ratio PTA
to Cu(I) in solution was higher than 0.5 and the copper concentration was greater than
1.0 mM, a white precipitate formed in solution. The elemental analysis revealed that the
solid compound was a coordination compound with formula [Cu(PTA)]Cl. It was also
observed that the quantity of precipitate did not increase as the PTA/copper molar ratio
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was further increased. On the contrary, the precipitate was dissolved rapidly in water when
the ligand to metal ratio was 4. This observation suggests that Cu(I) should form up to four
mononuclear successive complexes in NaCl 1.0 M and that the highest of these complexes
is more soluble than the lowest.
The blue curve in Figure 2.10(b) is the voltammogram of the solution in which the molar
ratio PTA:Cu(I) is 4. Interestingly, the oxidation peak of the copper chloride complex
does not appear in this voltammogram. The anodic peak at 0.460 V also disappeared;
it is replaced by a new anodic peak at 0.543 V to be attributed to stable Cu(I)–PTA
complexes with stoichiometry higher than 1:1. This voltammogram was extended up to a
final potential in the region of PTA oxidation. A comparison of the voltammetric pattern
of the CuCl – PTA system with that of PTA alone (dotted curve) shows the presence of a
small quantity of free PTA in the system, which confirms the formation of complexes of the
type [Cu(I)(PTA)n]+, with n > 1.
It should be noticed that the Cu(I) – PTA system at a 1:4 molar ratio shows a cathodic
peak at 0.268 V, which might be assigned to the reduction Cu(II) to Cu(I). The potential of
this peaks is significantly more positive than that observed for Cu(II) in the absence of PTA
(0.190 V). Moreover, the anodic peak at 0.543 V, arising from oxidation of the Cu(I)–PTA
species prevailing in the presence of excess PTA, is shifted by about +0.080 V with respect
to the peak initially observed for the Cu(I)/PTA system under 1:1 ratio. These data may
be wrongly ascribed to an interaction between Cu(II) and PTA due, for example, to the
formation of Cu(II) – PTA complexes by coordination of the metal ion by an amino nitrogen
of the phosphine. This possibility was however excluded by the subsequent calorimetric
measurements, which show that Cu(II) does not form any complexes with PTA.
The voltammetric response recorded for Cu(I) oxidation in the presence of 4-fold excess
of PTA suggests the presence of a catalytic reaction in which PTA is oxidized by Cu(II)
generated at the electrode. First, the oxidation peak in Fig. 2.10(b) does not present
its anodic partner for the reduction of the electrogenerated Cu(II). Second, and more
important, the anodic peak current is much higher (55 µA) than that recorded for the
same redox species in the absence of PTA (30 µA, compare the grey curve in Fig 2.10(a)
with the blue one in Fig. 2.10(b)). This behavior is typical of electrocatalytic systems in
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which an electrogenerated species is involved in a rapid redox reaction occurring in solution.
The rate of oxidation of Cu(I) at the electrode is enhanced by the fast regeneration Cu(I)
near the electrode as a result of the redox reaction of Cu(II) with PTA. In other words,
once Cu(I) is oxidized at the electrode, instead of definitively leaving the vicinity of the
electrode it reacts with PTA whereby it is reduced back to Cu(I), which is forced to return
to the electrode where it gets oxidized again, thus starting a new cycle. The result of this
alternating electro-oxidation and homogenous reduction involving the Cu(II)/Cu(I) couple
is an increase of the anodic peak current for Cu(I).
In order to get details on the reactions occurring when Cu(II) and PTA are mixed in
aqueous solution and to verify the initial hypothesis concerning the solution redox behavior,
a final set of CV experiments was carried out. For this purpose, a solution of 1.0 mM CuCl2
in NaCl 1.0 M was prepared in the CV cell and increasing volumes of PTA 20.0 mM were
added to the solution cell until the PTA:Cu(II) molar ratio was 1. The voltammograms were
recorded in the range of potentials from 0.00 to 1.10 V. After each addition of the phosphine,
the solution was stirred for few minutes to allow completion of the eventual reaction.
The voltammograms (Fig. 2.11) show that the successive additions of phosphine bring
about a progressive decrease of the intensity of both the anodic and cathodic peaks of the
redox couple Cu(II)/[Cu(I)Clm]1 m, clearly indicating a decrease of Cu(II) concentration,
presumably because of its reaction with PTA. In concomitance with the decrease of the
peak couple for Cu(II)/[Cu(I)Clm]1 m, ill-defined broad reduction peaks attributable to the
oxidation of Cu(I) appear in the range from 0.5 V to 0.8 V and increase with increasing
PTA concentration. This is indicative of the formation of Cu(I)–PTA complexes, which
stabilize the monovalent state of copper shifting its oxidation potential to values to 0.5–0.8
V.
Some 31P-{1H}–NMR measurements were also run. A Cu(II) 1.0 mM solution in NaCl
1.0 M (D2O) with an excess of PTA (1:10) was prepared and filled in a NMR tube. After
verifying that the solution did not contain any trace of precipitate, the spectrum was
collected. In Figure 2.12 the spectrum of this solution is reported in blue whereas, for
comparison, the PTA NMR spectrum is reported in grey. The blue spectrum strongly
suggests that all the Cu(II) in the initial solution reacted with PTA to form Cu(I). In
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Figure 2.11.: cyclic voltammetry of 1 mM Cu(II) in 1 M NaCl, in the absence and presence of
di erent amounts of PTA. vscan = 0.2 V/s.
Figure 2.12.: 31P-{1H}–NMR spectrum of a PTA solution (gray) and of a Cu(II)/PTA solution
(1:10) in NaCl 1 M.
fact, if the paramagnetic ion Cu(II) would have been present in solution, it would have
prevented the acquisition of the spectrum. Otherwise, even if the spectrum could have
been collected, the peak positions would have been shifted to ppm ranges very different
from those observed. The signal at –98.5 ppm, characteristic of the phosphorus of PTA
not complexed (grey in the figure), does not appear in the spectrum of the Cu(II)/PTA
solution (blue), while the intense signal at –3 ppm, characteristic of the oxidation product
O=PTA, is observable. The broad peak at –93 ppm finally indicates the presence of PTA
involved in the Cu(I) complex formation.
In conclusion, different experimental techniques confirmed the initial hypothesis which
42
2.2. Formation of Cu(I)–PTA complexes
admit a series of reactions between Cu(II) and PTA according to the scheme in equation
(2.13) on page 36. The total heat developed in these reactions is about 45 kJ/mol.
These evidences also point out another interesting consequence: Cu(I), even if stabilized
by chloride, may undergo oxidation to Cu(II) by oxygen in aqueous solution. It turns out
that, if Cu(I) is oxidized by unwanted traces of oxygen in solution, the Cu(II) so formed can,
in turn, oxidize the phosphine and form copper(I). This process becomes Cu(II)-catalyzed
in the presence of O2 and continues till all the oxygen dissolved in solution disappears. This
latter consideration is valuable, because it gives an indication of how much care is needed
to carry out experiments on these systems. Moreover it could have considerable effects
on the biological tests of the [Cu(PTA)4]+ compounds, as the presence, even in traces, of
Cu(II) during the biological tests (which cannot be carried out in anoxic atmosphere) could
bring to an oxidation of the phosphines coordinated to Cu(I), progressively reducing the
concentration of the complex and possibly inhibiting its cytotoxic effect.
2.2.3. Formation of Cu(I)–PTA complexes in aqueous solution
Methods. Stock solutions of CuCl 50 mM were prepared by dissolution of the salt in 1.0 M
NaCl. The milliQ-grade water employed for the preparation of the stocks was freshly boiled,
degassed under anoxic nitrogen and stored in a oxygen-free drybox (Braun MB II ) prior to
use. To avoid Cu(I) hydrolytic reactions the acidity of the stock solutions was adjusted to
pH 4 by addition of HCl. Moreover, the stock solutions were stored in sealed bottles and
maintained in drybox under stirring in the presence of metallic copper. Such precaution
ensured that any unwanted trace of copper(II), spontaneously would comproportionate
to Cu(I) in the presence a high chloride concentration. In his way, Cu(II) concentration
in solution becomes of course negligible, however Cu(I) concentration may vary slightly.
Therefore, the real concentration of Cu(I) was determined by spectrophotometry prior to
the preparation of each dilute solution. To do this, the Cu(I) present in weighed quantities
of the stock solutions was oxidized to Cu(II) and diluted in known volumes of 1.0 M
ammonia solutions, where Cu(II) forms the amino complex, characterized by a blue color.
The spectrum of the solution was collected, the absorbance at 607.0 nm was measured
and the copper concentration was calculated on the basis of the known value of the molar
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Figure 2.13.: PTA protonation.
absorbivity of copper(II) amine complexes at this wavelength: 52.6± 0.2 cm 1 mol 1 dm 3
(this work).
The study concerning the formation of Cu(I) and PTA complexes was undertaken by
means of spectrophotometric and microcalorimetric techniques. Experiments were carried
out in aqueous solutions at 25 °C, in NaCl 1.0 M.
PTA is a basic species in solution and it is quantitatively protonated at pH lower than
5.5 at one of its aminic nitrogens (see Figure 2.13). Therefore, the UV-Vis spectroscopic
experiments have been designed to study the complex formation at neutral or weakly
basic pHs where PTA does not present protonated amine functions. In this way the study
of the system was considerably simplified, since it was focused only on the formation of
the four successive complexes [Cu(PTA)n]+ (n = 1–4), according to the reaction (2.14).
Microcalorimetric experiments were instead carried out in solutions with different acidity in
order to study also the equilibrium (2.15), concerning the formation of phosphine protonated
complexes.
Cu+ + nPTA  [Cu(PTA)n]+ (2.14)
Cu+ + n(HPTA)  [Cu(HPTA)n]n+1 (2.15)
Throughout the spectrophotometric study we adopted a series of methodological ap-
proaches to avoid Cu(I) oxidation by the atmospheric oxygen. In particular, we took care to
carry out all the operations necessary for the preparation of the solutions and the filling of
the cuvette in a controlled-atmosphere drybox. Accordingly, all the titrations of Cu(I) were
carried out batchwise. First by preparing in drybox, by dilution of a stock solution, several
solutions of Cu(I) (0.05 - 4.5 mM). Then by transferring the same known volume of these
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solutions into a series of vials to which different amounts of a standard solution of PTA
were added in order to realize solutions with PTA/Cu(I) molar ratios from 0 to 10. Aliquots
of the solutions so prepared were then filled into the spectrophotometric cell. The cell was
sealed, taken out from the drybox and the absorption spectrum of the solution collected.
Always operating in this way we collected 67 absorption spectra in the wavelength range
210–340 nm. The spectra are characterized by a strong charge-transfer absorption band of
the phosphine (210–220 nm) and of the complexes [Cu(PTA)n]+ (220–300 nm, analytical
data of the experiments in Table A.2 on page 102).
The spectral data were then used to obtain the data-input files for the minimization
program Hyperquad, by which we obtained the stability constants for the formation of the
four Cu(I)/PTA complexes (see Table 2.2 on page 46). Once verified that the values of the
stability constants obtained by spectrophotometry were of an order of magnitude suitable
to allow the study of the system by microcalorimetry (see next section), we used this
technique to confirm the spectrophotometry results. For this purpose, we designed a series
of microcalorimetric titrations which allowed us to obtain simultaneously the enthalpies and
the stability constants for the complex formations. A first series of experiments was carried
out at pH close to the neutrality, to study formation of phosphine unprotonated complexes;
a second series of titrations was performed in acidic conditions, to study also the formation
of complexes with the protonated PTA. Typically, the microcalorimetric titrations were
carried out by adding increasing volumes of PTA (30–50 mM) to solutions of Cu(I) (0.2–0.5
mM). However, a series of titrations during which PTA solutions 0.5–10 mM were added to
known volumes of CuCl 10 mM, were also performed in order to obtain accurate values
of the formation enthalpies of the complexes [Cu(PTA)3]+ and [Cu(PTA)4]+. A total of
15 titrations were carried out to perform this part of the study (analytical data in Table
A.1 on page 101). Also in this case, in order to minimize the risk of reagent contamination
by atmospheric oxygen, the whole set of operations necessary to perform the calorimetric
experiments (the cell loading and its connection to the calorimeter head, the burette filling
and the insertion of the capillary cannula of the burette into the calorimeter head) were
carried out in drybox.
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Table 2.2.: Formation (stability) constants and corresponding thermodynamic functions for Cu(I)–
PTA and Cu(I)–(HPTA) complexes (NaCl 1.0 M, T = 25 °C). Comparison between logK values
obtained by spectrophotometry (UV-Vis) and microcalorimetry (microcal.) is shown. In the Table:
M = Cu+, L = PTA, H = H+. Ionic charges omitted for convenience.
Species logb ± 3sv logb ± 3sv DG ± 3sv DH ± 3sv TDS ± 3sv
UV-Vis microcal. kJ/mol kJ/mol kJ/mol
HL 5.94 ± 0.25(*) -33.9 ± 1.4 -17.8 ± 0.6 16.1 ± 1.5
ML 6.36 ± 0.11 6.3 ± 0.6 -36.0 ± 3.3 -53.0 ± 1.7 -17 ± 4
ML2 12.0 ± 0.6 12.1 ± 0.4 -69.3 ± 2.5 -110 ± 5 -41 ± 6
ML3 18.2 ± 0.2 17.7 ± 0.6 -101 ± 3 -148.0 ± 1.2 -47 ± 4
ML4 22.5 ± 0.2 21.4 ± 0.6 -122 ± 4 -188.0 ± 0.8 -66 ± 6
HML – 11.2 ± 0.8 -64 ± 4 -67.5 ± 1.2 -3 ± 4
H2ML2 – 20.8 ± 0.7 -118 ± 4 -160 ± 4 -41 ± 5
HML3 – 22.0 ± 0.8 -125 ± 4 -170 ± 7 -45 ± 8
reaction logK± 3   Gstep ± 3   Hstep ± 3  T Sstep ± 3 
(microcal.) kJ/mol kJ/mol kJ/mol
H+ L  HL 5.94± 0.25(*) -33.9 ± 1.4 -17.8 ± 0.6 16.1 ± 1.5
M+ L  ML 6.3± 0.6 -36.0 ± 3.3 -53.0 ± 1.7 -17 ± 4
ML+ L  ML2 5.8± 0.7  33.3± 4.2  57.0± 5.3  24± 7
ML2 + L  ML3 5.6± 0.7  31.7± 4.2  38.0± 5.1  6± 6
ML3 + L  ML4 3.7± 0.8  21.1± 4.8  40.0± 1.4  18± 5
M+ (HL)  M(HL) 5.3± 0.8  30.2± 4.5  49.7± 1.3  20± 5
M(HL) + (HL)  M(HL)2 3.6± 1.0  20.4± 6.0  74.2± 3.8  54± 7
(*) Obtained by potentiometry
2.2.4. Results
Figure 2.14 shows the UV-vis absorption spectra collected during the spectrophotometric
study. Experimental data (Volume of titrant added and absorbance of the solution at
different wavelengths) were processed with the program Hyperquad 2006 [78] which allows to
calculate the molar absorbance and the formation constants of the species in solution on the
basis of any assumed speciation model (see Appendix D.3 on page 126 for details concerning
the calculation). In this case, according with the indications of previous measurements, we
assumed a speciation model consistent with the formation of four successive mononuclear
complexes ([Cu(PTA)n]+, n = 1–4). For each of these species, Hyperquad calculated the
corresponding molar absorbance and formation constant (Table 2.2). Figure 2.15 shows
the good agreement between the values of absorbance obtained experimentally and those
calculated by the program.
Experimental data obtained by the microcalorimetric titrations (Qobs, heat of reaction
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SET 1. CL ⇡ 2.2 mM; CL/CM = 0.5  9.7;
path length = 0.0104 cm.
SET 2. CL ⇡ 0.6 mM; CL/CM = 0.2  5.5;
path length = 0.0104 cm.
SET 3. CL ⇡ 0.05 mM; CL/CM = 0.2  4.1;
path length = 0.100 cm.
SET 4. CL ⇡ 0.017 mM; CL/CM = 0.2  2.0;
path length = 0.100 cm.
Figure 2.14.: UV-Vis spectra of the Cu(I)–PTA complexes (batch spectrophotometric titrations,
analytical data in Table A.2 on page 102); M = Cu+, L = PTA.
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Figure 2.15.: fitting of spectrophotometric data by Hyperquad minimization. Figure on the left
shows the absorbance of the solutions of a set at a given wavelength (245 nm in the figure).
Experimental absorbance values in blue, calculated values in red. Figure on the right shows the
observed and calculated absorption spectrum for one of the experimental set (Table A.2 on page
102). The calculated molar absorbances of PTA and of the four Cu(I)–PTA complexes is shown.
mJ, and Vadd, added volume, mL) were processed with the minimization program Letagrop
Kalle [86, 104]. The refinement algorithm minimizes the differences between observed
and calculated reaction heats, Qobs  Qcalc, on the basis of the enthalpies and formation
constants of any assumed speciation model (see Appendix D.4 for details). The data
collected in the first series of titrations were used to obtain DH and  n for the unprotonated
complexes; the processing of the experimental data of the second series allowed calculation
of DH and  n of the protonated species, [Cu(HPTA)n]n+1.
The, already obtained, formation enthalpies and stability constants of the unprotonated
complexes were assumed as known parameters (and therefore constant) in the minimization
procedure for the calculation of DH and  n of the protonated species. Figure 2.16 shows
that the result of the minimization procedures is very good: as a matter of fact, the values
of DH and  n we obtained, allowed to reproduce the experimental data very well.
Noteworthy, the values of the formation constants of the complexes [Cu(PTA)n]+ ob-
tained independently with the microcalorimetric and spectrophotometric study are in good
agreement each other (see Table 2.2).
Figure 2.17 shows the experimental data-fit for the titrations of solutions of Cu(I) with
different initial acidities. The agreement between the experimental and calculated values is
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Figure 2.16.: Overall experimental heat (mJ) vs CPTA/CCu (ligand to metal molar ratio) for the
titrations T1–T9 (analytical data in Table A.1, page 101). Squares, experimental values; lines
calculated with the values of DH and  n given in Table 2.2. For sake of clarity, some of the
experimental points have been omitted.
(a) (b)
Figure 2.17.: Examples of microcalorimetric titrations: overall formation enthalpy per mole of
metal (Dhv, kJ/mol) vs CL/CM. Squares, experimental values; lines calculated with the values of
DH and  n given in Table 2.2. Left axes show the variation of the relative percent abundances
of the complex species, calculated on the basis of the speciation model given by minimization
with Letagrop. (a) Titration carried out at neutral or slightly basic pH; the prevalent complex
species in these conditions are the complexes [Cu(PTA)n]+ containing the neutral phosphine (blue
curves). (b) Titration carried out at acidic pH (⇡ 3  4); the prevalent species in this case are the
protonated complexes (red curves).
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especially good. Figures 2.17(a) and 2.17(b) show, in addition, the changes of the solution
compositions for two titrations carried out in regions of neutral and acidic pH, respectively.
The almost straight increment of  hv in the first part of the titration and the marked
inflection at a CL/CL ⇡ 4 in Figure 2.17(a) show, and are a consequence, of the formation of
four strong deprotonated [Cu(PTA)n]+ complexes, the last of which has a molar formation
enthalpy close to 190 kJ/mol. The data in Figure 2.17(b) show the effect of the formation
of protonated complexes on the heat of reaction ( hv). The speciation curves in the figure
show that the complexes with the protonated phosphine become prevalent in solution when
the pH is lower than 4.
The histograms in Figure 2.18 show the values of the thermodynamic functions for the
stepwise formation of the first two complexes of Cu(I) with the protonated and deprotonated
phosphine, respectively (MHL and ML in Figure 2.18). In both cases the spontaneity of
the process is due to the enthalpic factor, while the entropy change, negative, opposes the
complex formation, as expected for the general soft-soft metal-ligand interaction scheme.
At this point of the discussion it is important to remark that: a) Cu(I) in 1 M NaCl exists
as [CuCl2]  (⇡ 67%) and [CuCl3]2  (⇡ 33% ). As a consequence, the formation constants
of the complexes (and the corresponding thermodynamic functions) reflect the substitution
reactions of chloride in the solvatation sphere of the metal according to the reactions (2.16):
[CuCl2,3](1,2)  + L  [CuLCl(2,3) n]((1,2)+n)  + nCl 
[CuCl(2,3) n]((1,2)+n)  + L  [CuLCl(2,3) n m]((1,2)+n+m)  +mCl 
[CuLCl(2,3) n]((1,2)+n)  + L  [CuL2Cl(2,3) n]((1,2)+n+m)  +mCl 
(2.16)
where n and m may be different; b) that the ligand has a considerable steric hindrance
and therefore, on the complex formation, it undergoes a significant decrease of its degrees
of freedom. In addition it removes from the solvatation sphere of the metal ion n and m
chloride ions which are characterized by a higher solvatation, and thus they may exert a
higher ordering effect on the solution than the phosphine. The entropy decrease for the
formation of the first two complexes of Cu(I) (ML and ML2 in Figure 2.18), indicates
that, despite the number of species in solution does not change(1), or even increases(2),
1if m and n are equal to 1.
2if n and m are greater than 1.
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Figure 2.18.: stepwise thermodynamic functions of the first two Cu(I)–PTA complexes with the
protonated and the neutral form of the phosphine, respectively. In the Figure: M = Cu+, L = PTA.
the decrease in entropy that occurs when the ligand enters into the solvation sphere of
the metal is certainly larger than the translational entropy gained by chlorides released
on complexation. The small difference between the changes of entropy (less negative for
the formation of ML) and enthalpy (more favorable for the formation of ML2) could be
interpreted assuming that n is greater than m, thus leading to an increased energetic cost
for the removal of chlorides from the first complex, and consequently a more favorable TDS.
Anyway, the system is too complicate to draw any definitive conclusion just on the
basis of the results of the thermodynamic study. To get additional information on this
point we have recently undertaken a theoretical DFT study, in order to relate the complex-
formation thermodynamic quantities with the energies of formation of complexes with
different stoichiometry calculated by DFT. Results of this study are on the next section.
The stability of the complex M(HL), lower than that of ML, can be justified considering
that the ligand in M(HL) is positively charged. Although this charge does not consistently
influence the donor properties of the phosphorous atom bound to Cu(I) (the stability of
the two complexes is not much different), it may however weaken the interaction M–HL,
due to the electrostatic repulsion between the metal and the ligand, positively charged.
Moreover, the very negative values of TDS and DH for the formation of M(HL)2 may
indicate that the formation of this complex occurs with a quantitative removal of chloride
from the coordination sphere of Cu(I), leading to the formation of a complex with a high
net positive charge, therefore promoting a greater solvation, the reaction exothermicity and,
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consequently, the remarkable entropy decrease. Also in this case, however, it would be very
useful to confirm our hypotheses with the results of the DFT calculations.
2.2.5. Theoretical DFT calculations on Cu(I)–Cl–PTA complexes
Methods. The minimum energy structures of the complexes [Cu(PTA)nClm(H2O)y]1 m
(n, m, y  4, n +m+ y = 4) were calculated by means of theoretical methods, carried out
using the Density Functional Theory (DFT) [105, 106]. This kind of approach proved to be
useful in the calculation of the spectroscopic, structural and energetic properties of metal
complexes, providing accuracy similar to that of post Hartree-Fock ab-initio calculations,
which are nevertheless characterized by a greater computational cost.
DFT routines are generally classified on the basis of the different approximations used for
the calculation of exchange and correlation terms of the energy of the system. The exchange-
correlation functional used in the present work was the well-known B3LYP [107, 108]. This
routine was chosen, given its good performance in the calculation of the properties of metal
complexes [105, 106].
The set of functions used as basis, for the description of the atomic orbitals (and
of the electronic density) are a linear combination of Gaussian-shape curves, namely
6–311++G(2d,p) [109, 110]. The term “6–311” concerns the number of primitive Gaussians
used for the description of the core and the valence orbitals, while the letters d and p indicate
that more functions have been added, to take into account of the effects of polarization. The
“+” symbol indicates the addition of functions that are “diffused” in the space. This basis set
was applied to all the elements except for Cu(I). In order to improve the calculation speed, a
number of electrons of the copper core have been actually replaced by an effective potential
(Effective Core Potential, ECP), which represent their effect on the outer electrons.
Implicitly, it is assumed that the chemical environment does not influence the core elec-
trons, because of the strong nuclear attraction. An ECP (Stuttgart-Dresden pseudopotential)
[111], implemented right in the calculation software (Gaussian09 ) [112] was chosen in the
case of copper.
The structures were optimized in the vacuum until a minimum energy configuration was
attained (corresponding to an energy gradient below a fixed cut-off value). The Hessian of
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the energy and of the vibrational frequencies was calculated in order to verify the nature of
minimum of the steady state obtained, and the absence of one or more imaginary frequencies
was checked.
2.2.6. Results.
The structures of [Cu(PTA)nClm(H2O)y]1 m (n, m, y  4, n +m+ y = 4, see Figure
2.19) complexes, listed in Table 2.3, were optimized. Results of the calculations indicate
that both [CuCl2]  and [CuCl3]2  complexes are stable species. A linear coordination in
[CuCl2]  and a trigonal coordination in [CuCl3]2  have been predicted, in agreement with
the results of a XAS study in solution by Brugger [15]. The optimization of the structure of
the complex [CuCl4]3  leads to the dissociation of two chloride anions from Cu(I), with the
subsequent formation of the stable [CuCl2]  species. This suggestion is in agreement with
the results of a molecular dynamics literature study by Sherman [98], which indicates the
formation of up to three stable chlorocomplexes [CuClm]1 m (m = 1–3) in aqueous solution,
whereas a fourth complex is rather unstable. This last suggestion is also corroborated by a
thermodynamic study in aqueous solution carried out by Sharma and Millero [92].
DFT calculations also suggest that water molecules are generally weakly bonded to Cu(I).
The linear complex [CuCl(H2O)] is the only stable species predicted, while in the case of
[CuClm(H2O)]1 m (m = 2, 3), Cu(I) dissociates the water molecule (see Table 2.3).
The optimized structures of the stable species are reported in Figure 2.19. Calculations
indicate that dicoordinated copper(I) complexes are characterized by a linear geometry,
whereas trigonal and tetrahedral arrangements are found in all the tri- and tetra-coordinated
species respectively.
Table 2.4 shows the comparison between the calculated metal-ligand bond length in
[CuClm]1 m and [Cu(PTA)nClm] (n = 1–4; m = 1–3; n + m = 1–4) and the corresponding
literature values. The Cu–Cl distance found in the linear [CuCl2]  complex is 2.156 Å,
in agreement with the value of 2.13 Å reported in a previous work [113]. The calculated
Cu–Cl distance in the trigonal [CuCl3]2  complex is 2.384 Å, significantly larger than that
reported by Brugger (2.235 Å) [15]. The average Cu–P bond length in the PTA complexes
with a linear geometry is about 2.18 – 2.19 Å, whereas longer distances of about 2.27 – 2.31
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(1) [CuCl2]  (2) [CuCl3]2  (3) [CuCl(H2O)]
(4) [Cu(PTA)]+ (5) [Cu(PTA)Cl2]  (6) [Cu(PTA)Cl]
(7) [Cu(PTA)(H2O)]+ (8) [Cu(PTA)2]+ (9) [Cu(PTA)2Cl]
(10) [Cu(PTA)2Cl2]  (11) [Cu(PTA)3]+ (12) [Cu(PTA)4]+
Figure 2.19.: structures of the Cu+–H2O–Cl –PTA complexes optimized by DTF calculations.
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Table 2.3.: starting structures and final structures (optimized by DFT calculations) of the Cu(I)
complexes.
Cu coordinative geometry Symmetry Starting complex Final structure/s Cu coordinative geometry
in the starting complex in the final complex
tetrahedral C2v [CuCl4]3  [CuCl2]  + 2Cl  linear
trigonal D3h [CuCl3]2  [CuCl3]2  trigonal
tetrahedral Cs [CuCl3(H2O)]2  [CuCl3]2  + H2O trigonal
tetrahedral Cs [CuCl2(H2O)]  [CuCl2] + H2O linear
trigonal Cs [CuCl(H2O)2] [CuCl(H2O)] + H2O linear
linear C3v [Cu(PTA)]+ [Cu(PTA)]+ linear
linear Cs [Cu(PTA)Cl] [Cu(PTA)Cl] linear
trigonal Cs [Cu(PTA)Cl2]  [Cu(PTA)Cl2]  trigonal
linear C1 [Cu(PTA)(H2O)]+ [Cu(PTA)(H2O)]+ linear
trigonal C1 [Cu(PTA)(H2O)Cl] [Cu(PTA)(OH)Cl]  + H+ trigonal
trigonal C1 [Cu(PTA)(H2O)2]+ [Cu(PTA)(H2O)]+ + H2O linear
trigonal C2 [Cu(PTA)2]+ [Cu(PTA)2]+ linear
trigonal Cs [Cu(PTA)2Cl] [Cu(PTA)2Cl] trigonal
tetrahedral C1 [Cu(PTA)2Cl2]  [Cu(PTA)2Cl2]  tetrahedral
tetrahedral C1 [Cu(PTA)2(H2O)Cl] in progress
tetrahedral C1 [Cu(PTA)2(H2O)2]+ in progress
trigonal Cs [Cu(PTA)3]+ [Cu(PTA)3]+ trigonal
tetrahedral Cs [Cu(PTA)4]+ [Cu(PTA)4]+ tetrahedral
Å have been found in the complexes with a trigonal arrangement. A Cu–P bond length of
2.364 Å was found in the tetrahedral [Cu(PTA)4]+ complex. In a previous work, Kirillov
et al [114] obtained a crystal structure of the solid [Cu(PTA)4]NO3 complex (see Figure
2.20) and reported an average Cu–P bond length of about 2.28 – 2.29 Å. The calculated
metal-ligand bond lengths of [CuCl3]2  and [Cu(PTA)4]+ are significantly larger than
those expected on the basis of the experimental literature data. This suggests that the
interactions of Cu(I) with the concerned ligands in these complexes should be somewhat
underestimated.
In order to compare the relative stability of the different Cu+–Cl –PTA complexes, and
ascertain the best stoichiometry of the equilibrium species, the free energies concerning the
stability of the species (1) – (12) in Figure 2.19 were calculated. A first calculation was
carried out in-vacuum, then a successive was performed to take into account the solvent
effect. In this case, the solvent was implemented as a polarizable continuum medium, which
surrounds the solutes (Polarizable Continuum Model, PCM) [115]. The reactions concerning
the complex formations and the corresponding DG° are reported in Table 2.5.
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the 31P–63Cu spin coupling (63Cu and 65Cu, I = 3/2) is ob-
served. In agreement, the 63Cu NMR spectrum of 2 (Fig-
ure 2) shows a 1:4:6:4:1 quintet, with the same 1JP–Cu at δ
= 181.5 ppm (relative to [Cu(MeCN)4][PF6]), although no
63Cu resonance was detected in the case of 1, even upon
long acquisition time.
Figure 2. 63Cu NMR spectrum of 2 in D2O (or 1 after addition of
NaOH).
Hence in our systems, protonation of PTA appears to
have a marked effect on the rate of that dynamic process in
solution and/or on the quadrupolar relaxation of the Cu
nuclei in the 63Cu NMR spectroscopy.[14] The significance
of distortion from the regular tetrahedral geometry in the
solid state[14–16] cannot be ascribed in our case, namely in
view of the fluxional behaviour in solution. The effect of the
phosphane Tolman cone angle also cannot be recognized in
our study since PTA and PTAH are expected to have sim-
ilar values of the cone angle (103° for PTA[1,17] is a relatively
small value in comparison with those of common organ-
ophosphane ligands). This differs from other systems for
which the type of 31P{1H} NMR spectrum was associated
with the Tolman angle. For example, as for complex 1 (in
spite of its small PTAH cone angle), a broad singlet was
observed in the 31P{1H} NMR spectrum (without reporting
any 63Cu NMR signal) of [Cu(PPh3)4][BF4][15] bearing a
phosphane ligand with a cone angle higher than 136°.
However, for [CuL4][PF6] (L = PMe3, PMe2Ph, PPh2H,
PPhH2)[15] and [Cu{P(CH2OH)3}3{P(CH2OH)2-
(CH2O–)}],[7b] which also have a distorted geometry of the
metal centres but bear phosphane ligands with the Tolman
cone angle lower than 136° (as in complex 1), the character-
istic quartet due to the coupling with copper (as in complex
2 but not in 1) was detected. The chemical shift (δ =
181.5 ppm) observed in the 63Cu NMR spectrum of 2 is
comparable to those reported for other tetrahedral CuI
complexes, for example, [Cu(PMePh2)4][BF4] (δ =
192 ppm),[15] while 1JP–Cu (761 Hz) is also close to the val-
ues of 796 and 785 Hz found for [Cu(PMe3)4][PF6] and
[Cu(PMe2Ph)4][PF6], respectively, although at different
chemical shifts (i.e., δ = 287 and 265 ppm, respectively).[15]
Interestingly, upon changing the pH of the aqueous solu-
tion of 1 to a slightly basic value (i.e., pH ≈ 8 after addition
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of NaOH), one observes in the 31P{1H} NMR spectrum
the conversion of the singlet (Figure 1, a) to the 1:1:1:1
quartet of 2 (Figure 1, d), in agreement with the deproton-
ation of 1 to afford 2 (Scheme 1, b). A corresponding fea-
ture is revealed by the 63Cu NMR spectrum (Figure 2)
which shows the appearance of the 1:4:6:4:1 quintet of 2.
The conversion of 1 into 2 can also be monitored by 1H
NMR spectroscopy which displays an upfield shift of the
NCH2N protons.
Elemental analyses agree with the proposed formulations
of 1 and 2 which are authenticated by single-crystal X-ray
diffraction studies, as discussed now.
X-ray Crystal Structures
The asymmetric unit of 1 consists of the [Cu(PTAH)4]5+
cation bearing a +5 charge (due to the protonated character
of all the phosphane ligands), which is balanced by five
nitrate ions. A thermal ellipsoid plot of the cationic part of
1 is depicted in part (a) of Figure 3. The nearly tetrahedral
coordination environment about the copper centre is filled
by four phosphorus atoms with the corresponding P–Cu–P
Figure 3. Thermal ellipsoid plots of the cationic parts of 1 (a) and
2 (b) with a partial labelling scheme. The methylene hydrogen
atoms are omitted for clarity. Displacement ellipsoids are drawn at
the 50% probability level. Hydrogen atoms are represented by
circles of arbitrary radii.
Figure 2.20.: crystal structure f [Cu(PTA)4]+ btained by Kirillov et. al [114].
Table 2.4.: Cu–Cl, Cu–O and Cu–P bond lengths (Å).
Species geometry r (Cu–Cl) r (Cu–P) Literature value
Å Å Å
[CuCl2]  linear 2.156 - 2.13 [113]
[CuCl3]2  trigonal 2.384 - 2.235 [15]
[Cu(H2O)Cl] linear 2.085 -
[Cu(PTA)]+ linear - 2.189 –
[Cu(PTA)Cl] linear 2.115 2.177 –
[Cu(PTA)(H2O)]+ linear - 2.184 –
[Cu(PTA)Cl2]  trigonal 2.335/2.236 2.279 –
[Cu(PTA)2]+ linear 2.244 - –
[Cu(PTA)2Cl] trigonal 2.237 2.267 –
[Cu(PTA)2Cl2]  tetrahedral 2.436 2.268 –
[Cu(PTA)3]+ trigonal - 2.311 –
[Cu(PTA)4]+ tetrahedral - 2.364 2.28/2.29 (Fig. 2.20) [114]
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Reaction (1), in the table shows that the complex [CuCl3]2  is weaker than [CuCl2] ,
both in vacuum and in solution, since its formation occurs with a marked positive free
energy. The positive  G° (PCM) for reaction (1) shows that the linear [CuCl2]  complex
is the prevalent species in chloride solutions; in addition, its relatively small value suggests
a possible equilibrium between [CuCl2]  and [CuCl3]2 . This findings are in agreement
with the experimental data of literature previously discussed. Reactions (4) – (10) indicate
that all Cu(I)–PTA complexes result to be unstable in vacuum, with respect to [CuCl2] .
However, calculations with PCM lead to an entirely different result: the negative  G°
indicate in this case, that the formation of the successive Cu(I)–PTA species is a favored
process. This suggestion nicely fit the strong evidences from our thermodynamic study on
the particular stability of Cu(I)–PTA complexes.
The  G° (PCM) of reaction (11), close to zero, shows that complexes [Cu(PTA)Clm]1 m
(m = 1, 2) have similar stability, and therefore it suggests that possibly formation of
1:1 Cu:PTA complex occurs in solution with the simultaneous formation of the linear
[Cu(PTA)Cl](aq) and the trigonal [Cu(PTA)Cl2]  complexes.
The positive  G° (PCM) for reaction (13) shows that the tetrahedral [Cu(PTA)2Cl2] 
complex should spontaneously dissociate one chloride to give [Cu(PTA)2Cl](aq). In addition,
reaction (12) shows that [Cu(PTA)2Cl](aq) is more stable than the linear [Cu(PTA)2]+. It
turns out that, among the three [Cu(PTA)2Clm]1 m complexes (m = 0–2), the trigonal
[Cu(PTA)2Cl](aq) results to be the more stable.
All the above findings indicate that the reactions leading to the formation of the first
two Cu(I)–PTA complexes occur without a quantitative displacement of chloride anions
from copper.
Free energies for reaction (14) and (15) indicate that formation of [Cu(PTA)3]+, occurs
with a quantitative removal of chloride from the metal center. In particular, the slightly
positive value of  G° (PCM) for reaction (14) suggests that the formation of [Cu(PTA)3]+
from [Cu(PTA)2Cl](aq) is somewhat unfavored, possibly, since it occurs through removal of
a tightly bound Cl .
The results obtained by this DFT study agree with our thermodynamic findings (see
section 2.2.3), according to which the formation of the first two PTA complexes occurs with
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Table 2.5.: Free energy reaction values, calculated in vacuum and in a continuum polarizable
medium (PCM).
Reaction DG° gas phase DG° (PCM)
(kJ/mol) (kJ/mol)
(1) [CuCl2]  +Cl    [CuCl3]2  296 10.5
(2) [CuCl2]  +H2O  [Cu(H2O)Cl] + Cl  187 53.6
(3) [CuCl2]  + PTA+H2O  [Cu(H2O)PTA]+ + 2Cl  672 114
(4) [CuCl2]  + PTA  [Cu(PTA)Cl] + Cl  115 – 15.5
(5) [CuCl2]  + PTA  [Cu(PTA)Cl2]  32.6 – 14.6
(6) [CuCl2]  + 2PTA  [Cu(PTA)2]+ + 2Cl  110 – 6.7
(7) [CuCl2]  + 2PTA  [Cu(PTA)2Cl] + Cl  120 – 36.4
(8) [CuCl2]  + 2PTA  [Cu(PTA)2Cl2]  40.2 – 27.6
(9) [CuCl2]  + 3PTA  [Cu(PTA)3]+ + 2Cl  95.4 – 35.1
(10) [CuCl2]  + 4PTA  [Cu(PTA)4]+ + 2Cl  101 – 55.2
(11) [Cu(PTA)Cl] + Cl    [Cu(PTA)Cl2]  – 82.0 0.9
(12) [Cu(PTA)2]+ +Cl    [Cu(PTA)2Cl] 10.5 – 30
(13) [Cu(PTA)2Cl] + Cl    [Cu(PTA)2Cl2]  – 79.9 8.8
(14) [Cu(PTA)2Cl] + PTA  [Cu(PTA)3]+ +Cl  – 24.7 1.3
(15) [Cu(PTA)2Cl2]  + PTA  [Cu(PTA)3]+ + 2Cl  55.2 – 7.5
(16) [Cu(PTA)3]+ + PTA  [Cu(PTA)4]+ 5.9 – 20.1
similar and high exothermicities ( H1 ⇡  H2 ⇡  55 kJ/mol), whereas formation of the
third and fourth copper-PTA complexes are markedly less exothermic ( H3 ⇡  H4 ⇡  38
kJ/mol) (see Table 2.2 on page 46).
The markedly less favorable enthalpy for the third coordination step agrees with the cal-
culated slightly positive  G° for reaction (14) in Table 2.5, which involves the displacement
of a chloride from the coordination sphere of the metal center.
2.3. Formation of Ag(I)–PTA complexes
The values of the formation constants of complexes Ag(I)–PTA were obtained by means
of a series of potentiometric titrations. Experiments were carried out in an aqueous solution,
in NaNO3 0.1 M at 25 °C. Since Ag(I), unlike Cu(I), is stable in aqueous solution, the
background electrolyte is not required to play a stabilizing effect, although it is required
for reliable thermodynamic equilibrium data (see appendix C on page 113). The study
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Figure 2.21.: potentials, E (mV) vs Vadd (mL) for titrations T1–T6. Squares, experimental values;
lines, calculated with stability constants and analytical data on Table A.3, p. 103. For clarity, some
experimental points are omitted.
was divided into three parts, in order to obtain separately: a) the protonation constant
of the phosphine; b) the formation constants of the silver complexes with the protonated
phosphine [HmAg(PTA)n]m+1, c) the formation constants of the silver complexes with the
neutral ligand, [Ag(PTA)n]+. The experimental data from potentiometric titrations (Vadded,
mL and E, mV) were processed with the Hyperquad 2006 minimization suite.
Study of the protonation of the ligand in NaNO3 0.1 M was carried out by adding known
volumes of a standard solution of HNO3 to solutions containing known concentrations of
PTA. The changes in pH during titrations were measured with a glass electrode. The
formation of silver(I) complexes was followed with a silver electrode, to determine the
concentration of free cation in the solutions. To follow the formation of the acidic complexes
[HmAg(PTA)n]m+1, the solutions of Ag(I) containing an excess of mineral acid (HNO3)
were titrated with acidic solutions of the phosphine. Speciation of complexes [Ag(PTA)n]+
with the unprotonated ligand was studied with the same approach, in solutions without
any excess of mineral acid.
Processing of experimental data with Hyperquad 2006 yielded the number, composition
and formation constants of the complexes in solution (see Table 2.6). Figure 2.21 shows
the experimental data (E, mV vs Vadded, mL) and the corresponding values calculated by
Hyperquad. The fit between experimental and calculated values is very good.
The enthalpies of formation of Ag(I)–PTA complexes were determined by means a series
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Figure 2.22.: stepwise reaction heats (mJ vs Vadded, mL.) for titrations T1–T6. Squares, experi-
mental values (Qexp); lines, calculated (Qcalc) with stability constants and analytical data in table
A.4, p. 103.
of microcalorimetric titrations. Measurements were carried out in the same experimental
conditions as the potentiometric studies. The stepwise experimental reaction heats (Qexp,
mJ) were processed with Letagrop, to obtain the values of the reaction enthalpies (see
Table 2.6 on p. 61). In this minimization process, the stability constants obtained by
minimization of potentiometric data were assumed as known parameters.
Figure 2.22 shows the data-fit for the calorimetric titrations. Also in this case, the match
between the experimental and calculated values is good.
2.3.1. Results
The speciation model for the formation of Ag(I)–PTA complexes which allows the best-fit
of the experimental data is consistent with that previously obtained for the analogous
Cu(I)–PTA complexes. Also in this case, the model is consistent with the presence of four
mononuclear successive complexes, with formula [Ag(PTA)n]+ (n = 1–4), forming when
the solution pH is close to neutrality or slightly basic, and three complexes containing the
acidic phosphine, with general formula [HmAg(PTA)n]m+1 (n = 1–3, m = 1, 2). Complexes
[Ag(PTA)n]+ do form according to an exothermic process and negative entropy, as in
the case of the corresponding complexes of copper. The stepwise formation constants
indicate that their stability decreases as the number of phosphine ligands increases. The
same predictable trend is observed for the stepwise stabilities of the [HmAg(PTA)n]m+1
complexes.
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Table 2.6.: Formation (stability) constants and corresponding thermodynamic functions for Ag(I)–
PTA and Ag(I)–(HPTA) complexes in NaNO3 0.1 M, T = 25 °C. In the Table: M = Ag+, L =
PTA, H = H+. Ionic charges omitted for convenience.
species log   ± 3   G± 3   H± 3  T S± 3 
kJ/mol kJ/mol kJ/mol
HL 5.72± 0.01  32.65± 0.06  15.6± 0.3 17.1± 0.3
ML 8.19± 0.01  46.75± 0.06  56.3± 0.5  9.6± 0.5
ML2 13.67± 0.02  78.0± 0.1  97.7± 0.7  19.7± 0.7
ML3 17.67± 0.02  100.9± 0.1  135.6± 0.9  34.7± 0.7
ML4 20.35± 0.12  116.2± 0.7  177.3± 1.8  61.1± 1.9
HML 12.02± 0.01  68.62± 0.06  61.6± 1.3 7.0± 1.3
H2ML2 21.14± 0.02  120.7± 0.1  112.4± 4.3 8.3± 4.3
HML2 17.72± 0.04  101.2± 0.2  104.8± 5.8  3.6± 5.8
H2ML3 26.40± 0.09  150.7± 0.5  135.4± 8.2 15± 8
reaction logK± 3   Gstep ± 3   Hstep ± 3  T Sstep ± 3 
kJ/mol kJ/mol kJ/mol
H+ L  HL 5.72± 0.01  32.65± 0.06  15.6± 0.3 17.1± 0.3
M+ L  ML 8.19± 0.01  46.75± 0.06  56.3± 0.5  9.6± 0.5
ML + L  ML2 5.48± 0.02  31.3± 0.1  41.4± 0.9  10.1± 0.9
ML2 + L  ML3 4.00± 0.03  22.9± 0.1  37.6± 1.1  14.7± 1.1
ML3 + L  ML4 2.68± 0.12  15.3± 2.0  41.7± 2.0  26± 3
M+ (HL)  M(HL) 6.30± 0.01  35.96± 0.08  46.0± 1.3  10.0± 1.3
M(HL) + (HL)  M(HL)2 3.40± 0.02  19.4± 0.1  35.2± 4.5  16± 5
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A fourth acidic complex with formula [Ag(PTA)(HPTA)2]3+ was suggested by Hyperquad
2006 treatment of potentiometric data, although, the value of the stepwise stability constant
of this complex is very small and its possible presence in solution is limited to very acidic
conditions (pH < 3).
The stability constants of the silver–PTA complexes were used to calculate (HySS 2009
program) [116] some speciation diagrams which provide the relative percentage distribution
of the silver complexes as a function of the ligand to metal molar ratio. In particular, Figure
2.23(a) shows the diagram of a solution with a total Ag+ concentration close to that of the
ESI-MS experiments and biological in vitro trials (see Introduction). Speciation plots show
that the dicoordinate [Ag(PTA)2]+ complex is the prevailing species in solution, when the
concentration of silver is 10 5 M, molar ratio Ag to PTA is 1:4 (equal to that achieved
when the solid complex is dissolved in aqueous solution) and the solution pH is close to 7.3.
Figure 2.23(b) shows the speciation plot when the total silver concentration in solution is
10 2 M, near that used in NMR experiments. In this case, the speciation plots shows that
the prevalent species in solution is the tetracoordinate [Ag(PTA)4]+, partially dissociated
as [Ag(PTA)3]+, and the negligible presence of the dicoordinated complex. The plots in
the figure indicate that, in general and regardless of silver concentration, the presence
in solution of protonated species is certainly negligible at physiological pH (pH = 7.32).
Instead, these species appear in solution at about pH = 5 (Figure 2.24(a)) and become
prevalent at pH < 4 (Figure 2.24(b)).
For information on the above equilibria, some 31P{1H}–NMR spectra of v 10 2 M
solutions of complex [Ag(PTA)4]+ were collected. However, the experiments provided few
indications, since the spectra only showed a single broad peak of 31P, shifted to higher fields
than the corresponding signal of the free phosphine. Such a spectrum certainly reflects
coordination of the phosphine to the metal center, although the exchange kinetics between
the free and coordinated ligands is too rapid to obtain any valuable information.
Interesting information regarding the nature of the complexes in solution came from
the trend of the values of logKstep of complexes [Ag(PTA)n]+ in solution, concerning the
reactions shown in Tables 2.7 and 2.6 on page 61.
The values of logKn show that the difference between the formation constants of the first
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(a) (b)
Figure 2.23.: Ag+ speciation plots: percentage distribution of Ag+–PTA complexes, relative to
[Ag+]tot as function of PTA/silver molar ratio, CL/CM; pH = 7.32. (a) [Ag+]tot = 10 5 M; (b)
[Ag+]tot = 10 2 M.
(a) (b)
Figure 2.24.: Ag+ speciation plots: percentage distribution of Ag+–PTA complexes, relative to
[Ag+]tot as function of PTA/silver molar ratio, CL/CM and [Ag+]tot = 10 2 M. (a) pH = 5.0;
(b) pH = 4.0.
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Table 2.7.: stepwise formation constants of Ag(I)–PTA complexes . M = Ag+, L = PTA (ionic
charges omitted for convenience).
reaction logKn, step   logKn
M+ L  ML 8.19
2.7
ML+ L  ML2 5.48
1.5
ML2 + L  ML3 4.00
1.3
ML3 + L  ML4 2.68
two complexes is larger by more than one order of magnitude, compared with the difference
between the formation constants of the successive species, which varies very little. These
trends in Kn, characterized by discontinuities in the decrease of the formation constants of
the successive complexes, are often the result of variations in coordinative geometries at the
metal center during the formation of the species. In the case of Cu(I)–PTA complexes, as
previously discussed, the formation of the Cu–P bonds was accompanied by displacement
of chloride anions from the coordination sphere of the metal: thus, the thermodynamic
functions related to the formation of the phosphino complexes which we calculated reflect
presence of chloride ions in some of them. The formation of Ag(I)–PTA complexes obviously
does not involve such mechanisms, and the relative difficulty concerning the formation
of the second complex may be related with the particular nature of the silver aquoion in
solution. A recent EXAFS study in solution showed that the structure of the aquoion
complex of Ag(I) is characterized by coordinative geometry intermediate between linear
and tetrahedral [117]. In particular, the results of the study indicate that Ag(I) coordinates
up to two water molecules, with a significant covalent contribution, leading to a complex
with linear structure. Ag(I) is affected by the electrostatic interaction of two other weakly
bonded water molecules, which significantly alter its structure to that similar to a distorted
tetrahedron.
Thermodynamic parameters for the stepwise formations of Ag(I)–PTA complexes, shown
in Table 2.6 on page 61, clearly show the origin of their enthalpic stability. All the enthalpy
values are negative (they favor the formation of the complexes), whereas the entropies
of reaction, also negative, act in the opposite direction. This observation matches the
64
2.3. Formation of Ag(I)–PTA complexes
considerations made for the similar Cu(I)–PTA complex. The values of DHj,step also show
that DH1,step is very different, and more favorable, than the other three: DH1,step =  56.3
kJ/mol, as opposed to DHj,step ⇡ 40 kJ/mol for j = 2–4. The entropic term is always
unfavorable to the course of the reaction, especially in the last stage of complexation.
According to the indications concerning the structure of Ag(I) aquoion, the first coordina-
tion of the phosphine to the metal center may be interpreted as reflecting displacement of
one, or both, of the more labile water molecules from the coordination sphere of Ag(I). The
values of DHj,step and TDSj,step for the coordination of the second and third phosphines
to the metal would indicate substitution reactions involving similar mechanisms, whereas
the value of TDS4,step, much lower than the previous, may be the consequence of a change
in the coordinative structure at the metal center, from trigonal to tetrahedral. This may
also account for DH4,step, more favorable, since the transition from trigonal to tetrahedral
coordination should not involve displacement of water molecules from the solvation sphere
of the metal.
2.3.2. Comparisons between Cu(I) and Ag(I) complexes of PTA
As already noted, the formation of complexes Cu(I)–PTA in 1 M NaCl takes place
through a series of substitution reactions of chloride ions from the coordination sphere
of Cu(I) by PTA, whereas formation of Ag(I) complexes, in 0.1 M NaNO3, is due to the
ability of the ligand to displace water molecules from the solvation sphere of the metal.
Taking into account the chloride competition (see Table 2.1 on page 32) the “true” formation
constants between the free Cu(I) ion and PTA would be higher by approximately two orders
of magnitude than the values reported in Table 2.2, p. 46.
The histogram and diagram of Figures 2.25 and 2.26 (data in Table 2.8) compare the
values of the stepwise thermodynamic functions for the formation of the four mononuclear
complexes of Cu(I) and Ag(I) with PTA. Both figures show the difference between the
thermodynamic functions characterizing the formation of complexes of Cu(I) and Ag(I).
In particular, the formation of the first two species occurs with  DG1,Cu <   G1,Ag and
 DG2,Cu ⇡   G2,Ag whereas the values of  DG3,Cu and  DG4,Cu are higher than those
for Ag(I) complexes.
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Figure 2.25.: stepwise thermodynamic func-
tions for the formation of four successive com-
plexes [M(PTA)n]+ (M = Ag(I), Cu(I); L =
PTA; n = 1–4).
Figure 2.26.: trends of stepwise thermody-
namic functions for the formation of four suc-
cessive complexes [M(PTA)n]+ (M = Ag(I),
Cu(I); L = PTA; n = 1–4).
Table 2.8.: comparison between the stepwise formation constants of the [M(PTA)n]+ complexes
(M = Cu+, Ag+, L = PTA). Ionic charges omitted for convenience.
Reaction logK ± 3sv DGstep ± 3  DHstep ± 3  TDSstep ± 3 
kJ/mol kJ/mol kJ/mol
M = Cu+ Ag+ Cu+ Ag+ Cu+ Ag+ Cu+ Ag+
M+ L  ML 6.3± 0.6 8.19± 0.01  36± 3  46.75± 0.06  53± 2  56.3± 0.5  17± 4  9.6± 0.5
ML + L  ML2 5.8± 0.7 5.48± 0.02  33± 4  31.3± 0.1  57± 5  41.4± 0.9  24± 7  10.1± 0.9
ML2 + L  ML3 5.6± 0.7 4.00± 0.03  32± 4  22.9± 0.1  38± 5 -38±1  6± 7  15± 1
ML3 + L  ML4 3.7± 0.8 2.7± 0.1  21± 5  15± 2  40± 1  42± 2  19± 5  26± 3
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The histogram shows also that the first two Cu(I) complexes form with very high
reaction enthalpies ( DH1,step <  DH2,step), favorable to complexation, and negative
entropies, unfavorable ( TDS1 <  TDS2). Instead, the formation of the corresponding
Ag(I) complexes occurs with  DH1,step >  DH2,step and  TDS1,step ⇡  TDS2,step. As a
result of the compensation between the enthalpic and entropic contributions, the decrease
in free energy for the formation of the first Cu(I) complex is lower than that of the first
Ag(I) complex, whereas the values of  DG2 for the formation of the complexes ML2 are
similar.
The formations of the third and fourth complex of Cu(I) and Ag(I) show an opposite
trend: the enthalpy values are similar for both complexes ( DH3,step   DH4,step), whereas
the entropies of formation of silver complexes are more unfavorable than those of copper.
It follows that the stability of [Cu(PTA)3]+ and [Cu(PTA)4]+ is higher than that of
[Ag(PTA)3]+ and [Ag(PTA)4]+.
Figure 2.25 shows that the stability of the complexes of the two metals with PTA decreases
as the number of ligands coordinated to them increases. However, whereas this decrease is
quite regular for Ag(I) complexes, the stability trend for the copper complexes is almost
constant for the first three species, whereas the formation of the fourth complex occurs
with a significant decrease in  DG4.
In addition, the stability order of the copper and silver complexes is: K1,Cu < K1,Ag;
K2,Cu ⇡ K2,Ag; K1,Cu and K3,Cu > K1,Ag and K3,Ag. This apparently anomalous trend in
the stabilities of the first two Cu(I) complexes may reflects the energy demand required to
remove the chloride ions from the coordination sphere of the metal. This would lead to an
increase of charged and more solvated species in solution which exert a greater ordering
effect.
2.4. Formation of Cu(II), Ag(I), Cu(I) complexes with the
amino acid methionine in aqueous solution
The natural amino acid methionine, HMet, is a chemical species which gives two acid-base
equilibria in aqueous solution, according to the scheme in Figure 2.27.
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H3N COOH
S CH3 -H+
H3N COO
S CH3 -H+
H2N COO
S CH3
H2Met+
pKa = 2.22 pKa = 9.08
HMet Met-
Figure 2.27.: successive protonation equilibria of amino acid methionine.
In order to study: a) the protonation reactions of the aminic and carboxylic acid
functions of HMet; b) the formation of methionine complexes with Cu(II), c) the formation
of methionine complexes with Cu(I) and Ag(I), three sets of microcalorimetric titrations
were carried out.
2.4.1. Protonation of methionine in aqueous solution
Methionine (Aldrich, pur. > 99%) was purified by recrystallization from water. The
resulting product is the neutral species (HMet), present in solution as a zwitterion.
Study of the protonation of the amine and carboxyl functions of HMet consisted of a
series of microcalorimetric titrations in aqueous solution and an ionic medium of NaCl 1.0
M at 25°C. During these titrations, solutions of methionine with known concentrations
(2.5–10.5 mM) were titrated with solutions of strong mineral acid (ca. 0.5 M) or base (ca.
0.1 M) (analytical data in Table A.5, p. 103). The values of the two protonation constants
of the ligand and the related enthalpies were simultaneously obtained by minimizing the
enthalpy data (Qobs, mJ vs. Vadded, µL) with the program Letagrop (results in Table 2.12
p. 78). Figure 2.28 shows the good match between the experimental data (dotted line) and
those calculated (solid line). Figure 2.28(a) shows the total heat measured as a function of
the volume of titrant; Figure 2.28(b) shows the Dhv value (overall formation enthalpy of
protonated species per mole of H+ added) as a function of the average number of protons
coordinated to methionine (Nbar).
It is interesting to note that the logK values obtained as a result of minimization of the
microcalorimetric data clearly match those obtained in previous potentiometric studies
[118]. Comparison of the values determined in this study and those in the literature are
listed in Table 2.9.
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(a) (b)
Figure 2.28.: (a) Qtot, mJ vs Vadd, µL; (b) Dhv vs Nbar; ⌥ T1, T2,   T3, T4 (see Table
A.5, p. 103).
Likewise, the values of the protonation enthalpies fit those estimated in one of the previous
works [96] through the Van’t Hoff relation, and with those obtained by Grigorova [119] by
means of a calorimetric study of the solvatation heats of methionine in water.
Table 2.9.: comparison between the values of the protonation constants and protonation enthalpies
of methionine and determined in this study (see Table 2.12) with those in the literature.
reaction H+ +Met    HMet H+ +HMet  [H2Met]+
logK1  H1, kJ/mol logK2  H2, kJ/mol
Pettit, 1981 [118] 9.06 – 2.14 –
25°C, 0.10 M (KNO3)
Sharma, 2003 [96] 9.15 –44.7 (*) 2.25 –2.8 (*)
25°C, 0.10 M (NaCl)
Grigorova, 2010 [119] 9.22 –44.3 1.97 –7.2
25°C, (water)
This work 9.08 –46.3 2.20 –3.8
25°C, 1.0 M (NaCl)
(*) 0.25 M (NaCl)
These results represent another clear indication of the reliability and accuracy of the results
which can be achieved when the microcalorimetric approach is applied to complex formation
equilibria in solution. In addition, the excellent match between the thermodynamic
quantities of the protonation reactions of methionine obtained here and those in the
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literature is an example of the flexibility of the technique, since the protonation equilibria
of the amino acid have values which differ by several orders of magnitude.
2.4.2. Formation of Cu(II) complexes with methionine
This study was carried out because, in view of the ease with which Cu(I) can be oxidized to
Cu(II) by atmospheric oxygen, we were interested in evaluating what kind of side-reactions
would occur between methionine and Cu(II), in the following study HMet/Cu(I).
The anhydrous CuCl2 salt used to prepare Cu(II) solutions, subsequently employed for
thermodynamic studies, was prepared by recrystallization from water of the dihydrate salt
(Aldrich> 99%), followed by dehydration under vacuum at 120 °C for 24 hours, according
to published procedure [120].
Preliminary titrations were first carried out, to verify that Cu(II) does not interact at all
with HMet in acidic environment. During these experiments, an acidic (pH = 2–3) HMet
solution was added to dilute solutions of CuCl2 (0.10–1.0 mM) with an excess of mineral
acid (approximately 1.0 mM). During these experiments no heat changes were observed,
indicating that, in these regions of pH, Hmet, which is the dominant species in solution,
has no affinity for Cu(II). Since the amino group of methionine is protonated in acidic
solution, the result was expected according to many data in the literature [121–123], which
report that methionine can only bind Cu(II) via its amino group. For instance, Lenz and
Martell [121], by a series of potentiometric measurements, showed that methionine forms
two successive mononuclear complexes, [Cu(Met)]+ and [Cu(Met)2](aq), quite strong (logK1
= 7.87, logK2 = 6.85), but not strong enough to be formed at acidic pH. More recently,
Tewari [123], by means of electrophoretic techniques, obtained logK values lower than those
of Lenz and Martell (log K1 = 6.40, logK2 = 4.50) (see Table 2.10).
A successive series of microcalorimetric titrations was then carried out in order to study
the formation of copper(II)–methionine complexes in slightly basic conditions. In this study
we measured the heat changes in the calorimeter cell when known volumes of a buffer
solution HMet/Met  (pH = 8–9) were added to diluted solutions of CuCl2 (0.10–1.0 mM).
All experiments were carried out in NaCl 1.0 M at 25 °C (analytical data in Table A.6 on
page 104).
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Table 2.10.: comparisons between formation constants and enthalpies of complexes [Cu(Met)]+,
[Cu(Met)2](aq) obtained in this study, with those in literature.
reaction Cu2+ +Met    [Cu(Met)]+ [Cu(Met)]+ +Met    [Cu(Met)2](aq)
logK1  H1, kJ/mol logK2  H2, kJ/mol
Lenz, 1964 7.87 – 6.85 –
25°C, 0.10 M (KNO3)
Tewari, 2007 6.40 – 4.50 –
25°C, 0.10 M (KNO3)
This work 8.42 –26.3 5.78 –31.9
25°C, 1.0 M (NaCl)
In this case too, the thermodynamic functions for the complex formation ( j and DHj)
were obtained by processing only the experimental data from microcalorimetric titrations
by Letagrop. In this way, we obtained the formation constants and related DH of two
successive copper(II)–methionine complexes. The values of the formation constants of these
complexes (logK1 = 8.42, logK2 = 5.78) do not confirm any of the previous results even if
they are closer to those reported by Lenz and Martell (see comparisons in Table 2.10). It is
of interest to point out that the protonation constants of methionine we have obtained with
the microcalorimetric study match those in the literature. So, we are confident that also the
stability data reported herein are a better estimate of the formation constants of the Cu(II)
complexes. The values of formation enthalpies, which have never been measured before,
match those expected according to the interaction of an amino group with a divalent metal
ion [124]. The complex formation is favored by an exothermic process, which generally
accompanies also the formation of complexes between Cu(II) and other amines.
In conclusion, by these studies we determined the optimal pH conditions to carry out
successive speciation experiments between Cu(I) and methionine (pH < 7) and avoid, at
the same time, any interference due to the possible formation of complexes of Met  with
Cu(II) in the case of unwanted oxidation of Cu(I). In addition, with this study we obtained
accurate data on the thermodynamic formation functions (DGj, DHj, TDSj) of complexes
of Cu(II) with methionine. Some of these data (the reaction enthalpies) were not previously
available in the scientific literature, although they are useful for a more comprehensive
overview about the affinity of this amino acid toward soft divalent cations, such as Cu(II),
in aqueous solution.
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2.4.3. Formation of Cu(I) complexes with methionine
As it was shown, the complex formation between Cu(II) and methionine is pH-dependent,
on the contrary, Cu(I) binds methionine through a pH-independent process where the
thioether sulfur, which does not undergo acid-base reactions in solution, is involved [23, 24].
In general, studies of the formation of complexes between Cu(I) with biological substrates,
even with simple amino acids, are very rare in the literature, probably because of the
considerable experimental difficulties related to the intrinsic instability of Cu(I) in water.
Rubino et al. recently quantified [21, 22], by means of ESI mass spectrometry and circular
dichroism UV-vis absorption techniques, the interaction between Cu(I) or Ag(I) and some
“Mets” peptide sequences like “MXXM” and “MXMXXM” (M = methionine residue, X =
several amino acid residues). As previously discussed (see Introduction), these sequences
are the main coordination site for Cu(I) in membrane proteins hCtr1, used for specific
intracellular intake of copper. Results showed that these peptide sequences have good
affinity toward Cu(I) and coordinate the metal through the thioether groups of methionine
residues, with stability constant values in the range of 105   106 mol 1dm3. The study
also shows that the affinity of Cu(I) toward these substrates increases with the number of
methionines in the chain, up to a maximum of three residues. This observation suggests
that Cu(I) can coordinate no more than two or three thioether groups of the same peptide
sequence, as shown in Figure 2.29.
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The study of the complexation of Cu(I) by methionine was carried out to gain information
about the stability of complexes Cu(I)–HMet in conditions similar to those in biological
systems, and also to provide reliable data about possible side-reactions. At the same time,
we studied the interaction of Ag(I) with methionine, to compare the relative affinities of
the two monovalent cations toward the amino acid.
The formation of Cu(I)–Hmet complexes was studied by microcalorimetry, according
to the method already used for the studies of Cu(I)–PTA complexes. Also in this case,
experiments were carried out in aqueous solution, in the presence of a constant ionic medium
of NaCl 1.0 M, at 25°C. Experimental data (Qreact, mJ vs Vadd, mL), were processed by
Letagrop.
In a first set of experiments, solutions of methionine of known concentration or buffer
solutions HMet/Met  were titrated with solutions of Cu(I) (for analytical data, see Table
A.7 on page 104). During a subsequent series of titrations, concentrated methionine solutions
(0.100 M) were added to solutions of Cu(I) (1.0 – 5.0 mM). The initial acidity of the metal
solution was maintained at pH ⇡ 3 by adding known volumes of standard HCl to the
calorimeter cell. In these experimental conditions, the only species in solution is HMet,
which, as previously shown, is unable to bind Cu(II) but able to coordinate Cu(I), through
its thioether group.
Also in this case data processing was carried out by Letagrop. Various speciation models
were examined and tested during the minimization process, since the maximum number of
ligands which the metal can coordinate was uncertain from the literature data. The best
data fit was consistent with the formation of two successive complexes, [Cu(HMet)]+ and
[Cu(HMet)2]+. Diagrams in Figure 2.30 show the excellent match between the experimental
values and those calculated on the basis of the formation constants and enthalpies of reaction,
obtained by minimization (see Table 2.12 on page 78).
The stepwise formation constants in Table 2.11 show that Cu(I)–methionine complexes
are markedly weaker than Cu(I)–PTA ones. The soft thioether group is known to be
relatively weak-coordinating toward a number of transition metal ions, especially those with
a hard character (see Appendix B). In addition, HMet does not compete as effectively as
PTA toward the chloride of the ionic medium (1.0 M). The formation constants determined
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(a) (b)
Figure 2.30.: (a) Qtot, mJ vs Vadd, µL; (b) Dhv vs Nbar; ⌥ T1, T2,   T3, T4, T5 (see
Table A.7, p. 104, T6 not reported for sake of clarity).
with this study are significantly lower than those reported by Rubino [21] for the formation
of adducts between Cu(I) and “Mets” peptide sequences. The individual contributions of
Cl  and HMet toward stabilization of complexes Cu(I)–HMet in NaCl 1.0 M cannot be
assessed only on the basis of thermodynamic results. Consequently, neither the competition
reactions between chlorides and methionine toward coordination of copper(I) nor the number
of chlorides the complexes contain can be ascertained. According to the trends of the
stepwise formation functions of the two species [Cu(HMet)j]+ (j = 1, 2, see Table 2.11),
only a qualitative hypothesis about the stoichiometry of these complexes in solution can
be proposed. Thermodynamic data show that, whereas the formation enthalpy of both
complexes is exothermic, as expected in the case of soft-soft interactions, the entropy
change is only slightly negative for the first formation step and significantly negative for
the second one. The marked difference in entropic terms and the higher exothermicity for
the formation of the second adduct are compatible with the displacement from Cu(I) in the
first coordination step of two and one chloride anions, respectively, as shown in reaction
scheme (2.17).
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[CuCl3]2  +HMet  [CuCl(Met)](aq)+2Cl 
[CuCl2]  +HMet  [CuCl(HMet)](aq)+Cl 
[CuCl(Met)](aq) +HMet  [Cu(HMet)2](aq)+Cl 
(2.17)
Here too, a theoretical DFT study is planned to compare the calculated energies involved
in these processes, together with the observed stabilities of the Cu(I)–Cl–HMet adducts in
solution.
Table 2.11.: stepwise formation constants and related thermodynamic functions of [Cu(HMet)]+,
[Cu(HMet)2]+ complexes (see Table 2.12). HL = HMet. Ionic charges omitted for convenience
reaction logK± 3   Gstep ± 3   Hstep ± 3  T Sstep ± 3 
kJ/mol kJ/mol kJ/mol
Cu(I) + (HL)  Cu(I)(HL) 2.52± 0.65  14.4± 3.7  16.8± 7.9  2± 9
Cu(I)(HL) + (HL)  Cu(I)(HL)2 2.0± 1.0  11.5± 5.9  53± 12  41± 13
Cu(I) + 2(HL)  Cu(I)(HL)2 4.54± 0.79  25.9± 4.5  69.8± 9.0  44± 10
2.4.4. Formation of Ag(I) complexes with methionine
In order to study the system Ag(I)–PTA, a series of microcalorimetric titrations was
performed. Experiments were carried out in NaNO3 0.100 M at a constant temperature of
25 °C. Titrations were carried out over a wide range of acidities (pH = 3.0 – 9.8). To study
the formation of silver complexes with HMet or Met , the heat changes were collected,
measured when known volumes of methionine or HMet/Met  buffer solutions were added
to solutions of Ag(I) (1.0 – 4.0 mM) in the presence of different excess of mineral acid (0.02
– 10.0 mM) (analytical data in Table A.8 on page 104). The results of the minimizations of
the sum of the squares of the difference between experimental and calculated heat changes
with Letagrop are consistent with the formation of two complexes in acidic or nearly neutral
pH conditions ([Ag(HMet)]+ and[Ag(HMet)2]+) and a third species, [Ag(Met)](aq), forming
at basic pHs (8 – 9.8). The formation constants of these species agree with those previously
obtained by Pettit in KNO3 0.1 M [118] by means of potentiometric measurements (seeTable
2.12).
Also in this case, the fit between experimental and calculated data testifies the good
representation of the solution equilibria obtained by using the microcalorimetric technique
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(a) (b)
Figure 2.31.: (a) Qtot, mJ vs Vadd, µL; (b) Dhv vs Nbar; ⌥ T1, T2,   T3, T4, T5 (see
Table A.8, p. A.8, T6, T7 not reported for sake of clarity).
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Figure 2.32.: Ag(I)–methionine adduct formed in basic pH conditions (pH > 9).
to calculate simultaneously the enthalpies and the stability constants of the species in
solution (see Figure 2.31 ). The formations of [Ag(HMet)]+ and [Ag(HMet)2]+ are enthalpy
driven processes. The entropic factors, TDSj, do not give any particular contribution to
the stability of the species. Similar trends are typical for soft-soft interactions.
The formation constant of [Ag(Met)](aq) is greater than that of [Ag(HMet)]+: logK =
4.58 and 3.98, respectively. Since the main interaction which stabilizes both complexes is the
same, the relatively small difference between the unprotonated and protonated complexes
could be ascribed to the formation of a six-term chelate complex trough the coordination of
the deprotonated amino group (see Figure 2.32). According to this hypothesis the enthalpy
of formation of unprotonated complex is much more negative than that of the protonated
one, whereas its formation entropy is much more unfavorable.
The formation constant of [Ag(HMet)2]+ is greater by about three order of magnitude
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than that of [Cu(HMet)2]+. Then, even if the competition between copper(I) and chloride,
characterizing our Cu(I)–HMet study, is taken into account, this result shows that the silver
complexes with methionine are stronger than those of Cu(I). This is in agreement with the
Rubino’s studies [21, 22] which indicate that Mets sequences certainly bind silver(I), and
do so preferentially over copper(I).
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Table 2.12.: Formation (stability) constants and corresponding thermodynamic functions for the
systems H+/Ag+/methionine (NaNO3 0.1 M); Cu2+/methionine and H+/Cu+/methionine (NaCl
1.0 M); T = 25 °C. In the Table: L = PTA, H = H+. Ionic charges omitted for convenience.
species log   ± 3   G± 3   H± 3  T S± 3 
kJ/mol kJ/mol kJ/mol
HL 9.08± 0.37  51.8± 2.1  46.3± 0.1 5.5± 2.1
H2L 11.3± 0.5  64.5± 2.9  50.1± 0.3 14.4± 2.9
AgL 4.58± 0.45  26.1± 2.6  54.6± 0.8  28.5± 2.7
HAgL 12.9± 0.6  73.4± 3.5  75.6± 2.4  2± 4
H2AgL2 25.0± 0.4  143± 2  140± 3 3± 4
HCu(I)L 11.4± 0.6  65.1± 3.3  63.0± 7.9 2± 9
H2Cu(I)L2 22.3± 0.7  127± 4  162± 9  34.9± 9.7
Cu(II)L 8.42± 0.09  48.1± 0.5  26.3± 0.2 21.8± 0.5
Cu(II)L2 14.2± 0.6  81.0± 3.4  58.2± 0.6 22.9± 3.5
reactions logK± 3   Gstep ± 3   Hstep ± 3  T Sstep ± 3 
kJ/mol kJ/mol kJ/mol
H+ L  HL 9.08± 0.37  51.8± 2.1  46.3± 0.1 5.5± 2.1
(HL) + L  H2L 2.2± 0.6  12.7± 3.6  3.8± 0.3 8.9± 3.6
Ag + L  AgL 4.59± 0.44  26.2± 2.5  54.6± 0.8  28.4± 2.6
Ag + (HL)  Ag(HL) 3.98± 0.69  22.7± 3.9  29.4± 2.4  7± 5
Ag(HL) + (HL)  Ag(HL)2 3.24± 0.90  18.5± 5.2  17.7± 4.1 1± 7
Ag + 2(HL)  Ag(HL)2 7.22± 0.58  41.2± 3.3  47.1± 3.4  6± 5
Cu(I) + (HL)  Cu(I)(HL) 2.52± 0.65  14.4± 3.7  16.8± 7.9  2± 9
Cu(I)(HL) + (HL)  Cu(I)(HL)2 2.0± 1.0  11.5± 5.9  53± 12  41± 13
Cu(I) + 2(HL)  Cu(I)(HL)2 4.54± 0.79  25.9± 4.5  69.8± 9.0  44± 10
Cu(II) + L  Cu(II)L 8.42± 0.09  48.1± 0.5  26.3± 0.2 21.8± 0.6
Cu(II)L + L  Cu(II)L2 5.78± 0.61  33.0± 3.5  31.9± 0.6 1± 4
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CHAPTER 3
Relationship between ESI behavior, stability and cytotoxic
activity of M(I) phosphino complexes
Mass Spectrometry (MS) is a powerful analytical technique, useful as test bench to obtain
information on the biological activity of target compounds. Since MS allows to examine the
speciation of analytes in solution, it make also possible to investigate the stability of active
compounds, predict their behavior in the environment of interest, and obtain structure-
reactivity relationships for new molecules with potential pharmacological applications. For
example, electron ionization and metastable-ion studies provide evidence of correlations
between the mutagenic properties of a series of aryl and heteroaryl triazenes and mass
spectrometric data [125, 126]. Similarly, a linear relationship between the energetics of
C(O)–O bond cleavage of some carbamic acid O-aryl esters and their fatty acid amide
hydrolase (FAAH) inhibition activity has been proven by electrospray-ionization ion-trap
mass spectrometry [127–129].
Interestingly, MS studies on compounds with potential applications in medicine can
usually be carried out in solutions where the concentration of the pro-drug the ionic medium
and pH conditions are close to those of biological trials.
In view of our interest in evaluating Cu(I)–PTA complex stability in solution, a series of
MS experiments on dilute solutions of the complex [Cu(PTA)4][PF6] were carried out. The
results of these experiments have recently been published [130]. They provide useful com-
parisons with those from thermodynamic studies on the formation of Cu(I)–PTA complexes,
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Figure 3.1.: structures of the coinage metal-phosphine complexes which stability in solution have
been studied by ESI-MS and cytotoxicity in vitro tested (M = Cu+, Ag+, Au+).
and give deeper insights into the correlation between the stability of the complexes and their
behavior in biological tests. A previous study [72] demonstrated an inverse correlation be-
tween the stability of these copper phosphino complexes and their in vitro biological activity.
Results of this study showed that solid complexes [Cu(PTA)4][X] ([X] = [BF4] , [PF6] ),
once dissolved in aqueous solutions at micromolar concentrations (near those employed in
biological trials) are partially dissociated to lower stoichiometry species [Cu(PTA)3]+ and
[Cu(PTA)2]+. The inverse relationship between the thermodynamic stability in solution
and biological activity of these complexes suggested that the dissociation of one or more
phosphine ligands from the metal center is the process underlying the biological activity of
these compounds.
A new series of ESI-MS studies has also been extended to [Ag(PTA)4]+, [Au(PTA)4]+
and [Cu(thp)4]+ complexes (Figure 3.1). In the next sections a comparison between the
stabilities of the different complexes found in ESI-MS conditions and in thermodynamic
studies will be discussed.
The last section of this chapter reports the results of in vitro cytotoxicity assays of these
compounds.
3.1. Experimental
Samples. Phosphino copper(I) complexes [Cu(thp)4][PF6] and [Cu(PTA)4][PF6] were
prepared according to published procedures [12, 73]. [Ag(PTA)4][PF6] and [Au(PTA)4][PF6]
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were synthesized as reported elsewhere [74].
MS measurements. Mass spectra were obtained with a LCQ Fleet Thermo-Scientific
mass spectrometer equipped with an ESI ion trap operating in the positive ion mode.
All compounds were solubilized in milliQ water, giving stock solutions of about 10 2 M.
These were subsequently diluted to about 10 5 M solutions in milliQ water, methanol or
acetonitrile, and directly infused into the ESI source by syringe at a flow rate of 8 ml/min.
Ions were produced with a spray voltage of 4 kV and entrance capillary temperature of
280°C. Other instrumental parameters were adjusted for each solution to optimize the
signal-to-noise ratio. Tandem mass spectrometric (MS/MS) experiments were performed
by resonant excitation of the ion of interest through a supplementary r.f. voltage in the
range 10-35% of its maximum value (5 V peak-to peak). The isolation width was set at 1
mass unit for the gold complex and 4 for copper and silver complexes.
3.1.1. Results and discussion
In a previous mass spectrometry study, focused on [Cu(thp)4]+ and [Cu(PTA)4]+, it
was established that such complexes undergo dissociation in ESI(+) conditions, with
the formation of coordinative unsaturated [Cu(P)3]+ and [Cu(P)2]+ species (P = thp,
PTA). That study was performed in water, in order to simulate physiological conditions.
Dissociations were accomplished with the production of water adducts for both complexes,
indicating that the solvent probably plays a role in the decomposition of the original species
and/or the rearrangement of collisionally generated fragments inside the ion trap.
To clarify the function of the solvent, metal complexes [M(PTA)4]+ were dissolved in
three solvents suitable for MS studies: water, methanol, and acetonitrile. The ESI(+)
spectra of solutions of complex [Cu(PTA)4]+ in the three solvents are shown in Figure
3.2. Almost overlapping behavior was observed for metal-based adducts in the water and
methanol solutions, showing the most abundant ion at m/z 377, corresponding to the
bis-substituted [Cu(PTA)2]+ species. Less abundant ions at m/z 534 and m/z 158 were
attributable to the tris-substituted [Cu(PTA)3]+ species and the protonated form of the
phosphine ligand (HPTA)+. Instead, the spectrum in acetonitrile showed a quite different
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Figure 3.2.: ESI(+) spectrum of [Cu(PTA)4]+ in water (a), methanol (b), and acetonitrile (c)
profile, with a base peak at m/z 261 attributable to solvent adduct [Cu(PTA)·(MeCN)]+
and low abundant ions at m/z 377 and 220, corresponding to bis-substituted [Cu(PTA)2]+
and mono-substituted [Cu(PTA)]+ species, respectively.
Also in the case of [Cu(thp)4]+ solvent-dependent behavior was detected in the in
acetonitrile solution, adduct [Cu(thp)·(MeCN)]+ (m/z 228) being the base peak in the
ESI(+) spectrum (Figure 3.3). Low abundant ions at m/z 435 and 311 corresponded to
coordinative unsaturated [Cu(thp)3]+ and [Cu(thp)2]+ species, respectively, and that at
m/z 145 corresponded to the bis-solvent adduct [Cu(MeCN)2]+, never previously detected.
The [Ag(PTA)4]+ spectra in the three solvents were instead dominated by the ion at m/z
421, corresponding to the bis-substituted [Ag(PTA)2]+ species. Only in the acetonitrile
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Figure 3.3.: ESI(+) spectrum of [Cu(thp)4]+ in acetonitrile.
solution were some other low abundant ions observed, at m/z 305 and 158, corresponding to
solvent adduct [Ag(PTA)·(MeCN)]+ species and the protonated form of PTA, respectively.
Another peak including two silver ions at m/z 556, attributable to the rearranged adduct
[Ag(PTA)2·AgCN]+, was also detected.
Irrespective of the solvent used, the [Au(PTA)4]+ spectra were invariably dominated
by the ion at m/z 511, corresponding to [Au(PTA)2]+ species, without any additional
fragment.
The combined analysis of the full spectra of solutions of [M(PTA)4]+ complexes in
the three solvents provided the following evidences: 1) complexes dissolved in water or
methanol showed very similar behavior, but methanol ensured better a signal-to-noise
ratio and better sensitivity (signal twice as high); 2) methanol did not interfere with
rearrangements, whereas water only participated in some rearrangements with copper,
although to a limited extent; 3) decomposition of [Cu(PTA)4]+ was strongly promoted by
acetonitrile, giving primarily solvated species when acetonitrile was used, whereas, in similar
experimental conditions, [Ag(PTA)4]+ was mildly affected and [Au(PTA)4]+ not affected
at all by acetonitrile as solvent. The formation of acetonitrile adducts of copper in ESI(+)
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conditions was also validated in the case of [Cu(thp)4]+. The strong affinity of copper for
acetonitrile is confirmed by the number of coordination compounds of copper(I) containing
acetonitrile molecules found in MS conditions, especially in dimeric complexes [131]. Since
ESI-MS analyses of diluted solutions of [M(PTA)4]+ complexes in water and in methanol
are very similar (reflecting similar solution behavior) and using methanol ensured better
signal-to-noise ratios and enhanced sensitivity, methanol was selected for the following
studies with the above class of complexes.
Although [Cu(PTA)4]+ represents the correct formulation of the complex in the solid
state, as confirmed by several X-ray structures, and also in the solution state at elevated
concentration (31P and 63Cu NMR at ca. 10 2 M), ESI(+) measurements did not show
such a tetra-coordinated complex but always [Cu(PTA)2]+ as the base peak of the spectrum.
Therefore, the formation of coordinative unsaturated species in dilute solutions is an intrinsic
property of this class of “Cu(P)4”-type compounds, as proposed in our previous MS study. It
is consequently reasonable to presume that similar dissociation occurs in the case of heavier
silver and gold complexes, the base peaks in the ESI(+) spectra being those corresponding
to [Ag(PTA)2]+ and [Au(PTA)2]+.
The fragmentation profiles observed in the spectra of water and methanol solutions of
[Cu(PTA)4]+, [Ag(PTA)4]+ match the speciation models obtained from our thermodynamic
studies. In particular, Figure 3.4 shows the relative percentage abundance of complexes
[M(PTA)n]+ (M = Cu(I) in (a), and Ag(I) in (b)), in aqueous solutions in which the total
concentration of complex [M(PTA)4][PF6] was about 10 5 10 6 M, near that found during
these ESI-MS experiments.
The above percentages, calculated according to the stability constants of the complexes
(Table 2.2, page 46 and Table 2.6, page 61), clearly show that, in high dilution conditions, the
prevalent complex species is generally the bis-substituted complex [M(PTA)2]+, according
to the MS evidence. In particular, Figure 3.4 shows that the dicoordinated [Ag(PTA)2]+
complex is largely prevalent in these conditions. This is a direct consequence of the higher
value of the stepwise formation constant of the complex [Ag(PTA)2]+ with respect to those
of the two following species [Ag(PTA)3]+ and [Ag(PTA)4]+. This observation also explain
why the mass spectra of solutions of phosphine complexes of Ag(I) only show the presence
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Figure 3.4.: percentage relative abundance of [M(PTA)n]+ complexes (M = Cu(I), Ag(I), n = 1  4,
CM, total = 10 5   10 6 M) calculated on the basis of their formation constants obtained by
thermodynamic studies (chapter 2). In the figure: P = PTA, ionic charges omitted for convenience.
of complex [Ag(PTA)2]+.
3.2. In vitro cytotoxicity assays of phosphino complexes
In vitro cytotoxic activity of phosphino complexes copper(I), silver(I) and gold(I) of PTA
and the two other phosphines, thp and thpp, have recently been evaluated for their cytotoxic
activity toward a panel of seven human tumor cell lines [74], containing samples of ovarian
(2008 and C13), cervical (HeLa), lung (A549), colon (HCT-15), breast (MCF-7) cancers
and melanoma (A375). Cytotoxicity was evaluated by MTT tests after 48 h of treatment
with increasing concentrations of the tested compounds. For comparison purposes, the
cytotoxicity of cisplatin, which is still the most frequently used anticancer metallodrug, was
evaluated in the same experimental conditions. IC50 values, calculated from dose-survival
curves, are listed in Table 3.1. It should be noted that a previous study proved that
phosphines thp, thpp and PTA, when not coordinated to a metal center, show no cytotoxic
activity against all tested cancer cell lines (data not shown in table) [12, 73].
Among the tested compounds, metal-thp species generally showed better cytotoxic activity
compared with metal-PTA and metal-thpp ones, and copper derivatives were always found
to be the most efficacious. Figure 3.5 compares the various in vitro cytotoxicities of these
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Table 3.1.: In vitro cytotoxic activity of [M(P)4]+ compounds (M = Cu+, Ag+, Au+, P = PTA,
thp, thpp). [74]
Compound IC50 (µM) ± S.D.
A549 MCF-7 A375 HCT-15 HeLa 2008 C13 RF
[Cu(thp)4][PF6] 9.11± 2.71 11.08± 0.52 4.58± 2.41 2.00± 0.03 8.21± 1.50 1.48± 0.21 2.88± 1.07 1.9
[Ag(thp)4][PF6] 18.22± 2.11 17.75± 2.71 32.12± 1.22 21.32± 1.34 12.32± 1.24 20.15± 1.72 36.65± 2.24 1.8
[Au(thp)4][PF6] 17.4± 1.76 18.32± 1.98 23.99± 1.67 13.21± 2.11 18.43± 1.21 16.21± 1.43 30.22± 1.41 1.8
[Cu(PTA)4][PF6] 7.31± 0.87 21.51± 1.31 12.76± 0.70 15.3± 1.5 7.42± 0.65 13.81± 1.16 10.67± 1.31 0.8
[Ag(PTA)4][PF6] 24.43± 1.55 26.44± 1.99 21.11± 2.01 13.52± 1.13 21.65± 2.33 11.23± 1.65 13.52± 1.13 0.8
[Au(PTA)4][PF6] 50.32± 1.53 50.72± 2.41 44.63± 1.71 32.23± 1.62 53.43± 1.99 29.52± 1.92 38.33± 1.97 1.2
[Cu(thpp)4][PF6] 18.4± 3.24 27.31± 1.53 31.26± 1.65 8.65± 3.11 17.96± 2.78 20.41± 1.43 39.43± 2.64 1.9
[Ag(thpp)4][PF6] 55.64± 1.76 77.41± 1.56 74.51± 1.23 42.93± 2.41 55.57± 2.65 64.52± 1.87 90.30± 2.32 1.4
[Au(thpp)4][PF6] 79.53± 1.56 92.34± 1.87 73.57± 2.54 67.89± 1.97 79.34± 2.84 87.32± 1.27 99.34± 1.54 1.1
Cisplatin 29.21± 1.92 19.04± 1.51 20.33± 1.33 25.34± 1.31 10.50± 1.51 12.96± 1.72 89.18± 4.50 7.02
Figure 3.5.: In vitro cytotoxic activity of [M(P)4]+ compounds (M = Cu+, Ag+, Au+, P = PTA,
thp, thpp, see Table 3.1). [74]
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metallodrugs. In detail, [Ag(thp)4][PF6] and [Au(thp)4][PF6] showed similar cytotoxicity,
about four times lower than that of [Cu(thp)4][PF6], with IC50 (mmol/dm3) average values
of 5.64 (1.48–11.08), 22.64 (12.32–36.65) and 19.68 (13.21–30.22) for copper–, silver– and
gold–thp complexes, respectively. The cytotoxic potency was roughly three to four times
lower from thp- to the bulkier thpp-complexes, with average IC50 (mmol/dm3) values of
23.34 (8.65–39.43), 65.84 (42.93–90.30) and 82.76 (67.89–99.34) for Cu(I)-, Ag(I)- and
Au(I)-thpp complexes, respectively. Intermediate average IC50 values were shown by Cu(I)–
and Au(I)–PTA derivatives (13.19 and 42.74 mmol/dm3, respectively); [Ag(PTA)4][PF6]
exhibited cytotoxic efficacy (mean IC50 of 18.84 mmol/dm3) slightly better than that of the
silver-thp analog. A549 and HCT-15 tumor cell lines were generally more sensitive to all
tested compounds, with six out of nine metal(I) complexes having better cytotoxic activity
than that of cisplatin. As A549 non-small cell lung and HCT-15 colon cancer cells have low
cisplatin sensitivity, these results indicate the ability of [M(P)4]+-type species to overcome
intrinsic cisplatin resistance, and agree with previous observations proposing a mechanism
of action different from platinum complexes for some of them.
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Conclusions
In the last few decades, many metal-based compounds have been developed in order to
find potential anti tumor drugs. In this context, some new [M(PTA)4][X] complexes (M =
Cu(I), Ag(I), Au(I), PTA = 1,3,5-7-triaza phosphadamantane, X = [PF6] , [BF4] ) have
recently been prepared and tested in vitro as anti-proliferative agents, showing promising
results. The cytotoxic activity of these compounds seems to be related to the ability of
copper to bind important biological substrates after dissociation of one ore more phosphines,
and this dissociation processes have been ascribed to the high dilution of the compounds
during the biological tests. The possibility of studying the in-solution stability of these
compounds in conditions similar to those of biological testing is therefore attractive, in
order to determine which species exist during in vitro trials, and to which of them biological
activity should be ascribed.
We therefore carried out a series of thermodynamic studies in order to define the formation
equilibria of Cu(I) and Ag(I) with PTA in aqueous solution. In these studies we used
microcalorimetric, potentiometric and spectrophotometric techniques and experiments were
carefully designed to provide accurate determinations of the thermodynamic functions
concerning the formation of the four successive complexes of the metal ions, [M(PTA)j]+, j
= 1–4, M = Cu(I), Ag(I).
In order to gain information about the coordinative geometry and stability of the copper
complexes, a theoretical DFT study by in-vacuum calculation was performed, and the
structures of several Cu(I)–PTA complexes were optimized. Results provide the most stable
coordinative geometry of each of the Cu(I)–PTA complexes. The calculation of the free
energies of all the species which had proved to be stable at the end of the optimization
process, was carried out both by in-vacuum and polarizable continuum solvent. The results
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of DTF calculations correlate well and corroborate the complex formation sequence obtained
by the thermodynamic study.
Speciations of the systems, calculated according to the thermodynamic studies, indicate
that both silver and copper complexes, characterized as tetracoordinated species in solid and
solution at relatively high concentrations (> 10 2 M), when diluted to about micromolar
concentrations typical of biological testing, are partially dissociated to lower stoichiometry
species. In particular, at the biological testing conditions the calculated speciations show
that dicoordinated [M(PTA)2]+ complex of both metals is the prevailing species in solution.
This indication is nicely supported by the results of MS studies in aqueous solution,
which gave information about the [M(PTA)4][PF6] complex dissociation processes and the
prevalent species in solution at micro-molar concentrations.
These novel phosphine compounds showed remarkable in vitro cytotoxicity, especially
against A549 and HCT-15 human tumor cell lines, with IC50 values near or lower than
those of cisplatin as reference. The copper derivatives generally showed higher cytotoxicity
than the silver ones. In addition, all these compounds exhibited marked cytotoxicity against
the C13 cisplatin-resistant cell line, with IC50 values lower by about one order of magnitude
than those of cisplatin. These results are definitely encouraging and indicate that this novel
class of compounds may have future promising applications in clinical use.
All the experimental results of thermodynamic studies, ESI-MS experiments and cyto-
toxicity assays strongly indicate that the dissociation equilibria of complexes [M(PTA)4]+
in solution are the crucial processes underlying their cytotoxic activity. More generally,
these studies show that the toxicity of a metal compound is intrinsically linked to its
stability in solution. The well-known concept of the relationship between the “structure and
activity” (SAR) of a metal compound with potential clinical use should thus be extended,
to take into account its stability in solution (SSAR). Although the solid state structure of a
metal coordination compound is known, it is always necessary to consider that in solution,
especially at high dilutions typical of the biological applications, it may dissociate leading to
marked changes in its stoichiometry, coordinative geometry and hence chemical properties.
Therefore, studies on the formation equilibria of the metal-based drugs, like those reported
in this thesis, are certainly valuable, since they may provide essential information about
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their potential as a drug for clinical use.
During this thesis project, a series of experimental methods, suitable for study Cu(I)
equilibrium systems in aqueous solution, were also developed. In particular, microcalorime-
try proved to be an affordable approach to studies on these systems, which are severely
hampered by Cu(I) instability in aqueous environment. Using this technique, for example,
the formation of two successive complexes between Cu(I) and the amino acid methionine
was studied. Results of this study provide useful information about the number of possible
adducts formed by the monovalent metal, which may help to explain some results concerning
the binding sites of copper transport proteins. All the experimental methods and procedures
may be used in the future, to study many other chemical processes underlying interactions
between Cu(I) and other biological substrates, for crucial information about the mechanisms
of intracellular copper uptake and its trafficking.
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APPENDIX A
Analytical details of the experiments
Table A.1.: analytical detail of the microcalorimetric titrations on the system Cu(I) – PTA (see
section 2.2.3 on page 43).
Tit n. C0Cu+ C
0
H+ C
0
PTA C
titrant
Cu+ C
titrant
H+ C
titrant
PTA V
0
mM mM mM mM mM mM mL
1 0.199 0.020 – – – 49.8 2.763
2 0.302 0.030 – – – 49.8 2.728
3 0.502 0.050 – – – 49.8 2.737
4 0.200 0.499 – – – 30.0 2.756
5 0.296 0.494 – – – 30.0 2.787
6 0.462 0.478 – – – 30.0 2.876
7 0.204 2.044 – – – 30.0 2.689
8 0.293 1.846 – – – 30.0 2.775
9 0.491 1.947 – – – 49.8 2.750
10 – – 0.504 11.0 – – 2.760
11 – – 0.989 11.0 – – 2.748
12 – – 2.00 11.0 – – 2.735
13 – – 10.8 11.0 – – 2.760
14 – 0.501 0.500 10.3 1.00 – 2.752
15 – 5.01 10.05 10.3 1.03 – 2.752
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Table A.2.: analytical details of the spectrophotometric batch titrations of the system Cu(I)–PTA
(see section 2.2.3 on page 43); spectra in Figure 2.14 on page 47.
SET 1 SET 2
point C0M C0L CL/CM V path point C0M C0L CL/CM V path
n. length n. length
mM mM mL cm mM mM mL cm
1 4.546 2.251 0.50 2.988 0.0104 1 0.607 0.106 0.18 3.045 0.0104
2 2.259 2.222 0.98 2.985 0.0104 2 0.612 0.218 0.36 3.020 0.0104
3 1.494 2.248 1.50 2.988 0.0104 3 0.607 0.329 0.54 3.024 0.0104
4 1.120 2.236 2.00 2.986 0.0104 4 0.606 0.448 0.74 3.013 0.0104
5 0.894 2.249 2.52 2.991 0.0104 5 0.616 0.561 0.91 3.020 0.0104
6 0.759 2.236 2.95 2.999 0.0104 6 0.624 0.673 1.08 3.015 0.0104
7 0.651 2.229 3.43 3.009 0.0104 7 0.615 0.787 1.28 3.007 0.0104
8 0.572 2.234 3.91 3.002 0.0104 8 0.613 0.900 1.47 3.013 0.0104
9 0.449 2.231 4.96 3.012 0.0104 9 0.610 1.022 1.68 3.011 0.0104
10 0.381 2.242 5.88 3.001 0.0104 10 0.603 1.124 1.86 3.027 0.0104
11 0.231 2.238 9.69 3.002 0.0104 11 0.607 1.252 2.06 3.028 0.0104
12 0.000 2.226 – 3.004 0.0104 12 0.608 1.440 2.37 3.022 0.0104
SET 3 13 0.607 1.659 2.73 3.007 0.0104
point C0M C0L CL/CM V path 14 0.614 1.949 3.17 3.009 0.0104
n. length 15 0.611 2.206 3.61 3.025 0.0104
mM mM mL cm 16 0.607 2.784 4.59 2.991 0.0104
1 0.050 0.010 0.19 2.980 1.000 17 0.606 3.346 5.52 2.995 0.0104
2 0.050 0.020 0.39 2.989 1.000 18 0.611 – – 3.006 0.0104
3 0.049 0.028 0.57 3.042 1.000 SET 4
4 0.050 0.042 0.84 3.005 1.000 point C0M C0L CL/CM V path
5 0.048 0.049 1.01 3.110 1.000 n. length
6 0.050 0.060 1.21 3.014 1.000 mM mM mL cm
7 0.050 0.070 1.40 2.994 1.000 1 0.017 0.003 0.20 9.088 1.000
8 0.050 0.079 1.59 3.018 1.000 2 0.016 0.007 0.40 9.084 1.000
9 0.050 0.090 1.79 2.982 1.000 3 0.017 0.010 0.61 9.054 1.000
10 0.050 0.100 2.00 3.007 1.000 4 0.017 0.013 0.75 8.981 1.000
11 0.050 0.108 2.15 3.000 1.000 5 0.017 0.013 0.80 9.049 1.000
12 0.050 0.120 2.39 2.993 1.000 6 0.017 0.015 0.89 8.990 1.000
13 0.050 0.127 2.57 3.009 1.000 7 0.017 0.017 1.01 9.001 1.000
14 0.050 0.137 2.75 3.008 1.000 8 0.017 0.018 1.07 9.001 1.000
15 0.050 0.150 3.01 3.005 1.000 9 0.017 0.021 1.22 9.037 1.000
16 0.049 0.159 3.22 3.004 1.000 10 0.017 0.022 1.29 8.992 1.000
17 0.049 0.170 3.44 3.007 1.000 11 0.017 0.024 1.39 8.978 1.000
18 0.050 0.180 3.63 2.989 1.000 12 0.017 0.025 1.49 9.010 1.000
19 0.049 0.191 3.88 2.987 1.000 13 0.017 0.027 1.65 9.149 1.000
20 0.049 0.200 4.06 3.006 1.000 14 0.017 0.029 1.69 9.040 1.000
15 0.017 0.030 1.79 9.027 1.000
16 0.017 0.032 1.87 8.044 1.000
17 0.017 0.034 1.98 5.285 1.000
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Table A.3.: analytical detail of the potentiometric titrations on the system Ag(I) – PTA (see
section 2.3 on page 58).
Tit n. C0Ag+ C
0
H+ C
titrant
H+ C
titrant
PTA V
0
mM mM mM mM mL
1 1.811 0.992 1.006 10.23 16.73
2 0.952 1.003 1.006 10.23 15.71
3 0.485 – – 9.98 21.14
4 1.007 – – 9.98 20.06
5 2.010 – – 9.98 19.94
6 0.255 – – 9.98 19.98
Table A.4.: analytical detail of the microcalorimetric titrations on the system Ag(I) – PTA (see
section 2.3 on page 58).
Tit n. C0Ag+ C
0
H+ C
0
PTA+ C
titrant
Ag+ C
titrant
PTA V
0
mM mM mM mM mM mL
1 – – 5.052 100.2 – 2.709
2 – – 1.011 20.00 – 2.691
3 0.9909 0.05046 – – 51.12 2.726
4 1.000 0.942 – – 51.12 2.702
5 1.001 0.986 – – 51.12 2.704
6 0.9899 2.998 – – 51.12 2.710
Table A.5.: analytical detail of the microcalorimetric titrations for the protonation of methionine
(section 2.4.1 on p. 68).
Tit n. C0HMet CtitH+ C
tit
OH  V
0
mM mM mM mL
T1 9.72 517 – 2.733
T2 9.72 – 101 2.728
T3 2.48 – 101 2.703
T4 7.51 – 101 2.717
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Table A.6.: analytical detail of the microcalorimetric titrations on the system Cu(II)/methionine
(section 2.4.2 on page 70)
Tit. n. C0H+ C
0
Cu2+ C
tit
H+ C
tit
Met  V
0
mM mM mM mM mM
T1 0.0125 0.122 0.822 13.1 2.749
T2 0.0256 0.256 1.65 26.4 2.750
T3 0.050 0.504 3.30 52.8 2.749
T4 0.100 1.023 3.30 52.8 2.749
Table A.7.: analytical detail of the microcalorimetric titrations on the system Cu(I)/methionine
(see section 2.4.3 on p. 72)
Tit. n. C0H+ C
0
Cu+ C
0
Met  C
tit
H+ C
tit
Cu+ C
tit
Met  , mM V
0
mM mM mM mM mM mM mL
T1 99.9 – 99.9 – 4.98 – 2.720
T2 50.3 – 50.3 – 4.98 – 2.708
T3 24.9 – 24.9 – 4.98 – 2.692
T4 9.80 – 9.80 – 4.98 – 2.694
T5 0.960 4.51 – 99.9 – 99.9 2.723
T6 0.970 2.52 – 99.9 – 99.9 2.718
Table A.8.: analytical detail of the microcalorimetric titrations on the system Ag(I)/methionine
(see section 2.4.4, p. 75)
Tit. n. C0H+ C
0
Ag+ C
tit
H+ C
tit
Met  V
0
mM mM mM mM mL
T1 10.02 0.970 110.2 10.03 2.683
T2 0.01 1.01 10.50 100.2 2.694
T3 0.04 4.03 10.50 100.2 2.690
T4 0.02 2.00 10.50 100.2 2.687
T5 9.85 4.05 110.2 100.3 2.722
T6 10.09 1.96 110.2 100.3 2.574
T7 0.04 4.00 99.46 99.46 2.703
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APPENDIX B
The solution chemistry of soft transition metal complexes
From “Interpretation of solution stabilities of metal complexes”
by Gerold Shwarzenbach [132]
B.1. Hard and soft complexes
Transition metal cations are characterized by very diverse coordination chemistry, which
depends on the electronic configuration of the d valence shell of the metal, its oxidation
state and its ionic radius. Given this, different transition metal cations have very distinct
affinities toward ligands. Depending upon the ligands, we can distinguish between two
types of behavior (or characters), which we shall call hard and soft.
The hard character. d0-cations show an extreme hard character: in aqueous solutions
they interact only with fluoride and oxygen donors to any appreciable extent. Many of the
d0-cation fluoride complexes have poor water solubility, but quite often they can be dissolved
by addition of an excess of the ligand, which drives the formation of high stoichiometry,
negative-charged, complexes, as in the case of the hexafluoro aluminate:
Al3+ + 3F  ! AlF3 (s)
AlF3 + 3F  ! [AlF6]3 
On the other hand d0-cation have no tendency to form complexes with the heavier
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halides: for example the [Al(H2O)6]Cl3 salt crystallizes from concentrated hydrochloric acid
solutions.
The most important ligands for d0-cation are the oxygen donors, including the hydroxide
ion, oxalate, citrate, tartrate and EDTA. In particular OH , in a similar way to F , can
form with Al3+ a hexahydroxo complex:
Al3+ + 3OH  ! Al(OH)3 (s)
Al(OH)3 + 3F  ! [Al(OH)6]3 
As far as the intensity of the interaction is concerned, it is generally observed that the
stability of the complexes rises rapidly with the charge of the d0-cation and falls as its
radius becomes larger:
K(I)⌧ Ca(II)⌧ Sc(III)⌧ Ti(IV)
Al(III)  Sc(III)  Y(III) > La(III)
This regularity suggests that the coordination of the d0-center is primarily due to
Coulombic forces. This explains why the favored ligands are those that bring the negative
charge on the ligand close to the metal center, such as fluoride and oxygen donors. Cyanide
and sulfide anions, even if charged, are rather not coordinating species for hard cations in
aqueous solutions. This is partly due to their remarkable basicity, so that these ligands add
a proton from water leading the formation of coordinating hydroxide ions in solutions.
The soft character. The low charged d10 centers Cu(I), Ag(I) and Au(I) are the best
examples of metal cations with a soft character. These monovalent cations form complexes
with heavy halides, much stronger than those formed by hard metal centers, and fluoride
in general is poorly coordinated (F  ⌧ Cl  < Br  < I ). Sulfur donor more than oxygen
ones, ammonia and amines are able to compete with the more polar H2O even in aqueous
solution (that means an environment with a very large excess of water). As discussed in
the present work, phosphino complexes are an important class of soft ligands for Cu(I),
Ag(I), Au(I).
The formation of this type of complexes cannot be explained in terms of electrostatic
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forces, as in the case of the hard complexes: charges and ionic radii are certainly not decisive
factors causing the stability of these adducts. Among these three prototypes of soft metals,
Au(I), which is the largest, forms the most stable complexes, and with the halide anions,
the one having the greatest radius, I , is preferred. Furthermore, the complex stability
with selective ligands is reduced when the charge on the metallic center is increased in
a series of isoelectronic d10 cations (e.g. Ag(I) > Cd(II)). All of these facts demonstrate
the formation of covalent bonds. The deciding factors for complex stability seem to be
the ionization potential of the metal ion (the more noble is the metal, more stable are
its complexes) and the electronegativity of the ligand (complex stability increases with
decreasing electronegativity of the ligand itself).
General and selective ligands. Fluorides and oxygen donors show to be suitable coordi-
nating ligands for both hard and soft d-valence metal cation, so they are generally referred
as “general ligands”. The other types are rather named as “selective ligands” and the more
so, the lower their negative charge, their polarity and the lower their electronegativity of
the ligand donor atom. The distinction between hard and soft characters is related to the
difference between an electrovalent and a covalent behavior. The lower the charge and the
grater the radius of the metal cation, the less marked is its hard character.
Transition metal cations ndq (0 < q < 10). The transition metal cations of the third
period, from 3d1 to 3d5 have a remarkable hard character. Therefore, their tendency to
coordinate selective ligands is small. Weak complexes with Cl , Br  and I  can be obtained
only in concentrated solutions of the corresponding hydrogen halide. Ammonia, sulfide
and cyanide usually act as a base and precipitate the corresponding hydroxide salt. The
behavior of a complete series of the divalent 3d5 to 3d10 cations can be described using the
the rule of Irving-Williams [133]:
Mn(II) < Fe(II) < Co(II) < Ni(II) < Cu(II) > Zn(II) (B.1)
The stability of these complexes generally increases from Mn(II) up to Cu(II) and falls
off again by passing on to Zn(II). However, zinc is not considered a transition metal [134],
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Table B.1.: stability constants of some complexes of 3d5 to 3d10 cations with some oxygen and
nitrogen donors ligands.
logK1
ligand donor Mn(II) Fe(II) Co(II) Ni(II) Cu(II) Zn(II)
oxalate O, O 3.9 4.5 4.8 5.2 6.2 4.9
glycinate O, O 3.2 3.9 4.6 5.7 8.2 5.2
ethylene diamine N, N 2.8 4.3 5.9 7.6 10.8 5.9
due to its d10 valence shell electronic configuration present in all of its oxidation states.
There are but a few exceptions to Irving rule. They include some complexes of multidentate
ligands which do not fit the coordination geometry favored by Cu(II) (as discussed in
the introduction, Cu(II) prefers to form tetracoordinate complexes with a square-planar
arrangement) so that the stability of the 3d9 ions such as Cu(II) falls too low in comparison
to what is expected according to the (B.1). Furthermore, the substitution of H2O in the
aquoion, is in some instances accompanied by a rearrangement of the valence electrons, for
example that with cyanide as in these two cases:
[Fe(H2O)6]2+ (high spin)! [Fe(CN)6]4  (low spin)
[Ni(H2O)6]2+ (octahedral, paramagnetic)! [Ni(CN)4]2  (sq. planar, diamagnetic)
Which causes these two complexes to become more stable than predicted by the (B.1).
The reason for the general validity of the Irving-Williams rule is not difficult to understand:
the radii of the cations decrease slightly from Mn(II) to Cu(II), whereas Zn(II) is larger
again. Furthermore, the ionization potentials of the metals considered increase from Mn to
Cu, but as well known Zn is less noble than Cu. Therefore, both the coordination due to
electrostatic forces (which depends upon charge and radii) as well as the covalency of the
bonds formed (depending on electronegativities) change as predicted by the relationship
(B.1). The values of the stability constants reported in table B.1 and plotted in Figure B.1
make it clear that the change in ionization potentials is much more important than the
differences in radii. With fluoride and oxygen donors the maximum at Cu(II), shown in the
figure, is much less pronounced than with nitrogen donors.
We give an insight to these facts by stating that all the 3dq cation have a dominant hard
character, but that more and more the soft character becomes mixed in as q increases, the
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Figure B.1.: trends of the stability constants of some complexes of 3d5 to 3d10 cations with some
oxygen and nitrogen donors ligands.
maximum being at q = 9, because the d9 Cu(II) is the most noble of the 3dq cations series.
However this behavior is not exhibited with the heavy halide anions, and their complexes
are surprisingly weak and formed only in concentrated solutions of hydrogenhalides, with
stability constants with values generally lower than 1.
In contrast with the 3dq case, the metal cations of the further periods, 4dq and 5dq are
characterized by a marked soft character, dominant for q > 5. Whereas aquoion complexes
of the third period transition cations can be easily obtained, those of the fourth and fifth
ones are more difficult to be obtained or even unknown. Conversely, complexes with heavy
halides of 4dq and 5dq cations are known. We can summarize that the coordination behavior
of the transition metal cations ndq as follow: 1) The third period transition metal cations
show a marked hard character, and a soft character increasing up to 3d9. 2) The soft
character of a transition metal center increases more with n than with q: fourth and fifth
transition cations show a soft behavior, finally becoming dominant in the nd5–nd10 (n =
4,5) configurations.
B.2. Enthalpy and entropy of formation of hard and soft
complexes
The free Gibbs energy, DG0, accounts for the spontaneity of a reaction. It is expressed
by the well-known Gibbs-Helmholtz equation, DG0 = DH0   TDS0. The formation of hard
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and soft complexes differ strikingly from one another with respect to the relative importance
of DH0 and TDS0 terms in the equation.
Hard complexes associations are characterized by TDS° values positive and dominant,
while DH° contributes little or nothing to the stability.
Soft complexes associations are characterized by DH° values negative (exothermic) and
dominant, and TDS° contributes little or nothing to the stability.
As previously explained, hard complexes are characterized by coordinative metal–ligand
bonds with a poor or negligible character of covalency. Therefore the formation of hard
complexes is a process driven by long-range Coulombic attractive forces, between the anionic
ligand and the metal center, usually bringing a high positive charge. A positive value of the
formation entropic term, TDS0, takes into account this type of association, in which are
involved reactants having opposite charges. Anyway, the complex formation with anionic
ligands is more or less concerned whether the metallic center reveals a soft or hard character.
This phenomenon has nothing to do with the nature of the bonds broken or newly formed
(be them electrovalent or covalent) during the reaction. It must therefore related with the
neutralization of the opposite charges following the formation of the complex and be caused
by structural changes occurring within the solvent. In fact, many polar solvent molecules
can be oriented by the field of forces created by ionic charges and then set free when these
charges are neutralized in the course of the reaction. This increases the disorder in solution,
which means an increment of the degree of freedom of the solvent particles present, and
therefore raises the entropy of the system.
Uncharged ligands, which are less polar than water, can only be coordinated in aqueous
solution if covalent bonds are formed. In this case the complex formation is due to the
establishment of short-range forces, which take into account of the exothermicity of the
reaction. A negative enthalpy value (a pronounced exothermicity of reaction) is the driving
force of the association process. In general, the entropy variation exerts a negative, but
most often a negligible, contribution to the stabilization of the complex formed.
Nevertheless, entropy is much more negative for reactions of soft metal cations with
phosphines and thioethers, such as in the case of the formation of complexes of Cu(I),
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Ag(I) with PTA and methionine, widely discussed in this work. In fact, these type of
ligands are the most selective ones known. In particular phosphines in general show a
high affinity toward soft cations, and are much less polar than the corresponding amine
obtainable by formal substitution of the phosphorous with a nitrogen atom. In the course of
a reaction with pronounced soft cations, strongly polar water molecules in the coordination
sphere of the metal are substituted by a less polar and less solvated phosphine or thioether.
The coordinative bond has a strong covalent character, which accounts for the reaction
exothermicity. Moreover the water molecules, weakly bonded to the metal cation, once
dissociated following the formation of the complex, result to be highly solvated by the
solvent, bringing to a decrease of the freedom degrees of the particles in solution, which
means a remarkable entropy decrease too.
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APPENDIX C
E ect of the ionic medium on the solution equilibria
The thermodynamic stability constant of an equilibrium system is expressed as a funtion
of the activities of the reagents. The equilibrium constants of this thesis work are conversely
stoichiometric stability constants, which are functions of the concentration of the species at
the equilibrium, obtained in a constant ionic medium by means of a high concentration of
an inert background electrolyte. In these conditions, the activity coefficients are constant,
and, using a correct model it is possible to convert the experimental stability constants to
the real thermodynamic ones.
Three models are mainly used to describe the ionic medium dependence of equilibrium
constants: 1) The Debye–Hückel Law, in which the activity coefficients of reactants and
products depend only on the ionic charge and the ionic strength. 2) The Specific ion
Interaction Theory (SIT), an extension of the Debye–Hückel, which accounts for the
medium specific properties, by introducing ion pairing between the medium ions and the
species involved in the equilibrium reactions. 3) The Pitzer models, which are a further
extensions of the SIT, used to evaluate the activity coefficients of the species in highly
concentrated ionic media.
C.1. The Debye–Hückel limiting Law.
The Debye–Hückel limiting Law [135, 136], eqn. (C.1) was the first empiric model,
developed in order to provide the calculation of the activity coefficients,  J of the species
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present in solution at the equilibrium.
ln  J =  z2j
A
p
I
1 +
p
I
(C.1)
The fundamental assumption of the law is that an ion in solution is mainly surrounded
by particles with opposite charge. This approximation is true for solutions with a low ionic
strength (I . 0.01 mol/dm3) and low contentrations of soluted to be studied: in these
conditions, as implied by the (C.1) the activity coefficient of a ionic species depends only on
the charge of the ion itself and on the ionic strength, regardless the chemical composition
of the background electrolyte.
For water solutions, A = 0.509. To note, according to this model, the activity coefficients
of neutral species in solution do not change as the ionic strength is varied, since for uncharged
species, zj = 0 and therefore ln  J = 0,  J = 1.
C.2. The Specific ion Interaction Theory (SIT)
The Specific ion Interaction Theory (SIT) is a theory developed by Bronsted [137] and
further developed by Guggenheim, Scatchard and Ciaviatta [138–140]. SIT is an extension
of the Debye–Hückel Law, used to estimate the values of the activity coefficients of species
at the chemical equilibrium, at relatively high ionic strengths (I . 1.0 mol/dm3). In
these conditions, deviations from the Debye–Hückel are significative, and the SIT-based
model account of them. In particular, first-order deviations due to specific interactions
with the background electrolytes are estimated. In the SIT model, the activity coefficients
of the species are set to depend both on the concentration of the ionic medium (as in
the Debye–Hückel expression), and on the particular chemical nature of the ions of the
background electrolyte. The value of the activity coefficient of a species J in the SIT model
is calculated by:
ln  J =  z2j
0.509
p
I
1 + 1.5
p
I
+
X
k
bj,kck (C.2)
Where the first term is derived by the Debye expression. The second term is a sum
which provide the first-order corrections to the Debye: bj,k is an empirical parameter which
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Figure C.1.: dependence of the activity coef-
ficient of Ag+ with the ionic strength (NaNO3
background electrolyte).
Figure C.2.: dependence of the activity coe -
cient of Cu2+ with the ionic strength (NaNO3
background electrolyte).
accounts for the specific interaction between the ion J with another ion K with opposite
charge in solution. The terms in the sum are linearly dependent on the concentration of the
interacting ionic species. The diagrams in the Figures C.1 and C.2 show the dependence of
the activity coefficients of Ag+ and Cu2+ respectively, as a function of the ionic strength, in
solutions with different concentrations of NaNO3 as background electrolyte. A comparison
between the calculation made on the basis of the Debye–Hückel law (black line) and with
the extended SIT expression (blue line) is reported. Diagrams show that at low ionic
strength (I  0.05 mol/dm3) the values of the activity coefficients calculated on the basis
of the two models are close each other and therefore the Debye–Hückel provides a reliable
determination of the activity coefficients. Marked deviations between the two models are
instead observed at higher ionic strength (> 0.15 mol/dm3 for  Ag+ and > 0.05 mol/dm3
for  Cu2+ .
The activity coefficients of neutral species calculated in the SIT model, are no longer
constant with respect to variations of the ionic strength, but depend linearly on I as:
ln  J = kJ · I (C.3)
Where kJ is an empiric parameter to be determined.
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C.3. The Pitzer models
These models, devised by Pitzer and coworkers [100] allow the calculation of the activity
coefficients of the species at the equilibrium, in solutions with multiple electrolytes, and in
presence of high concentrations of the ionic medium (up to 6 mol/dm3).
In very concentrated solutions (I > 3 mol/dm3, i.e. salt brines), the assumption that an
ion is mainly surrounded by solvent molecules and background electrolytes with opposite
charges is no longer valid. Pitzer models take therefore into account electrostatic interactions
between triplets of a cation an two anions or an anion with two cations. If the ionic medium
is much more concentrated than the analyte solutes, triple interactions comprising a couple
of cations or anions of the same solute are reasonably neglected. At lower ionic medium
concentrations (0.100 – 1.0 mol/dm3) triple interactions can be neglected at all, and the
only interaction between couples of ions with opposite charges is taken into account. In
these cases, Pitzer models behave likewise those of SIT.
In the model, three empirical parameters,  (0),  (1) and C  describe the interaction of
couples and/or of triplets of ionic species. They need to be determined by the fitting of
several experimental data collected during thermodynamic studies, carried out at different
ionic medium concentrations. The interaction parameters for the most common electrolytes
have been reported by Pitzer and coworkers [141] and are currently available in several
handbook and databases (Aspen Physical Property Methods & Models).
These models are very complex, and the determination of the parameters reported above
is not discussed here. Details are available in the literature [99, 100, 142, 143].
C.3.1. Application in the study of Cu(I)–chloride complexes
The Pitzer models have been used to estimate the activity coefficients of Cu+, Cl  and
Cu(I) chlorocomplexes in aqueous solution of NaCl 1.0 M, on the basis of the data mainly
provided by a literature work by Sharma and coworkers [92] (see section 2.2 on page 31).
The authors evaluated the stability constants of the three successive chlorocomplexes
with general formula [CuClm]1 m ( m, with m = 1 – 3), formed in solution at relatively
high concentrations of chloride (0.100 – 5.00 M). For these species, they also calculated the
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Table C.1.: Pitzer interaction parameters for aqueous Cu(I) solutions in NaCl.
interactions  (0)  (1) C  ref.
Na+, Cl  0.0765 0.2664 0.0013 [100]
Na+, [CuCl2]  0.0837 0.1595 0.0196 [91]
Na+, [CuCl3]2  -0.0016 1.8547 0.1142 [91]
Table C.2.: Activity coe cients and overall stability constants   calculated by the Pitzer model
(see Figure C.3).
Species NaCl, 0.1 M NaCl, 1.0 M
log  0 [92]   log     log  
Cu+ – 0.777 – 0.655 –
CuCl(aq) 3.10 1.013 2.87 1.141 2.68
[CuCl2]  5.42 0.767 5.20 0.635 5.07
[CuCl3]2  4.75 0.380 4.72 0.171 4.78
stability constants at I = 0, providing for each interaction between couples of ionic species
the corresponding three Pitzer parameters, reported on Table C.1. Parameters concerning
triple ionic interactions have been not taken into account, since the maximum chloride1
concentration investigated was 1.0 M. Since CuCl(aq) is a neutral compound, its activity
coefficient depends only on the ionic strength, as reported in eqn. (C.3), and no parameters
for specific interactions of this species are therefore reported in the Table.
The stability constants of the three chlorocomplexes in NaCl 1.0 M have been calculated
from the values of log  0 and  J of the different ionic species (Table C.2 and diagram in
Figure C.3). The stability constants have been subsequently used to calculate the relative
distribution of the chlorocomplexes in a 1.0 M NaCl aqueous solution (see section 2.2 on
page 2.2).
1Chloride is both a complexing species and the background electrolyte in this case.
117
C.3. The Pitzer models
Figure C.3.: log   (log10 values of the activity coe cients) of the Cu(I)–Cl  complexes vs I
(mol/dm3). Values of   at I = 0.1 and 1.0 M are reported on Table C.2.
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APPENDIX D
Numerical methods
D.1. The method of least-squares
The program Hyperquad, used for the minimization of the experimental data obtained by
potentiometry and spectrophotometry is based on the method of least–squares [77, 78, 144].
This method consists of finding a set of parameters that minimize an objective function. It is
called objective because it is the object of the method to minimize this function. In the case
of our experiments, which are made by means of titrations, the objective function depends
for instance on the experimental points, a set of couples of dependent/independent variables,
in which the dependent variable is the property we measure: electrodic potential E (mV) in
potentiometric titrations and absorbance spectra, {A 1, A 2, · · ·A n} in spectrophotometric
titrations; independent variable is the volume of titrant added (mL).
Nevertheless, the objective function also depends on some parameters, specifically on
a set of group parameters, which are the analytical concentrations of the titrand species
(those in the measure cell) and on the titrant ones (loaded in the burette) and on a
set of common parameters, which are the values of the formation constants chosen to
describe the chemical system. Regarding the group parameters, it is obvious that the
accuracy in the determination of the initial concentrations of the species, by means of
careful standardizations prior to the experiments is fundamental. Common parameters are
related instead to the model chosen for describing the chemical system.
Therefore, we begin by defining a model of the chemical system. Suppose that n measures
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have been made. Corresponding to each experimental quantity, f expi , there is a calculated
value, f calci (vi, p1, p2, . . . , pm), which is a function of the ith independent variable, the
volume vi and on a set of parameters pm as described above. This functional relationship
defines the model. We then define the residuals, ri, in equation (D.1):
ri = f
exp
i   f calci (vi, p1, . . . , pm) r = {r1, . . . , rn}T (D.1)
Now, the simplest objective function to be minimized is the sum of squared residuals of
the n measurements: the term “least squares” derives from this kind of function (D.2):
U =
nX
i=1
r2i U = r
T r (D.2)
The relation on the right in (D.2) is the same operation expressed in the vector/matrix
notation, so rT is the transpose vector of r. However, in defining the objective function in
this way we are making two important assumptions: 1) we assume that the calculated values
f calci as well as the independent variables are not subject to experimental error. The error
just affects the measured values f expi ; 2) we assume that the errors ei are all equal and not
statistically correlated each other. This last assumption is generally good when the program
is asked to minimize with respect to few dependent variable or parameters. In general,
the design of the experiments should be properly done in order to minimize correlations.
Anyway, a chemical system with multiple complexes present at the equilibrium requires, to
be described, a simultaneous calculation of several formation constants,  n, which values
obtained at the end of the minimization process allow to determine the relative distribution
of the species at the equilibrium. In the simplest case of potentiometric titrations, the
calculation involves the minimization of electrodic potential as dependent variable and
the refinement of the parameters  n. However electrodic potentials are related to the
concentration of the species by the Nernst’s Law and therefore a calculated value of the
electrodic potential can be obtained directly from the calculated values of the formation
constants.
120
D.1. The method of least-squares
On the other hand, the minimization process of microcalorimetric data involves the
simultaneous calculation of both the molar enthalpy of formation and the related value of
the constant for each species. This calculus is much more delicate than that of potentiometric
data and it is very common to observe a certain correlation between enthalpies and constants.
So, to be more general, we must accept that each observation is not only affected by an
error related on its single quantity, expressed by variance, but that different observations
are also subject to different errors and that the errors of each pair of observations are
connected trough a covariance term.
Variance is defined as (D.3):
 2 =
P
i(f
exp
i   f calci )2
n  1 =
P
i r
2
i
n  1 (D.3)
where n is the number of measurements; the correlation between pairs of observations
f expi and f
exp
j is estimated instead by the covariance, defined as (D.4):
COV(f expi , f
exp
j ) =
P
k=1,n(f
exp
ik   f calci )(f expjk   f calcj )
n  1 (D.4)
As suggested above, it is a good experimental practice to design properly the experiments
and to handle carefully the results of minimizations in order to try to reduce the covariance
to zero. Covariance is related to correlation coefficient ⇢ij by (D.5):
COVij =  i j⇢ij (D.5)
A correlation coefficient can only take values between +1 and –1. The more its value
is close to zero the less correlation between the pair measurements is estimated. The
correlation coefficients of the form ⇢ii are equal to 1, since the error on any quantity is
completely correlated with itself.
Together, variance and covariance make up the so-called variance-covariance matrix,
whose elements are given by (D.6):
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M =
0BBBBBB@
 21  1 2⇢12 · · ·  1 n⇢1n
 2 1⇢21  22 · · ·  2 n⇢2n
...
... . . .
...
 n 1⇢n1  n 1⇢n1 · · ·  2n
1CCCCCCA (D.6)
This matrix is symmetrical with respect its diagonal, because obviously  i j⇢ij =  j i⇢ji.
When no correlation between a pair of measurements f expi and f
exp
j is observable, the relative
covariance matrix element Mij is zero. Instead, variance (diagonal) elements Mii =  2i are
always non-zero.
So, we have allocated variance and covariance for a pair of observations as matrix elements
in the form Mhk; h = 1, n; k = 1, n where n is the number of measurements. We define
now W as the weight matrix, which is the inverse of the variance-covariance matrix as
follows:
WM =MW = I;
X
h=1,n
WihMhk = 1 (i = k);
X
h=1,n
WihMhk = 0 (i 6= k) (D.7)
We can therefore gain a more complete definition of the objective function U as follow:
U =
X
h=1, n
X
k=1, n
rhMhkrk U = r
TWr (D.8)
The expressions for the objective functions in equations (D.2) and (D.8) become equivalent
if no correlation is present ( Mhk = 0, Whk = 0).
The method of least-square is used to calculate that value of the m-vector p of parameters
that minimizes U. The minimum of the objective function can be found by setting its
partial derivatives with respect to each parameter to zero:
@U
@pj
=  
X
h
X
i
Whi
✓
rh
@fi
@pj
+ ri
@fh
@pj
◆
= 0; g =  2JTWr = 0 (D.9)
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g is called the gradient vector and contains the m elements @U/@pj . J is known as the
Jacobian matrix whose elements are the partial derivatives @fi/@pj .
In linear systems, fi is a linear combination of the parameters: f = Jp, therefore the
residual become r = f exp   Jp. If this expression for the residual is substituted into the
equation (D.9) we obtain the so-called normal equations (D.10):
 2JTW(f exp   Jp) = 0; JTWJp = JTWf exp (D.10)
However, in equilibrium systems, the models are non-linear and a numeric method by
means of an iterative process of successive approximations must be used. It is first necessary
to provide the program a proper speciation model, which is an input instruction containing
a description of the system, about how many complexes we expect to be present in solution
at the equilibrium, their stoichiometry and the estimated values of the formation constants
that will be subsequently minimized by the iterative process. Ideally, as usual when dealing
with iterative algorithms, in order to attain a fast and reliable convergence to the best-fit,
the starting estimates should be taken close to those for which the gradient vector is zero.
Let the vector of estimates be p0. Each element of the gradient vector is now expanded
as a first-order Taylor series about p0:
gj = g
0
j +
X
k=1,n
@gj
@pk
(pk   p0k); g = g0 +Hs (D.11)
Since g is zero at the minimum, equation (D.11) can be written as:
Hs =  g0 (D.12)
and the normal equations as:
Hs = 2JTWr (D.13)
where s is the shift vector. The matrix H in known as the Hessian and its elements are
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obtained by differentiating equation (D.9) as follow:
@gj
@pk
=  
X
h
X
i
Whi
✓
rh
@2fi
@pj@pk
+ ri
@2fh
@pj@pk
  @fh
@pk
@fi
@pj
  @fi
@pk
@fh
@pj
◆
(D.14)
Cjk =
X
h
X
i
Whi
✓
rh
@2fi
@pj@pk
+ ri
@2fh
@pj@pk
◆
(D.15)
H = 2JTWJ  2C (D.16)
On substituting equation (D.16) into the normal equation (D.13) we obtain the relation
(D.17), which is the expression of the Newton-Raphson equation:
(JTWJs C)s = JTWr (D.17)
The residual vector r represents the difference between the observed values f expi and the
values calculated with the initial parameters estimates f0i . Now, by setting the matrix C
equal to zero, as it is in a linear system where f = Jp, we therefore obtain equation (D.18),
the normal equation of the Gauss-Newton method:
JTWJs = JTWr (D.18)
Solution of this equation yields the shift vector s. Now, if the first-order Taylor series
expansion (D.11) is valid, then adding the shift vector s to the vector of parameter estimates
p0 gives those parameters for whose values the gradient vector g is zero. If the expansion is
a broader approximation, the sum s+ p0 becomes the new parameter estimates vector for
the subsequent iteration. The iterative process continues until an established convergence
criterion is satisfied. At that point the objective function has reached its minimum value,
Umin. Upon convergence, the variance-covariance matrix of the parameters is obtained by
error propagation as:
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M(p) =
Umin
n m(J
TWJ) 1 (D.19)
Hence the parameter standard deviations and correlation coefficients are given by:
 i = [M(p)ii]
1/2; ⇢ij = [(Mij/MiiMjj)]
1/2 (D.20)
D.2. Calculating the concentrations of the species at the
equilibrium
Let be a set of nr reactant A, B, . . . present in a titrand solution. The total concentration
T 0A of the reactant A is analytically calculated as:
T 0A =
n0A + C
tit
A · Vadded
V0 + Vadded
(D.21)
where: n0A is the initial quantity of A in the titrand solution; CtitA is the concentration of
A in the titrant solution. V0 is the initial volume of the titrand solution.
These reactant form nk species at the equilibrium, with stoichiometric coefficients a, b,
. . . as:
aA+ bB+ . . .  AaBb . . . (D.22)
The concentration of the generic j th species, AajBbj . . . is given by:
Cj = [AajBbj . . .] =  j [A]
aj [B]bj . . . (D.23)
Where  j is the overall formation constant of the species AajBbj . . . For sake of clarity,
in this example any charges of the species have been omitted. The total concentration of
each reactant in solution is constrained by a condition of mass balance:
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TA = [A] +
P
j ajCj
TB = [B] +
P
j bjCj
. . .
(D.24)
If the formation constants of eqn. (D.23) are known, the set of nr equations (D.24) can
be solved for the “free” concentrations [A], [B], . . . and therefore the concentration of the
species AajBbj . . . can be calculated by (D.23).
D.3. The program Hyperquad: the minimization of
potentiometric and spectrophotometric data
Hyperquad [77, 78, 144] is a software based on a suite of programs, developed for the
minimization of potentiometric and spectrophotometric data in order to obtain the value of
the formation constants in complex chemical systems with multiple equilibria. As many
other minimization softwares, Hyperquad calculation is based on the lest-squares approach
[144]. In Hyperquad, the sum of the squares residuals of the objective function is minimized
by means of the Gauss–Newton–Marquardt algorithm.
The core of the calculation is the determination of the free concentrations of the species,
which is carried out by solving the non-linear simultaneous equations of mass balance (eqn.
D.24) using the Newton-Raphson method. Potentiometric data points (E, mV and Vadded,
mL) are weighted by formula that allows for greater potential errors in the region of an
end-point than elsewhere. For absorbance data points a relative weighting scheme is used.
In order to obtain a reliable speciation model for a chemical equilibrium system is in
general a good idea to make use of more than one kind of analytical technique, and it
would be indeed useful to use the same approach to minimize experimental data from
these technique. With this aim, Hyperquad was developed in order to process both
potentiometric and spectrophotometric data together. However, working on different kind
of data simultaneously, make imperative that a full and rigorous weighting scheme is used.
Given this, is possible to apply simple statistical tests for the goodness of the fit, with an
expectation value of unity for the sample variance [78].
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Calculation. A simple system of three reagents, including a metal M, a ligand L and the
proton H, is taken as example to describe the calculation principles of Hyperquad (ion
charges are omitted for convenience). In this outline the system is studied by means of
potentiometric measurements, using an electrode responding to H, and by spectrophotometry,
during which measurements are taken at nl wavelengths. The speciation model consists in
a set of nk equilibrium constants.
The objective function is given in matrix notation simply as U = rTWr, as in eqn. (D.8),
r is given by eqn. (D.1),W is the matrix of weights (eqn. D.7) and the functions calculated
in the residuals are the potential values (mV) or the absorbance data (Aobs). To minimize
the objective function, is used the Gauss–Newton–Marquardt method, which expression
derives from eqn. (D.18):
(JTWJ+  D) p = JTWr (D.25)
Where J is the Jacobian matrix and  p is the vector of shifts to be applied to the
parameters. D is taken as equal to the diagonal elements of JTWJ and   is the Marquardt
parameter which may, of course, be zero. For the minimization of potentiometric data, the
elements of the Jacobian relative to any unknown parameter x (a stability constant) are
obtained from the expression of the Nernst Law:
E = E0 +
RT
nF
ln[H] = E0 + slope · ln[H] (D.26)
Where E0 is the standard potential of the electrode and slope is equal to RT/nF in the
ideal case. We therefore obtain:
@E
@x
=
@E
@[H]
@[H]
@x
=
slope
[H]
@[H]
@x
(D.27)
For the spectrophotometric data minimization, the elements are found from the expression
of the Lambert-Beer Law:
A  = l
X
j=1,na
✏ jCj (D.28)
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@A 
@x
= l
X
j
✏ j
@Cj
@x
(D.29)
The system is subject to the constraint that the equations of mass balance are satisfied,
as in eqn. (D.24). Furthermore, given the expression for the the stability constants in eqn.
(D.23) we obtain an equation for the total metal M concentration:
TM = [M] +
X
j=1,nj
pj j [M]
pj [L]qj [H]rj = [M] +
X
k=1,nj
pjCj (D.30)
Where pj . . . rj are stoichiometric coefficients. Similar expression can be written for L
and H. Moreover, the total concentration of M can be obtained as analytical value from the
initial amount nM and its eventual concentration in the burette, as reported in eqn. (D.21):
TM =
n0M + C
tit
M · Vadded
V0 + Vadded
= [M] +
X
k=1,nj
pjCj (D.31)
Again, similar expression can be written for L and H.
Now, the partial derivatives @[M]/@x . . . are obtained by solving the set of simultaneous
equations:
0BBB@
[M] @TM@[M] [L]
@TM
@[L] [H]
@TM
@[H]
[M] @TL@[M] [L]
@TL
@[L] [H]
@TL
@[H]
[M] @TH@[M] [L]
@TH
@[L] [H]
@TH
@[H]
1CCCA
0BBB@
x
[M]
@[M]
@x
x
[L]
@[L]
@x
x
[H]
@[H]
@x
1CCCA =
0BBB@
 x@TM@x
 x@TL@x
 x@TH@x
1CCCA (D.32)
The coefficients on the left-hand side are found by derivatization of the general expression
(D.30). The right-hand side takes different forms according to the nature of the parameter.
In this example the only parameters we take into account are the formation (stability)
constants. Alternatively, a parameter may be the initial quantity of a species, or the titrant
concentration. The unknown free concentrations are found by solving the equations (D.31)
of mass balance. The solution consists of an iterative Newton-Raphson refinement, using:
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0BBB@
[M] @TM@[M] [L]
@TM
@[L] [H]
@TM
@[H]
[M] @TL@[M] [L]
@TL
@[L] [H]
@TL
@[H]
[M] @TH@[M] [L]
@TH
@[L] [H]
@TH
@[H]
1CCCA
0BBB@
 [M]
[M]
 [L]
[L]
 [H]
[H]
1CCCA =
0BBB@
 TM
 TL
 TH
1CCCA (D.33)
D.4. The program Letagrop: the minimization of
microcalorimetric data
Letagrop [82, 84, 104] was the very first computer program to be applied to the study
of equilibrium systems [77]. In the present work, a minimization algorithm developed in
Fortran and based on the Letagrop approach has been used to minimize the experimental
data obtained by the microcalorimetric titrations, in order to obtain the values of the
formation constants and the related enthalpies of the species present in solution.
The refinement of the microcalorimetric data (experimental heat, mJ and volume added,
mL) of an equilibrium system is a quite delicate task, since the program is usually asked to
calculate at the same time a relatively large number of common parameters: the formation
constants and the related enthalpies of the complexes. Therefore the algorithm of the
program must be quite robust in order to avoid the calculation of wrong values, especially
if the minimization runs through a false-minimum of the objective function.
Peter Gans and coworkers developed a Hyperquad suite [144] suitable for the minimization
of such data by means of the Gauss–Newton–Marquardt approach. In this work we instead
used a Letagrop-based software specifically designed by our research group.
Letagrop calculation of the best-fit is made by means of a numerical method based on the
so-called pit-mapping approach. Two main minimization routines are built in the program.
Each one performs a minimization on a different type of objective function U, defined as
previously as the sum of the squares residuals of the experimental values as in eqn. (D.1)
and (D.2).
The set of the common parameters p1, p2, . . . pm upon which the calculation of the
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minimum is made, are in this case both the values of the formation constants of the
complexes supposed to be present in solution ( j), and their related enthalpies ( Hj).
In the first routine the minimization is made over the residuals of the experimental reaction
heat, so: f expi = Qreacti . The program calculates the related reaction heat on the basis of
the estimated parameters. Concerning the formation of the complex species at a given
titration point i, the programs first calculates their molar concentrations, Cj (mol/dm3), on
the basis of the estimated values of their formation constants, as reported in eqn. (D.23).
In the Letagrop version we have used, the calculation of the species concentration is made
by means of the Newton-Raphson approach previously discussed. Secondly, given the
estimated values of the related molar formation enthalpies,  Hj (kJ/mol), the program
calculates the reaction heat, Qcalci , from the relationship:
Qcalci = Vi( H1C1 + H2C2 + . . .+ HjCj) + Hdil (D.34)
Where  Hdil is the dilution heat.
In the second minimization routine the minimization process is made over the sum of
residual squares of the overall complexation heat per mole of metal, Dhtotv given by:
 htotv =
Qreact, tot
nM
(D.35)
The pit-mapping approach. We introduce the idea lying behind the pit-mapping approach
with a simplified example, in which we assume that the objective function U , to be minimized,
is dependent on a single common parameter pj , so is U(pj). The program first calculates
U(pj) on the basis of an estimated value of pj , then pj is varied about a positive and a
negative quantity ±  chosen by the program, and the new values of the objective function,
U(pj ± sv) are therefore calculated. A second-order polynomial fitting of the three values
of U(pj), U(pj ± sv) is then made. In the diagram in Figure D.1 is reported a suggestion
of such calculation. The minimum point of this curve (red in the figure) provide the new
calculated value of U from which a corresponding new value of pj is obtained and used as
new estimation value in the subsequent iteration step. It is possible to demonstrate that
the iterative process runs toward convergence of the true value of pj .
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Figure D.1.: simplified example of pit-mapping minimization, in the calculation of the minimum
of an objective function U (the sum of the squared residuals of the experimental and the calculated
values)
Real systems with multiple equilibria, and therefore several formation constants and
enthalpies to be calculated, can be treated as a generalization of the previous example. In
this cases U is calculated upon a set of many common parameters pj ; in a single iteration
step the program varies several of these parameters simultaneously and the fitting is made
by means of a multi-dimensional parabola, where the number of dimensions depends on
the number of parameters changed. Usually Letagrop changes the values of a chosen set of
formation constants, and the values of the related enthalpies, alternately. The minimization
process ends when an established convergence criterion is finally reached.
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